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1. TAUOPHATIES 
 
Tauopathies are clinically, morphologically and biochemically heterogeneous 
neurodegenerative diseases characterized by the deposition of abnormal Tau 
protein in the brain. The neuropathological phenotypes are distinguished based 
on the involvement of different anatomical areas, cell types and presence of 
distinct isoforms of Tau in the pathological deposits. Neuropathological 
phenotypes comprise Pick’s disease (PID), progressive supranuclear palsy (PSP), 
corticobasal degeneration (CBD), neurofibrillary tangle-only dementia (NFT-
dementia) and a recently characterized entity called Globular Glial Tauophaty 
(GGT). Mutations in the encoding gene of the microtubule-associated protein 
Tau (MAPT) are associated with frontotemporal dementia (FTD) and 
Parkinsonism linked to chromosome 17 (FTDP-17). Several neurodegenerative 
conditions with diverse etiologies may be associated with Tau pathology defined 
as secondary tauopathies, as other proteins play a central role in their 
pathogenesis. Alzheimer’s disease (AD) is one major neurodegenerative disorder 
showing neuronal Tau pathology and it defined as a primary tauophaty (table 1). 
 
 
Table 1: Diseases with Tau-based neurofibrillary pathology 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alzheimer’s disease (AD) 
Frontotemporal dementia (FTD) 
Amyotrophic lateral sclerosis/parkinsonism–dementia complexa (SLA) 
Argyrophilic grain dementiaa (AGD) 
Corticobasal degenerationa (CBD) 
Creutzfeldt-Jakob disease (CJD) 
Diffuse neurofibrillary tangles with calcificationa 
Down’s syndrome 
Frontotemporal dementia with Parkinsonism linked to chromosome 17a (FTDP-17) 
Gerstmann-Sträussler-Scheinker disease 
Hallervorden-Spatz disease 
Myotonic dystrophy 
Niemann-Pick disease, type C  
Non-Guamanian motor neuron disease with neurofibrillary tangles 
Pick’s diseasea (PID) 
Postencephalitic Parkinsonism 
Prion protein cerebral amyloid angiopathy 
Progressive subcortical gliosisa 
Progressive supranuclear palsya (PSP) 
Subacute sclerosing panencephalitis 
Tangle only dementiaa (NFT-dementia) 
Globular glial tauopathy (GGT) 
aDiseases in which tau-positive neurofibrillary pathology is the most predominant neuropathological 
feature. 
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Arnold Pick provided the first clinical description of frontotemporal dementia in 
1892 [1]. In 1911, Alois Alzheimer described the neuropathological lesions 
characteristic of Pick’s disease [2]. In the 1960s, these so-called Pick bodies were 
shown to contain abnormal filaments [3], which are now known to be made of 
hyperphosphorylated microtubule-associated protein Tau [4-5]. 
They resemble the neurofibrillary lesions described by Alzheimer in 1907 in the 
disease subsequently named after him [6-7]. The Alzheimer’s disease, being the 
major neurodegenerative disorder showing neuronal Tau pathology, is the most 
studied tauophaty in the literature. For this reason, it will often be used in this 
work as a reference. Therefore, we decide to describe briefly the major 
characteristics of Alzheimer’s disease and, subsequently, the exact pathology that 
affects the animal model used in our study (Frontotemporal dementia or FTD). 
Alzheimer's disease (AD) is a progressive neurodegenerative disease that leads to 
dementia and affects about 10% of the population over 65 years of age [8]. 
Memory loss is the first symptom of cognitive impairment, followed by aphasia, 
agnosia, apraxia and behavioral disorders.  
The two main types of brain lesions seen in patients with AD are senile plaques 
of β amyloid and neurofibrillary tangles of hyperphosphorylated Tau (NFTs), a 
typical hallmark of tauopathies. 
The NFTs are abnormal aggregation of hyperphosphorylated Tau [9] located in 
pyramidal cells of the hippocampus and in the entorinal cortex; they have been 
identified in many cortical and subcortical areas, such as the basal nucleus of 
Meynert, the amygdala, the locus coeruleus and the dorsal raphe [10]. The 
presence of β amyloid plaques and NTFs in specific regions of the cerebral 
cortex is needed to establish the definitive diagnosis of AD [11].  
In fact, immunohistochemical studies of post-mortem brains showed a strong 
correlation between NFTs and Tau, indicating that Tau is a reliable indicator of 
the process of degeneration.  
These analyses have shown that the detection of pathological Tau is present in 
all brain areas studied, with the exception of regions like the primary motor 
cortex and visual cortex (Brodmann areas 4 and 17 respectively). The 
quantification of hyperphosphorylated Tau is increased in the associative cortex 
than the primary sensory cortex, with highest levels in neocortical and limbic 
temporal areas [12]. 
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1.1  Frontotemporal  Dement ia (FTD) 
 
Most forms of tauophaty may be associated with clinical features of 
frontotemporal dementia (FTD) including progressive aphasia.  
Frontotemporal dementia is the third cause of global neurodegeneration after 
AD; it has an incidence of 5-15 cases per 100000 in age group between 45 and 
65 years. Affected individuals exhibit a course of slowly progressive disease that 
leads in most cases to death within about six years from diagnosis [13]. 
Clinically it is characterized by several behavioral changes, disorders of language 
and cognitive impairment that appear later [14]. Many cases are sporadic, but 20-
30% are familiar [15-16]. The main pathologic feature of FTD is the atrophy of 
frontotemporal cortex with neuronal loss, gliosis and spongiosis of the 
superficial layers.  
The involvement of medial temporal lobe structures such as the entorhinal 
cortex, the hippocampus and the amygdala is highly variable, while is common 
the degeneration of substantia nigra and basal ganglia. The cases of FTD are 
pathologically heterogeneous and can be divided into three main subgroups 
based on the type of protein inclusions in the brain: FTD with Tau-positive 
inclusions, inclusions FTD with ubiquitin-positive, Tau-negative FTD without 
distinctive histopathology [17]. 
Pick's disease is the term reserved for cases of FTD with intra-neuronal 
argirophilic inclusions, calls bodies Pick, composed of abnormal Tau. The Pick 
bodies are present in 10-30% of cases of sporadic FTD [18]. 
About 30% of cases of familiar FTD is caused by mutations of MAPT gene and 
characterized by Tau pathology [15]; until today have been identified 71 
mutations of MAPT gene including 44 with pathogenetic effect clear, 1 with 
unclear effect and 16 non-pathogenic effect.  
The pathogenic mutations can be grouped based on their position in the gene, 
defining their effects on mRNA and on the protein, as well as the resulting 
pathology.  
Most of the mutations falls in the coding region and includes missense 
mutations, silent mutations and deletions. Most of the mutations of the coding 
region are located in the region of binding to microtubules (exon 9-12) or close 
to it (exon 13), but there are also two mutations in exon 1. Mutations that fall in 
exon 10 concern only the isoforms with four repeats, while the other all six 
isoforms (Fig.1). 
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Figure 1: Schematic representation of mutations in the Tau gene identified in frontotemporal 
dementia and Parkinsonism linked to chromosome 17. The longest human brain Tau isoform is 
shown with known coding region mutations indicated above. The gray boxes near the amino terminus 
represent the alternatively spliced inserts encoded by exons E2 and E3, whereas the black boxes 
represent each of the four microtubule (MT) binding repeats (not drawn to scale). The second MT 
binding repeat is encoded by E10. Part of the mRNA sequence encoding E10 and the intron following 
E10 is shown. Mutations in E10 and the downstream intron are indicated. Intronic nucleotides that are 
part of intron 10 are shown in lower case. 
 
The clinical presentation is related to the type and location of mutations in 
MAPT. In addition, there is a high variability inter and intra-family for some 
mutations. The age of onset for P301L and other mutations is between 45 and 
65 years, although there are cases of later onset (65-70 years) or, for some 
mutations intronic, more early (about 40 years) [19]. 
Clinical symptoms can develop at first, between 20 and 30 years in patients with 
P301S mutation, L315R, G335V and G335S [20-21], or between 30 and 44 years 
in patients with mutations L266V and N279K [22]. In cases with R5H and 
I260V mutations occurred late onset after 70 years. 
The average duration of the disease is between 8 and 10 years with the exception 
of the R406W mutation characterized by a slow rate of progression of the 
disease that lasts up to 25 years [23]. Patients with early age of onset often show 
a more aggressive progression of the disease, leading to death within 5 years [24]. 
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1.2  Tau Prote in 
Tau is a microtubule-associated protein involved in microtubule assembly-
stabilization and axonal transport [25-26]. It is encoded by MAPT (Microtubule-
Associated Protein Tau) gene, located on the long arm of chromosome 17 
(17q21) [27], it extends for approximately 100 kb and contains 16 exons. Three 
(4A, 6 and 8) of the 16 exons of the primary transcript are not present in mRNA 
brain. The exon 1 is part of the promoter; it is transcribed, but not translated, as 
well as exon 14. Exons 2, 3 and 10 undergo alternative splicing, giving rise to six 
different isoforms [28-29]. 
These isoforms differ for the presence or absence of 29 or 58 amino acid inserts 
in the amino-terminal half and the presence of three or four tandem repeats in 
the carboxyl-terminal region of the protein (Fig. 2).  
 
 
 
 
Figure 2: Human brain Tau Isoforms. The gene encoding Tau (also known as MAPT) is a multi-
exon gene that undergoes alternative post-transcriptional splicing of exons 2 (shown in blue), 3 (shown 
in yellow) and 10 (shown in green) to yield 6 isoforms in the brain. The exons shown in dark grey are 
not found in translated human Tau. Exons 9–12 encode microtubule-binding repeat domains, and the 
exclusion or inclusion of exon 10 results in Tau with three (3R) or four (4R) microtubule -binding 
domains, respectively (shown as orange bars). 
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In adult human brain, similar levels of 3R and 4R Tau isoforms are found 
whereas in fetal brain, only the shortest Tau isoform with 3R is present, 
demonstrating developmental regulation of Tau expression. Differently from 
humans only 4R Tau isoforms are expressed in adult rodent brain [30]. Tau 
repeats constitute the microtubule-binding domain of the protein and the 
alternatively spliced fourth repeat is encoded by exon 10.  
Tau is a phosphoprotein expressed constitutively and abundantly both in the 
nervous central system (CNS) and in the peripheral nervous system (PNS).  
In the CNS, Tau is expressed mainly in neurons and axons in the mature state 
and in growth, even if it is present in lesser amounts in oligodendrocytes and 
astrocytes. It was, however, demonstrated the presence of the protein in non-
neural cells, such as fibroblasts and lymphocytes [31-32]. The phosphorylation 
seems to affect its distribution in cell growth, with Tau phosphorylated mainly 
present in the somatodendritic compartment while dephosphorylated in the 
distal region of the axon [33]. 
The Tau protein is involved mainly in the polymerization and stabilization of 
microtubules, thus participating in the organization and in the integrity of the 
cytoskeleton, in fact, it is able to increase the rate of polymerization of 
microtubules and inhibit the depolarization. Stabilizing them, Tau can confer 
resistance to the poisons of microtubules. 
Tau binds to microtubules in two ways: when these are assembled binds to their 
outer surface [34], whereas when it is mixed with tubulin is incorporated into 
microtubules growing as an integral structure [35].  
A neuronal Tau is involved in the polarity of neurons in axonal transport and 
neuritic in stretching. It seems that Tau and other MAP can act cooperatively to 
adjust the axonal elongation and neuronal migration, offsetting any defective role 
of the protein. 
In the non-neuronal cells, Tau induces the formation of long cytoplasmic 
extensions [36]. Tau is also able to prevent the thermal denaturation of DNA, 
renaturing improve, protect it from damage induced by free radicals, suggesting a 
function of the chaperon like protein. Tau was found to be also an inhibitor of 
histone deacetylase 6 (HDAC6) which regulates the acetylation of tubulin. It has 
been shown that Tau interacts with many other proteins, including phosphatases, 
the serine/threonine kinase, the tyrosine kinase Fyn and scaffold protein 14-3-3, 
suggesting that Tau could play a role in regulating the location and function of 
other proteins. For example, it was shown that the formation of 
oligodendrocytes involves an interaction between Tau and Fyn and the 
recruitment of Tau by Fyn activated in rafts in membrane appears to be an 
important step in myelination, suggesting an essential role of Tau for the 
maturation of oligodendrocytes. 
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1.2.1  Post-Translat ional  Modi f i cat ions 
 
Tau is a phosphoprotein predominantly expressed in neurons, where it is mainly 
localized to axons. Phosphorylation is developmentally regulated such that fetal 
Tau is more phosphorylated than adult brain Tau [37]. 
The most important post-translational modification of Tau in tauopathies is 
hyper phosphorylation, which has serious functional effects [38]. Normal Tau is 
phosphorylated on two or three residues in contrast to hyperphosphorylated Tau 
that is phosphorylated at least on eight residues, but there are further epitopes 
that may theoretically be phosphorylated [39]. Phosphorylation of Tau has an 
impact on microtubule stability and axonal transport, dendritic positioning and 
synaptic health, cell signaling at plasma membranes, protection of DNA from 
cells stressors and release of Tau; in particular, the most studied of these residues 
has been serine/threonine phosphorylation.  
Tau is a phosphoprotein with 80 putative serine or threonine phosphorylation 
sites on the longest central nervous system (CNS) Tau isoform, which contains 
441 residues. These sites have been divided into two main groups: those that can 
be modified by proline-directed kinases like Tau protein kinase I (GSK3), Tau 
protein kinase II (cdk5), MAP kinase (p38), JNK and other stress kinases or 
cdc2; and those that can be modified by non-proline directed kinases like PKA, 
PKC, CaM kinase II, MARK kinases [40-41] or CKII, which modifies residues 
close to acidic residues mainly in exon 2 and 3.Several phosphatases, such an 
protein phosphatase (PP)1, PP2A, PP2B (calcineurin) and PP2C [42-43] are able 
to dephosphorylate Tau protein.  
However, only PP1, PP2 and PP2B have been shown to dephosphorylate 
abnormally hyperphosphorylated Tau. It seems probable that PP2A is the 
phosphatase that acts on most phosphorylation sites [43-44]. PP2A binds to Tau 
through its tubulin-binding region [45]. Mutations in that region could decrease 
the capacity of PP2A to bind to Tau, and consequently produce an increase in 
Tau phosphorylation, a feature that has been observed in some FTDP-17 
patients bearing such mutations [46]. 
Further post-translational modifications of Tau include N- and C-terminal 
truncation, acetylation, glycosylation, oxidative and nitrative injuries, 
transglutamination, deamination and formation of Tau oligomers [47]. 
Phosphorylation of Tau is tightly regulated during development; it is high in fetal 
neurons (which contain only 3R Tau) and decreases with age due to the presence 
of adult isoforms and modification of the relationship between kinase and 
phosphatase, for activation of the phosphatase [48]. 
In addition, Tau is present in all cellular compartments, but with different 
phosphorylation states. Phosphorylation, correlated with the type of isoform, 
modulates the properties of Tau.  
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Tau is also responsible of the physical characteristics of microtubules (stiffness, 
length, and stability), organization of microtubules and modulation of neurons, 
in particular the polarity and axonal growth (Fig.3). 
 
 
Figure 3: Schematic representation of the hyper phosphorylation sites (indicated as peptidic 
sequence) of the longest Tau isoform (2131101), and corresponding specific antibodies. 
Hyperphosphorylated sites are grouped in two clusters located on both sides of the microtubules 
binding domain, with the exception of Ser262/ Ser356. Phosphorylation-dependent antibodies (in 
italics) have been developed for each sites. AD-specific sites and corresponding antibodies are circled. 
Tau1 recognizes the dephosphorylated 189–207 amino acid sequence.  
 
1.2.2 Pathogenet i c  Role  o f  Tau 
 
Although it was no clear the cause-effect relationship between errors in the 
MAPT gene and neuronal death and dementia, the molecular basis underlying 
the pathogenetic mechanisms of tauophaty are not yet known. It is known that 
changes in the amount or conformation of Tau can lead to the formation of 
hyperphosphorylated Tau and/or aggregate into insoluble tangles as was 
observed in Alzheimer's disease (AD), the most common tauophaty.  
In the nerve cells affected are witnessing the shift of Tau from the axonal 
compartment that somatodendritic where it accumulates in the "pre-tangles", 
aggregated filamentous double helix (PHFs, Paired Helical Filaments) that 
eventually assembled in neurofibrillary tangles (NFT, neurofibrillary tangles) 
leading to neurodegeneration. There are several mechanisms that could lead to 
the pathogenic effect of the protein Tau (Fig.4). 
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Figure 4: Model of disease pathways in Tauopathies. Model of disease pathways in tauopathies. 
Mutations and/or polymorphisms in the Tau gene in conjunction with environmental and additional 
genetic factors initiate pathogenic processes that cause regional and cell type–specific Tau pathology 
and neurodegeneration, thus leading to specific clinic pathologic phenotypes. PID, Pick’s disease; 
CBD, corticobasal degeneration; PSP, progressive supranuclear palsy; FTDP-17, frontotemporal 
dementia and Parkinsonism linked to chromosome 17. 
 
• Aggregation of Tau: the protein accumulates inside the cell and then 
associates to microtubules, making filaments enriched in β-sheet 
structures. Upon reaching the critical concentration, the monomers of 
Tau unfolded become by conformational changes oligomers, who will 
associate in neurofibrillary tangles, until the complete loss of cell viability 
and formation of "ghost tangles “fibrillar aggregates extra-cellular. 
• Increase of Tau: the activity of the protein is in a range that must be 
controlled by homeostatic mechanisms, in order to ensure the neuronal 
survival. An increase of the protein could inhibit the transport of vesicles, 
neurofilaments and organelles in neurons [49] and, consequently, impair 
the axonal transport mediated by microtubules. Alterations in the amount 
or structure of Tau may also compromise its role in the stabilization of 
the microtubules, which in turn can affect the localization and 
organization other subcellular structures such as mitochondria or 
lysosomes. 
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The mechanisms for which the increased expression of 4R Tau involves 
neurodegeneration have not yet been identified, but it has been 
hypothesized that this increase in saturated sites binding to microtubules, 
and that the remaining Tau 4R soluble in excess is more susceptible to the 
phosphorylation and aggregation into insoluble filaments [50]. 
• Toxicity of Tau: the toxicity of Tau neurons was also correlated with 
conformational changes of protein, which could lead to the aggregation of 
the truncated protein, even if this hypothesis needs confirmation, from 
the moment that the human neurons can live for decades, while limiting 
the tangles neurofibrillary tangles [51]. Phospholipids, including 
arachidonic acid, are capable of inducing changes conformational protein 
that may facilitate the phosphorylation and increase the formation of 
filaments rights. The conformational changes may also make the filaments 
resistant to proteolysis, since the potential binding sites of the protease are 
hidden inside of the filaments becoming inaccessible, so that they can 
accumulate. The Tau protein isolated from the tangles, neurofibrillary 
tangles, is extensively modified at the post-transcriptional level by 
phosphorylation, glycation, racemization, and ubiquitination. Some of the 
modifications, such as phosphorylation, truncation and glycosylation, 
seem to occur at the early stage of tauophaty, while ubiquitination and 
glycation to be late events in the neurodegeneration. In any case, the 
hyperphosphorylation seems to be the modification more involved in the 
pathogenicity of the protein. 
• Hyperphosphorylation of Tau: the hyperphosphorylation of Tau is not 
only associated with diseases, but is also used by the neuron to decrease 
transiently and reversibly its activity, as occurs during development. It is the 
state not reversible of abnormal hyper phosphorylation of Tau in tauophaty 
that involves an involuntary slowing of neuronal activity and the resulting 
chronic progressive neurodegeneration accompanied by the clinical 
phenotype of dementia [38]. The hyperphosphorylated Tau is prone to form 
aggregates, which can block the traffic intracellular neurotrophic protein and 
other functional proteins, giving as result in the loss or decline of transport 
axonal or dendritic arborisation in neurons [52]. The hyper phosphorylation 
of Tau induced by phosphatase inhibitors leads the aggregation and 
impairment of the biological activities. The pseudo phosphorylation Tau 
(PHP Tau), in which the residues of the serine/threonine are replaced with 
glutamate, which mimics the structural and functional aspects of the Tau 
hyperphosphorylated exhibiting, for example, a reduced interaction with the 
microtubules and failing in their stabilization. 
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1.3 Tauopathies  and Mouse Models  
 
Experimental and TG animal models of tauopathies have been developed as 
informative system for elucidating the role of abnormalities in Tau in the onset 
and progression of a variety of neurodegenerative disorders. In addition, they 
may be useful models for the development and testing of novel therapies.  
Some models detailed below ablate the mouse Tau gene and thus the mice 
produce only human Tau, while others insert the human Tau gene but leave the 
endogenous murine gene intact. Thus, these model systems differ with respect to 
the presence of different ratios of mouse and human Tau isoforms, which 
complicates interpretation of findings in each of them. Many models also have 
cloned Tau transgenes that produce solely one isoform, which can further 
complicate comparisons between model systems. In addition to the splicing ratio 
difference, the N-terminal domain of the mouse Tau includes 14-amino-acid 
differences when compared to the human Tau. 
The first transgenic mouse model for Tau expressing the isoform of the human 
wild-type longer (2N4R) under the control of the promoter of the human 
neuron-specific Thy1.  
It was observed the formation of pre-tangles, the hyper phosphorylation of the 
Tau, but no neuropathological lesions. Another mouse model expressed the 
shortest human brain isoform of Tau, but it was found no NFTs in animals up 
to 19 months of age, attributing these findings to a pre-tangle stage of 
neurofibrillary pathology. 
In this TG mouse model the human transgenic Tau remained abundant in cell 
bodies and dendrites of a subset of neurons in the adult, while the endogenous 
murine Tau gradually decreased during development [53]. The replacement of 
the human promoter with the murine (Thy1.2) has led to the appearance of 
axonal degeneration, but not neurofibrillary tangles or cognitive and locomotive 
impairment [54]. 
An increase of the expression of the transgene was achieved thanks to the use of 
the murine promoter PrP, which has allowed an increase of the expression of the 
Tau protein is about 10 times with the formation of inclusions similar to the 
NFTs in cortical neurons and in the brainstem, that are related to the 
degeneration and reduction of the axonal transport, gliosis, and weakness. 
Subsequently, a model has been created (JNPL3), which expressed the protein 
Tau changed P301L and that, for the first time, reproduced the formation and 
aggregation of the tangles neurofibrillary tangles in the brainstem, the 
diencephalon, but especially in the spinal cord, with a loss of about 50% of the 
neurons, and the resulting motor dysfunction [55-56]. 
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The animals showed, in addition, gliosis, axonal degeneration and behavioral 
deficits. This is still the model the most used for the study of the mechanisms 
associated with Tau pathology. 
In a very interesting study was used this model with a vector inducible, which 
gave the possibility of suppressing the expression of P301L transgene with the 
addition of doxycycline. The suppression of the transgene led to a recovery of 
functions in memory, and to a stabilization of the number of neurons, despite 
the continuing build-up of tangles neurofibrillary tangles. 
This suggests that both the soluble Tau to be neurotoxic and not the NFTs, that 
alone is not sufficient to cause cognitive decline and neuronal death. 
The neuronal loss is greater in mice that express the P301S mutation compared 
the P301L, in agreement with the early onset of the disease in patients with this 
mutation [57]. Filaments were also found in mice transgenic mice expressing the 
R406W mutations [58], and V337M [59]. 
A recent study has led to the emergence of a new and interesting aspect of Tau: 
his transmission, secretion, and diffusion. In fact, the extract brain-derived 
P301S mice and injected into mice ALZ17 (which express the Tau WT and that, 
consequently, do not develop NFT) induces the formation of NFT that do not 
remain confined to only the site of the injection.  
Therefore, it seems that there is induction of the pathology, which would be 
responsible for the insoluble Tau. The theory is supported by a similar study that 
shows how the aggregated Tau can transmit the status fibril/not correctly folded 
from the outside to the inside of cells, in a manner similar to the prion. 
Patients with FTD show the presence of Tau inclusions in oligodendrocytes that 
in astrocytes. For this reason, some studies have tried to reproduce this 
characteristic in vivo through the expression of human Tau P301L and WT 
under the control of the promoters of the 2',3'-cyclic nucleotide 3'-
phosphodiesterase [60] and protein of glial fibrillary acidic (GFAP) respectively 
[61]. Both lines exhibit neuronal dysfunction and degeneration axonal, showing 
that the glial pathology also affects the neurons. 
In our study, we decided to use the model discovered by Lewis (P301L TG 
mice) in order to investigate the cognitive impairment and behavioral deficits 
associated to tauophaty.  
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Table 2: transgenic mouse models 
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1.4 Tauopathies  and Oxidat ive  Stress  
 
Oxidative stress is a pathological condition caused by the rupture of the 
physiological equilibrium in a living organism between the production and the 
elimination, on the part of the antioxidant defense systems, of oxidant chemical 
species. In all aerobic organisms, there is a delicate balance, said oxidation-
reduction, including the production of oxidants, such as reactive oxygen species 
(ROS), and the antioxidant defense system, which has the duty to prevent 
and/or repair any damage caused. 
Possible disturbances in this normal state red-ox may have toxic effects for the 
production of free radicals and reactive oxygen and nitrogen species, which 
damage all cell components, including proteins, lipids and DNA. The reactive 
species and free radicals play important physiological roles, such as the defense 
against bacteria, the transmission of biochemical signals between cells, the blood 
pressure control etc. 
It is only their excess, generally refers to one or more classes of oxidants, to be 
involved in oxidative stress, today considered associated with more than a 
hundred human diseases (such as retrolental fibroplasia, atherosclerosis, 
hypertension, Parkinson's disease, Alzheimer's, diabetes mellitus, colitis, 
rheumatoid arthritis, etc.), and it may also be important in the aging process [62-
63]. 
ROS and other reactive species are continuously produced by the organism 
through numerous biochemical processes [64]. Certain amount of oxidizing 
substances is in fact indispensable to maintain the proper functioning cellular 
mechanisms regulating its homeostasis. During the reactions of oxygen 
reduction, however, the reactive species generated can exceed the physiological 
threshold. If these molecules are not neutralized by antioxidants systems, can be 
established damage within the cell, capable of conducting the same apoptosis. 
Therefore, if it generates an imbalance between the production of ROS and the 
effectiveness of the system antioxidant defense, it establishes a condition of 
oxidative stress, as shown in Figure 5. 
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Figure 5: Modification of the normal balance between ROS and antioxidants 
 
The central nervous system is an organ particularly vulnerable to oxidative 
damage: it is rich in fatty acids easily peroxidable (20: 4; 22: 6); is responsible for 
about 20% of the total consumption of oxygen despite its weight is equal to 2% 
of total body weight; possesses poor antioxidant systems (catalase activity 
present in the encephalon is about 10% of the liver) and otherwise has a high 
content of iron and ascorbate ions which form powerful pro-oxidant 
compounds for cell membranes. 
Among the many neurological diseases in which oxidative stress may be 
involved, the neurodegenerative diseases play a major role because they share 
certain characteristics that predispose to oxidative stress and enhance it by 
triggering cascade mechanisms.  
These characteristics are:  
• neuroinflammation: activated microglia release nitric oxide, which in the 
presence of reactive oxygen species form peroxynitrite and other products 
nitrosylation; 
• protein misfolding; 
• the altered homeostasis of metal ions (Zn, Iron, Copper ..); 
• altered mitochondrial function. 
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There are many studies showing that levels of oxidative stress markers in tissues 
increases during the progression of the disease and that there is evidence 
documented by immunocytochemistry autopsies of oxidative damage to bio 
macromolecules in brain regions affected by the disease.  
The central issue is whether oxidative stress is a consequence of the degenerative 
process started by some other factor, such as genetic, or by itself as an early 
event that contributes fully to the etiology of the disease. Oxidative damage is 
the most common cause of cell death, and is one of the first event in patients 
with AD.  
It has been reported that the oxidative damage decreases with the progression of 
the disease and the formation of tangles, neurofibrillary tangles [65], and it has 
been proposed that the presence of tangles neurofibrillary tangles in AD protect 
the cellular components crucial from the attack of reactive species oxygen 
(ROS).  
These results indicate that the formation of tangles, neurofibrillary tangles, may 
represent a compensatory response to reduce the damage associated with ROS. 
In fact, the phosphorylation of Tau, the most regulated during oxidative stress 
[66], and Tau is modified by the products of oxidative stress, including the 4-
hydroxy-2-nonenal (HNE) [67-68]. 
The aggregation of Tau is also facilitated by oxidative adducts, although other 
studies have shown that some of the oxidants lead to the reduction of the 
phosphorylation of Tau. Therefore, it appears that, depending on the specific 
oxidants, you may induce either an increase or a decrease in the phosphorylation 
of Tau. 
Most of the researches about unemployment insurance are focused on the 
mechanism of oxidative stress and its importance in the pathogenesis of the 
disease. Multiple lines of evidence suggest that oxidative stress and free radical 
damage is implicated in the pathogenesis and etiology of AD. The first evidence 
to support the hypothesis of oxidative stress in AD is based on the discovery 
that metals are responsible for most of the production of free radicals. The 
chemical elements of most interest in AD are iron (Fe), aluminum (Al), mercury 
(Hg), copper (Cu) and zinc (Zn). The Fe is involved in the formation of the 
hydroxyl radical, which has deleterious effects as described by the Fenton 
reaction and the Haber-Weiss [69]. 
Several studies have shown alteration in the metabolism of Fe in brain of AD 
patients [69]. By techniques of histochemistry, it was found increased levels of 
Fe in the cerebral cortex of subjects suffering from the disease; in particular, it 
has been observed that the distribution of the Fe reflects the distribution of 
NFTs and amiloid plaques, the two key elements of the AD.  
Iron, ferritin and transferrin were found in SP of AD patients and ferritin is 
present in microglia in association with amiloid plaques in AD.  
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A study by Kennard and collaborators, in 1996, showed, in AD patients, a high 
concentration in the cerebrospinal fluid and plasma protein p97, a protein 
binding of Fe, which could be a marker of the disease. 
The possibility of the involvement of Cu in AD is supported by the fact that the 
ion can act as a catalyst in the production of ROS, and was put in evidence that 
APP molecules contain binding sites for the Cu.  
The APP reduces Cu2+ to Cu+ and this could increase the production of OH -
which, in turn, lead to neuronal damage.  
In fact, this metal is essential in the activity of many enzymes including 
cytochrome c oxidase (COX) and superoxide dismutase copper / zinc (Cu / Zn 
SOD). Recent studies show low concentrations of Cu in five regions of the brain 
of AD patients, particularly at the level of the hippocampus and amygdala [69]. 
The last metal cited as a possible factor of the development of AD is Zn, which 
induces rapid staining of amyloid plaques in humans, but not in rats.  
The APP binds Zn2+ and this binding modulates the functional properties of the 
secretases (eg. β inhibits the cutting of APP by β-secretase). 
Very important is the effect it has on the ROS membrane phospholipids; 
alterations in these structures may be specific for the pathogenesis of the disease.  
It has been shown that lipid peroxidation is the major cause of the depletion of 
membrane lipids in AD. One of the products of lipid peroxidation, HNE has 
been found in high concentrations in AD patients, it is found to be toxic in cells 
of the hippocampus in culture. 
Regarding protein oxidation, it was found that there are differences in the levels 
of oxidized proteins in the brain tissue of AD patients when compared with 
normal elderly controls [70]. 
In conclusion, the oxidative stress and its responses can:  
1- activate pro- inflammatory networks that exacerbate organelle dysfunction 
and pro-apoptosis mechanisms;  
2- stimulate APP gene expression and β-APP cleavage, resulting in increased 
formation of APP-Aβ neurotoxic fibrils;  
3- activate or dis-inhibit GSK-3β, which promotes Tau phosphorylation. 
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1.5  Tauopathies ,  Oxidat ive  Stress  and Dietary intervent ions 
 
Recent studies suggest that physical exercise and diets low in calories and ‘bad’ 
fats (cholesterol and saturated fats) [71-72-73] and high in “good” fats 
(polyunsaturated fatty acids from fish oil) may reduce the risk of AD and 
neurodegenerative diseases [75-75]. 
Because the underlying pathologies may start years before the cognitive and 
behavioral impairments are clinically evident, application of the knowledge on 
preventive nutritional strategies warrants early identification of the disease to be 
able to intervene and delay, or even prevent its onset. 
Although epidemiological studies sometimes report conflicting results, specific 
associations between nutritional components and the risk for AD have been 
found. These include the potential protective effects of specific polyunsaturated 
fats, B-vitamins and antioxidants [76]. 
These macro- and micronutrients are dietary components that can influence 
brain structure and function [77-78]. 
Nutritional intake may provide specific nutrients that can be used as building 
blocks for membrane and synapse formation and neurotransmitter production 
but can also directly influence the availability of nutrients, energy and oxygen to 
the brain.  
The neuronal loss and Tau protein pathology in the AD brain, as well as possible 
dysfunction of the cerebrovascular system and energy metabolism, may act 
together to accelerate the downhill cascade in cognitive and behavioral function. 
The potential of nutrition for neuronal maintenance rather than as an energy 
substrate is illustrated by the increasing evidence that nutrients not only stimulate 
neural plasticity, but also ameliorate the ongoing neurodegenerative process and 
show the ability to reduce the pathological burden in the brain. Additional 
mechanisms by which high fat/energy diets impair cognitive function are 
beginning to be elucidated and involve adverse effects on synaptic plasticity and 
neurogenesis (Fig. 6). The central nervous system (CNS) is particularly 
vulnerable to damage from free radicals for various reasons that include a limited 
effectiveness of the system antioxidant and a high consumption of oxygen to 
produce energy. Furthermore, the brain tissue, when compared with other 
tissues, presents abundant lipid content, particularly polyunsaturated fatty acids 
(PUFAs) which are highly susceptible to lipid peroxidation process [79-80]. 
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Figure 6: Mechanisms by which excessive energy intake and low levels of energy expenditure 
adversely affect synaptic plasticity and cognitive function. 
 
PUFAs are involved not only as structural constituents of the membrane lipids 
of neuronal cells, but also for their neuro-protective, anti-oxidants and anti-
inflammatory effects. The long-chain polyunsaturated fatty acids exist of two key 
families: omega-3 and omega-6; high total fat intake, in particular that of omega-
6 saturated fatty acids are associated with poor cognitive performance and 
present a risk factor for AD [81-82]. 
The brain is extremely rich in PUFAs, particularly omega-3 fatty acids, and on 
average 1 out of every three fatty acids is a PUFA of dietary origin. A higher 
ratio of omega-6 to -3 PUFA is also associated with decreased insulin sensitivity 
and Diabetes Mellitus Type II. One mechanism linking the intake of high total 
fat and saturated fat intake to cognitive impairment and dementia may be 
through the development of insulin resistance [83]. Insulin resistance leads to 
deficiencies in energy metabolism and increased oxidative stress [83-84-85]. Very 
high levels of fatty acids and lipids can be found in the neuronal membrane and 
the myelin sheath; particularly the omega-3 fatty acids, eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA), are incorporated into neuronal 
phospholipids (mostly phosphatidyl ethanolamine and phosphatidyl serine) [86]. 
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Incorporation of omega-3 fatty acids in the neuronal membrane increases 
fluidity of neuronal membranes and herewith improves neurotransmission and 
signaling via increased receptor binding and enhancement of the number and 
affinity of receptors and function of ion channels. 
Omega-3 fatty acids increase membrane fluidity by replacing omega-6 fatty acids 
and cholesterol from the membrane [87] maintaining an optimal membrane 
fluidity as obligatory for neurotransmitter binding and signaling within the cell. 
Large amounts of DHA are necessary during brain development, for neural 
membrane production used for synaptogenesis, axonal and dendritic outgrowth, 
in both brain and retina [88]. A decreased level of plasma DHA is associated 
with cognitive impairment with aging [89-90] and does not seem to be limited to 
AD patients. 
There are several possible reasons for this decline: a decrease in the ability of 
dietary fatty acids to cross the blood brain barrier due to impaired transport 
function in aging, or lipid peroxidation caused by enhanced free radicals [91], 
decreased dietary intake or impaired liver docosahexaenoic acid shuttling to the 
brain. The deficiency affected mostly the cortex and hippocampus, areas that 
mediate learning and memory. DHA is able to shift cholesterol from the 
neuronal membrane increasing membrane fluidity, but an increase in membrane 
cholesterol due to the age or a hypercholesterolemic diet can may contribute to 
loss of neuronal functionality. 
In addition, it has been shown that one of the types of toxicity at the level of the 
nervous structures rich in polyunsaturated lipids resulting from hydroxynonenal 
(HNE), product of lipid peroxidation that form adducts with glutathione and 
proteins. There is a strong correlation between nutrition and oxidative stress, 
being oxidative stress the result of an uncontrolled production of ROS or RNS 
that alters the structure of lipids, proteins and nucleic acids.  
Particular attention is paid to the role of proteins as the reactive species oxygen 
can interact with amino acid residues, in particular histidine, arginine and lysine, 
forming carbonyl functions. Some researchers have found that brain levels of 
these compounds increase with aging without, however, note a significant 
difference between the tissues from elderly subjects and tissues of AD patients. 
Subsequent studies, however, would indicate a greater presence of carbonyl 
proteins in hippocampus and in the inferior parietal lobule of the brain of AD 
patients [92]. Excessive glycol-oxidation of proteins could be an early event of 
cell neurodegeneration. The monosaccharides can induce an irreversible 
modification of proteins by two distinct mechanisms: the first is the formation 
of free radicals in the presence of transition metals, and this may give rise to 
reactive carbonyl groups, the second includes the involvement of a non-
enzymatic glycation which results in the formation of stable compounds known 
as final compounds of glycation or AGE [92]. 
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In neurodegenerative diseases a diet with a high protein content not only causes 
damage in the brain (as previously described), but also in peripheral organs such 
as the liver. Since the ROS free radicals implicated in oxidative stress, since 
mitochondria are a major source of ROS, an increased supply of protein can 
cause an increase in the production of mitochondrial ROS and can trigger 
oxidative stress in the liver. While ROS are able to cause cell death through a 
massive lipidic peroxidation which destroys the cell membranes [93-94], mostly 
they are implicated in the modulation of signal transduction pathways, 
influencing enzymes sensitive to the redox potential, organelles such as 
mitochondria, and transcription factors, thereby regulating or inducing cell death 
by apoptosis and necrosis.  
Thus oxidative stress generated by ROS can activate the way of c-Jun-N-terminal 
kinase (JNK) and caspases to trigger apoptosis. It is therefore evident the 
importance of a correct nutritional intake in neurodegenerative diseases, 
balancing in particular the content of fatty acids and proteins to try to prevent or 
reduce the incidence of pathologies, both at the central level both at the 
peripheral level. 
The importance of nutrition is also supported by animal studies in which 
cognition stimulating environments, exercise and caloric restricted diets inhibit 
neurodegeneration, enhance neurogenesis and improve cognition and 
furthermore, the intake of high cholesterol diets influence AD pathology and 
cognition in animal models [95- 96]. 
 
1.6 Diets  o f  Laboratory Animals  (mouse)  
 
A laboratory animal's nutritional status influences its ability to reach its genetic 
potential for growth, reproduction, and longevity and to respond to pathogens 
and other environmental stresses. A nutritionally balanced diet is important both 
for the welfare of laboratory animals and to ensure that experimental results are 
not biased by unintended nutritional factors. 
Laboratory animals require about 50 nutrients in appropriate dietary 
concentrations; feed palatability and intake, nutrient absorption and utilization, 
and excretion can be affected by physicochemical characteristics of feeds such as 
physical form, sensory properties, naturally occurring refractory or not nutritive 
compounds, chemical contaminants, and conditions of storage.  
Laboratory animals most commonly used are: mouse, rat, hamster, guinea pig, 
gerbil and vole; we decide to describe the model used in this study: the mouse 
model. The nutrient requirements of mice (table 3) have been defined by several 
different criteria including growth, reproduction, longevity, nutrient storage, and 
enzyme activity, gross or histological appearance of tissue lesions. 
Chapter 1 
 
 
32 
 
Traditionally, rapid growth leading to maximum body size at maturity has been 
the basis for measuring dietary adequacy on the assumption that a diet 
promoting maximum growth would be adequate for reproduction, lactation, and 
maintenance. 
 
Table 3: Estimated Nutrient Requirements of Mice 
 
 
NOTE: Nutrient requirements are expressed on an as-fed basis for diets containing 10% moisture and 
3.8 to 4.1 kcal ME/g (16–17 kJ ME/g) and should be adjusted for diets of differing moisture and 
energy concentrations. Unless otherwise specified, the listed nutrient concentrations represent minimal 
requirements and do not include a margin of safety. Higher concentrations for many nutrients may be 
warranted in natural-ingredient diets. 
a Equivalent to 2,400 IU/kg of diet. 
b Equivalent to 1,000 IU/kg of diet. 
c Equivalent to 32 IU/kg. 
 
Diet formulation is the process of selecting the kinds and amounts of ingredients 
(including vitamin and mineral supplements) to be used in the production of a 
diet containing planned concentrations of nutrients. Choice of ingredients will be 
influenced by the species to be fed and the experimental or production 
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objectives. Various types of diets are available for use with laboratory animals. 
Selection of the most appropriate type will depend on the amount of control 
required over nutrient composition, the need to add test substances, potential 
effects of feed microbes, diet acceptance by the animals, and cost.  
It is common to classify diets for laboratory animals according to the degree of 
refinement of the ingredients. 
• Natural-Ingredient Diets: diets formulated with agricultural products 
and by-products such as whole grains (e.g., ground corn, ground wheat), 
mill by- products (e.g., wheat bran, wheat middlings, corn gluten meal), 
high protein meals (e.g., soybean meal, fishmeal), mined or processed 
mineral sources (e.g., ground limestone, bone meal), and other livestock 
feed ingredients (e.g., dried molasses, alfalfa meal) are often called natural-
ingredient diets. 
• Purified Diets: Diets that are formulated with a more refined and 
restricted set of ingredients are designated purified diets. Only relatively 
pure and invariant ingredients should be used in these formulations (for 
examples of such ingredients are casein and soybean protein isolate as 
sources of protein). 
• Chemically Defined Diets: diets have been made with the most 
elemental ingredients available, such as individual amino acids, specific 
sugars, chemically defined triglycerides, essential fatty acids, inorganic 
salts, and vitamins. 
 
Diets for laboratory animals can be provided in different physical forms. The 
most common form in use for laboratory animals is the pelleted diet, which is 
typically formed by adding water to the mixture of ground ingredients and then 
forcing it through a die. The size and shape of the holes in the die determine 
pellet shape and rotating blades control the length; the diet is then dried to 
firmness. Extruded diets are similar to pelleted diets except the meal is forced 
through a die under pressure and at high temperature after steam has been 
injected, so the product expands as it emerges from the die.  
Diets in meal form are sometimes used because they permit incorporation of 
additives and test compounds after the diet has been manufactured. Natural-
ingredient diets for mice is the most common type of diet used in scientific 
research; it was calculated that a mouse consumes an average of 3.5 g diet/day 
during 14 days post weaning and the metabolizable energy (ME) content was 
estimated to be 3.9 kcal/g diet (16.2 kJ/g diet).  
To define the concentration of essential lipids in the diet for the needs of the 
mouse, Bossert et al. (1950) demonstrated that weanling (Dohme and Swiss-
Webster strains) mice gained weight equally well when fed diets containing 0.5 to 
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40 % fat; all diets contained 0.5 % corn oil with the remainder of the fat supplied 
by hydrogenated cottonseed oil and 0.68 percent linoleic acid.  
Typical diets fed to mice contain high concentrations of carbohydrate, although 
diets containing no carbohydrate (83 percent protein) have been shown to 
support growth rates of 0.1 g/day from 4 to 16 weeks of age in normal mice 
[97]. 
The requirement for protein to support maximal growth or reproduction 
depends on the content and digestibility of the amino acids in the diet and the 
growth and reproductive potential of the mice in question [98]. Growth rates of 
mouse strains used in research range from 0.6 to 1.2 g/day and litter size may 
vary from three to seven. The estimated requirement for a single amino acid 
depends on the amounts of other amino acids in the diet and the rate of growth. 
With the exception of D-lysine and probably D-threonine, the L-indispensable 
amino acid requirement may be met, in part, by D-amino acids.  
The concentration of amino acids in these diets exceeds the estimated 
requirement (National Research Council, 1978) by 25 to 200 %. Reports 
regarding the quantitative calcium and phosphorus requirements of mice have 
not been published; therefore, the estimated requirements for these minerals are 
based on the dietary concentrations that have resulted in acceptable performance 
in mice. Natural-ingredient diets containing 12 g Ca/kg and 8.6 g P/kg [99] also 
have been reported to support growth and reproduction in different strains of 
mice. Magnesium has been shown to be a dietary essential for mice, but the 
optimal intake for this species has not been well established.  
Sodium and chloride requirements of mice have not been studied.  
Two natural-ingredient diets containing 3.6 and 4.9 g Na/kg diet [99] and a 
purified diet containing 3.9 g Na/kg diet are known to support good growth and 
reproduction. However, the estimated requirement for sodium and chloride is 
0.5 g Na/kg diet and 0.5 g Cl/kg diet. Sorbie and Valberg (1974) reported that 
iron concentrations of 25 to 100 mg Fe/kg diet supported normal growth and 
hematopoiesis in male C57BL/6J mice, although, liver iron storage in these 
animals was low compared to mice fed natural-ingredient diets containing 
between 220 to 240 mg Fe/kg diet. The vitamin A (retinol) requirement of the 
mouse seems to be similar to the requirement of the rat; a dietary concentration 
of 2,400 IU/kg diet (2.5 µmol/kg diet; 0.72 mg/kg diet) is adequate to meet the 
requirements of the mouse. For the vitamin D, a dietary concentration of 0.025 
mg cholecalciferol/kg (0.65 µmol or 1,000 IU/kg) (American Institute of 
Nutrition, 1977) is adequate to meet the requirements of the mouse. 
The vitamin E requirement for mice is estimated to be 22 mg/kg or 32 IU/kg 
RRR - α-tocopherol/kg diet (50 µmol/kg diet) when lipids comprise less than 10 
percent of the diet; the estimated requirement of vitamin K for mice is 1 mg 
phylloquinone/kg diet (2.22 µmol/kg diet). 
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2. OBJECTIVES 
 
The aim of this study was to investigate the effects of two different diets, whose 
most important variables are constituted by the different protein and fat content 
(diet 1: 18% protein and 5% fat, diet 2: 14% protein and 3.5% fat) on survival, 
locomotor and exploratory activity and cognitive and mnemonic abilities in 
transgenic mice affected by tauophaty (P301L) and relative control mice, with 
the purpose to analyze the interaction nutrition-neurodegeneration, checking 
whether different diets can: 
- change of development of pathology;  
- change the incidence of diseases related to sex, age and overweight;  
- improve the well being of the animals. 
For this purpose, we decided to divide our work in four items, starting from the 
characterization of our transgenic mouse model, assessing then in our mouse 
model the effect of different diets, the interaction between oxidative stress, diets 
and tauophaty and finally investigating the interaction between disturbance of 
the metabolism and tauophaty. 
 
2.1 CHARACTERIZATION OF P301L TG MICE 
 
The aim of this study was investigated the interaction between gender, genotype 
and progression of neurodegenerative disease in males and females P301L TG 
mice and B6D2F1 control mice at 7 and 15 months of age, evaluating the 
growth curve of the body weight, survival rate, cognitive and locomotor 
impairment, immunohistochemical localization and deposition of 
hyperphosphorylated Tau, neuronal loss and astrogliosis in the brain. 
 
2.2 EFFECT OF DIFFERENT DIETS IN P301L TG MICE 
 
After the characterization of our mouse model, it was decided to investigate the 
effect of two different diets (high and low fat-protein diet) on the onset and 
development of neurodegenerative disease in males and females P301L TG mice 
and B6D2F1 control mice at 7 and 15 months of age, evaluating the growth 
curve of the body weight, survival rate, cognitive and locomotor impairment, 
immunohistochemical localization and deposition of hyperphosphorylated Tau, 
neuronal loss and astrogliosis in the brain. 
 
 
 
 
Chapter 2 
 
 
39 
 
2.3 INTERACTION BETWEEN OXIDATIVE STRESS, DIETS 
AND TAUOPATHY IN P301L TG MICE 
 
Since it is known in the scientific community as oxidative stress is a pathological 
condition associated with neurodegenerative diseases, it was decided to 
investigate a possible link between oxidative stress and tauophaty, considering 
how different diets administered to males and females P301L TG mice and 
B6D2F1 control mice at 7 and 15 months of age can change the oxidative 
damage. We investigated these interactions evaluating immunohistochemical 
localization and deposition of nitrotyrosine, acrolein and nitric oxide (NOS2 and 
NOS3).  
 
2.4 CORRELATION BETWEEN OXIDATIVE STRESS, DIETS 
AND TAUOPATHY IN P301L TG MICE: A CASE OF 
METABOLIC SYNDROME 
 
During necropsy analysis was detected a condition of hepatomegaly associated 
with hepatic steatosis in transgenic mice fed with a high fat-protein diet (diet 1) 
both male and female at 7 and 15 months of age. So we decided to investigate a 
possible interaction between diet, sex and disease, evaluating: macroscopy and 
histology of various tissues such as liver and spleen, the concentration of 
cholesterol, triglycerides, alanine aminotransferase and aspartate 
aminotransferase in plasma of males and females P301L TG mice and B6D2F1 
control mice at 7 and 15 months of age. 
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3. Interaction between gender and genotype in a mouse 
model of tauophaty: increase of cognitive impairment 
and locomotor dysfunctions in young and aged females 
Tau P301L mice 
 
AUTHORS: L. Buccarello1, G. Grignaschi2, A. Di Giancamillo1, C. Domeneghini1  
1Department of Health, Animal Science and Food Safety, Università degli Studi di Milano, Milan, Italy 
2Department of Animal welfare, IRCCS-Mario Negri Institute for Pharmacological Research, Milan, Italy 
 
3.1 ABSTRACT 
 
Mice expressing P301L mutant Tau mimics features of human tauopathies and 
provides a model for investigating the neuropathogenesis of diseases. We had 
investigated the interaction between gender, genotype and progression of 
neurodegenerative disease in males and females P301L TG mice and B6D2F1 
control mice at 7 and 15 months of age, evaluating the growth curve of the body 
weight, survival rate, cognitive and locomotor impairment, 
immunohistochemical localization and deposition of hyperphosphorylated Tau, 
neuronal loss and astrogliosis in the brain. 
Compared to control mice, P301L TG mice had a decreased body weight and a 
reduced survival rate, with an interaction between gender and genotype more 
pronounced in females than males in either time points. The behavioral analysis 
had revealed that in novel object recognition test P301L TG mice shown a 
cognitive impairment across the ages tested, with a further reduction of 
discriminatory activity at 15 months of age most marked in males than in 
females. In the open field test, compared to control mice, P301L TG mice had a 
reduced locomotor activity across the ages tested and a further reduction of 
exploration activity at 15 months of age. Females P301L TG mice showed a 
greater reduction in locomotor and exploratory performance than males age-
related. Immunohistochemical analysis revealed in the cortex and hippocampus 
of P301L TG mice the presence of aggregates of hyperphosphorylated Tau, 
reactive gliosis and neuronal loss age dependent. These results indicated that the 
P301L TG mice replicates the impairments found in patients affected by 
Tauophaty in a way age-gender-dependent. The finding that females were more 
affected than males suggests that more attention should be paid to sex 
differences in transgenic P301L mice for future potential treatments for 
tauopathies. 
Keywords: 
AD: Alzheimer disease, CTR: control, FTDP-17: familiar frontotemporal 
dementia, MAPT: microtubule-associated protein Tau, NFTs: neurofilaments, 
PP1: protein phosphatase 1, PP2A: protein phosphatase 2A, TG: transgenic 
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3.2 INTRODUCTION 
 
Tau aggregation is a common feature in Alzheimer’s disease (AD), 
frontotemporal dementia, and other tauopathies. The identification of Tau 
mutations has helped establish that Tau dysfunction is important to the 
neurodegenerative processes leading to dementia [1]. The most frequent human 
Tau mutation, P301L [2], results in the production of an aggregation-prone form 
of the protein. Expression of pathogenic P301L-Tau in mice results in the 
formation of Tau aggregates and neurofibrillary tangles, similar to those 
observed in AD brains; P301L-Tau was previously demonstrated to promote the 
assembly and accumulation of abnormal and insoluble Tau that triggers neuronal 
degeneration and loss [3]. 
Tauopathies are neurodegenerative disorders characterized by the accumulation 
of abnormal Tau protein leading to cognitive and/or motor dysfunction [4]. The 
progressive accumulation of Tau protein in tauopathies such as Alzheimer's 
disease (AD), progressive supranuclear palsy, corticobasal degeneration, and 
familiar frontotemporal dementia (FTDP-17) implicates Tau as one of factors in 
neurodegeneration. The discovery of mutations in the Tau gene in FTDP-17 
established that dysfunction of Tau alone causes neurodegeneration and leads to 
dementia [5-6-7]. 
Tau is a phosphoprotein and its biological activity is regulated by the degree of 
its phosphorylation, and in turn the phosphorylation rate regulates the 
interaction with tubulin and the promotion of microtubule assembly [8-9]. The 
control of Tau phosphorylation is a complex mechanism that includes the 
activity of several Ser/Thr kinases [10] and phosphatases, whose inhibition has 
been suggested as one mechanism by which Tau acquires its 
hyperphosphorylated state during the neurodegenerative process [11]. Both 
protein phosphatase 1(PP1) and protein phosphatase 2A (PP2A) associate with 
and dephosphorylate Tau with PP2A, accounting for 70% of the Tau 
phosphatase activity in the brain [12-13-14]. FTDP-17 mutations reduced the 
interaction between PP2A and Tau, suggesting another route by which these 
mutations would result in hyperphosphorylation and disease [15]. Really, 
abnormally hyperphosphorylated Tau polymerizes into straight filaments and 
paired helical filaments, which aggregate to form neurofibrillary tangles (NFTs), 
a neuropathological hallmark of many neurodegenerative diseases. 
Many models (both knock out and transgenic murine animal models) of 
tauophaty have been developed: some models ablate the mouse Tau gene and 
display only human Tau, while others insert the human Tau gene as well as the 
endogenous murine gene.  
There are also Tau transgenes that produce solely one isoform, which can 
further complicate comparisons among different animal models (table 1). 
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Table 1: transgenic mouse model 
Authors year Promotor Mutatio
n 
Isofor
m 
Begin of 
Tau 
pathology 
Characteristics 
Brion et al. 1999 Thy-1 P301L 3R 
murine 
6 months At 19 months detected NFT; Tau was 
also detected on microtubules in axons 
and in dendrites but not in cell bodies 
in astrocytes 
Ishiara et al. 1999 Thy-1 P301L Thy-1 3 months At 3 and 12 months of age detected 
NFT in cortical and brainstem neurons 
motor weakness 
Ishiara et al. 1999 Thy-1 P301L Thy-1 12 months At 12 and 24 months of age detected 
pretangles-tangles -NFT in cortical and 
brainstem neurons 
Duff et al. 2000 8cmice KI for 
human 
Tau 
Human 
Tau 6 
isoform
s 
7 months No NFT 
Lewis et al. 2000 PrP P301L 4R  5 months Locomotor deficit at 6.5 months 
(hemizygous) 
Gotz et al. 2001 Thy 1.2 P301L 4R 3 months Muscle atrophy and weakness, NFTs 
in cortical and brainstem neurons 
Lim et al. 2001 Thy-1 G272V 
P301L 
R406W 
- 1.5 months No abnormality up to 12 months 
Tatebayashi 
et al. 
2002 CamK-II R406W - 5 months No abnormality up to 23 months 
Allen et al. 2002 Thy 1.2 P301S 4R 5 months Locomotor deficit at 6.5 months 
(homozygous) 
Andorfer et 
al. 
 
2003 KO mice 
for Tau 
murine 
KO 
mice for 
Tau 
murine 
4R 13 months At 13 months of age detected Tau in 
cortical and brainstem neurons 
Santacruz et 
al. 
2005 CamK-II 
(inducibile
tet-off) 
P301L - 2.5 months Locomotor deficit at 9.5 months 
(hemizygous) 
 
 
The most common MAPT mutation is referred to as P301L, a human missense 
mutation of Pro301 Leu [16], this mutation appears to promote the self-assembly 
of mutant Tau protein in form of filaments and tangles. The P301L mutant Tau 
mice mimic features of human Tauopathies and provide a good model for 
investigating the pathogenesis of diseases with NFTs [17].  
Really these mutant mice have been shown to exhibit a phenotype characterized 
by altered behavioral aspects and pathological lesions early as 6.5 months of age 
in hemizygous animals and at 4.5 months in homozygotes.   
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NFT formation in the P301L mice was age and gene-dependent, with aggregates 
of hyperphosphorylated Tau in the cerebral cortex and hippocampus. Other 
authors indicate that age of phenotypic onset is later than previously described, 
starting around 10 months [18] and describe that abundant hyperphosphorylated 
Tau has been observed in the brains of mice at 10-18 months of age.  
Many studies described transgenic mouse models of tauophaty, focusing on the 
neuropathogenic mechanisms underlying the disease, without evaluating a 
possible impact that gender may have on the onset and progression of the 
disease. Infact, the aggregation of hyperphosphorylated Tau is one of the typical 
hallmarks of AD and age, sex, and stressful life events are known as 
etiopathogenic factors in AD: more in detail, women are more prone to develop 
AD [19] and elevated levels of glucocorticoid secretion are associated with 
hippocampal degeneration and cognitive deficits in AD patients [20-21-22].  
In this study young and old male and female transgenic P301L-Tau mice were 
studied in comparison with wild type mice to explore the possible mechanisms 
through which gender, age and genotype contributes to the onset and progress 
of tauophaty.  
Taken together, these results will possibly add new perspectives to our capability 
of understanding how genotype and gender contribute to the precipitation of 
AD and other Tau-related pathologies, with the aim to add new tool to potential 
treatments for Tauopathies. 
 
3.3 MATERIALS AND METHODS 
 
3.3.1 Animals   
Two hundred mice were used in this study. One hundred were hemizygous Tau 
transgenic mice of mixed gender with a mutant form (P301L) of human Tau 
protein including four-repeats without amino terminal inserts, and driven by the 
mouse prion promoter 6 (MoPrP) [23]. One hundred age-compatible wild type 
mice (B6D2F1) of mixed gender served as controls. Mice originated from 
Taconic Laboratories, USA, were bred at IRCCS Mario Negri Institute of 
Pharmacological Research in a Specific Pathogen free (SPF) facility with a 
regular 12:12 h light/dark cycle (lights on 07:00 a.m.), at a constant room 
temperature of 22 ± 2 °C, and relative humidity approximately 55 ± 10%. 
Animals were housed (n= 4 per group) in standard mouse cages; all mice were 
provisioned with bedding material (hard wood shavings) ad libitum food (Global 
Diet 2018S, Harlan Italy) and water. No environmental enrichment was used 
because it notably improves AD pathology in mouse models of AD [24-25]. 
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3.3.2 Ethics  s tatement 
Procedures involving animals and their care were in accordance with the national 
and international laws and policies (EEC Council Directive 86/609, OJ L 358, 1 
Dec.12, 1987; NIH Guide for the Care and use of Laboratory Animals, U.S. 
National Research Council, 2011). The Mario Negri Institute for 
Pharmacological Research (IRCCS, Milan, Italy) Animal Care and Use 
Committee (IACUC) approved the trials, which was conducted according to the 
institutional guidelines. These latter were in accordance with Italian laws (D.L. 
no. 116, G.U. suppl. 40, Feb. 18, 1992, Circular No.8, G.U., Juli14, 1994). The 
scientific project was approved by Italian Ministry of Health (Permit Number: 
71/2014 B). 
 
3.3.3 Study des ign 
The aim of this study was to investigate the interaction between gender and 
genotype (P301L mice TG and B6D2F1 mice CTR) on the onset and 
progression of neurodegenerative disease in the used mouse model of tauophaty. 
Animals (total number = 200) were divided into two separate groups for 
studying either behavior or survival profiles. The experimental group aimed at 
analyzing survival rate (accompanied by body weight records) was composed by 
120 animals, half TG half CTR mice, both of them equally composed by male 
and female mice. The experimental group aimed at performing behavioral tests 
(cognitive and locomotor aspects) was composed by 80 animals, half TG half 
CTR mice, both of them equally composed by male and female mice. 
In the second group, on the basis of the data from other authors [17-18], two 
time points of analysis were defined at 7 and 15 months of age (the first time 
point the symptoms of the disease were evidently expressed, the second time 
point was evidenced as the maximum survival for mice affected by tauophaty). 
The animals were sacrificed after the behavioral tests and the brains were 
analyzed for immunohistochemical (IHC) studies, aimed to labeling the 
neuropathological hallmarks of tauophaty such as aggregates of Tau and NFTs, 
neuronal death, inflammation aspects and gliosis (Fig. 1).  
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Figure 1. Time frame of experimental design. In the study were set the onset of neurodisease 
symptoms (7 months) and (15 months) two time points: the first as the manifestation of the 
neurodisease and the second as maximum survival of TG animals (time points for behavioral tests). 
During all experiment were valuated bodyweight and survival of all animals. 
 
3.3.4 Firs t  exper imental  group:  body weight  and surv iva l  rate  
Animals were monitored daily for wellbeing and welfare-related disease 
symptoms and their body weights were recorded weekly. A decrease in body 
weight greater than 15% in two consecutive weeks (15% +15%) was considered 
as humanitary end-point of the study and the respective animals were sacrificed. 
During the entire experiment, a large number of data was recorded, so we 
decided to group the values showing the average values for each experimental 
group every 4 weeks. This point of the trial was stopped after 18 months from 
the starting of the study on the basis of the higher and higher mortality rates 
recorded in TG groups. 
 
3.4 SECOND EXPERIMENTAL GROUP: BEHAVIORAL TESTS  
3.4.1 Nove l -ob j e c t  r e cogni t ion t e s t  (NORT) 
The novel-object recognition test (NORT) is a memory test relied on 
spontaneous without the need of stressful elements animal behavior [26-27]. In 
the present study, the object recognition task was conducted in an open-field 
arena (40 × 40 × 40 cm) with floor divided into 25 squares by black lines; three 
stimulus objects of similar size were used: a black plastic cylinder (4 × 5 cm), a 
glass vial with a white cup (3 × 6 cm), and a metal cube (3 × 5 cm). The task 
started with a habituation trial during which the animals were placed in the 
empty arena for 5 min, and their movements were recorded as the number of 
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line crossings, which provided an indication of both CTR and TG mice 
locomotor activities. In the next day, mice were re-placed in the same arena 
containing two identical objects (familiarization phase). The objects were 
randomly selected to avoid bias among animals and between groups. Exploration 
was recorded in a 10 min trial by an investigator blinded to the genotype and 
treatment. Sniffing, touching, and stretching the head toward the object at a 
distance of no more than 2 cm were scored as object investigation. Twenty-four 
hours later (test phase), mice were placed again in the arena containing two 
objects: one already presented during the familiarization phase (familiar object) 
and a new different one (novel object). The time spent exploring the two objects 
was recorded for 10 min. Following each session of NORT, the arena and 
objects were cleaned with 70% ethanol to ensure that the animal’s behavior was 
not guided by odor cues. Results were expressed as percentage time of 
investigation on objects per 10 min or as discrimination index (DI), i.e., (seconds 
spent on novel - seconds spent on familiar)/ (total time spent on objects). 
Animals with no memory impairment spent a longer time investigating the novel 
object, giving a higher DI.  
 
 
3.4.2 Open f i e ld  (OF) and spontaneous locomotor  ac t iv i ty  
The OF test is used to examine the general locomotion, as well as exploration 
activities, and consequent level of anxiety by exposing mice to a novel and open 
space [28-29]. We used a grey Perspex OF box (40 × 40 × 40 cm) with the floor 
divided into 25 (8 × 8 cm) squares. Mice were placed into the center of the floor 
defined as a ‘starting point’ and their behavior video-recorded for 5 min. The 
parameters analyzed as measure of spontaneous locomotor activity, exploratory 
activity and state of anxiety were: the duration of locomotion divided into the 
number of internal (the nine central squares) and external (the sixteen peripheral 
squares) squares crossed, the time spent in the central and external area of the 
open field, the number and duration of rearing (standing on the hind paws), the 
number and duration of self-grooming (rubbing the body with paws or mouth 
and rubbing the head with paws)[30].  
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3.4.3 Immunohis tochemistry  
At the end of behavioral tests animals were euthanized by cervical dislocation 
[31-32]; brains were removed and fixed in 10% formalin for 24–48 h with the 
usual procedure and embedded in paraffin. After deparaffinization brain coronal 
sections (3 µm thick; three slices per mouse) were stained for 
immunohistochemistry utilizing different primary antibodies (see table 2).  
The sections were incubated for 1 h at room temperature with blocking 
solutions [AT8 and AT100: 0.3% Triton X-100 plus 10% NGS; NFTS: 0.4% 
Triton X-100 plus 3% NGS; GFAP: 0.4% Triton X-100 plus 3% NGS; NeuN: 
0.1% Triton X-100 plus 10% NGS] and then overnight at 4°C with the primary 
antibodies. After incubation with the biotinylated secondary antibody (1:200; 1 h 
at room temperature; Vector Laboratories, Burlingame, CA), the sections were 
then incubated for 30 minutes at room temperature with the avidin-biotin-
peroxidase complex (Vector Laboratories, Burlingame, CA) and 
diaminobenzidine (Sigma). The sections were then slightly counterstained with 
hematoxylin. The specificity of the immunostaining was verified by incubating in 
parallel other sections with PBS instead of the specific primary antibodies. 
To determine the level of apoptosis in the brain, TUNEL assay were performed 
using Dead-end™ Colorimetric TUNEL System (Promega, nr G3250). Briefly, 
after the deparaffinization, sections were immersed at room temperature in a 
0.85% NaCl solution for 5 minutes, washed twice in PBS (5 min), placed in the 
Proteinase-K solution from the TUNEL assay kit for 10 min at room 
temperature and fixed in 10% buffered formalin solution (5 min).  
After washing in PBS three times (5 min each), sections were immersed in 
Equilibration buffer from the TUNEL assay kit (10 min), and incubated with a 
rTdT reaction mix (from the TUNEL assay kit) in a humidified chamber at 37°C 
for 1 h. To stop the reaction, sections were immersed in stop buffer for 15 min 
at RT and washed twice with PBS (5 min each); for blocking endogenous 
peroxidases, the sections were immersed in 0.3% hydrogen peroxide solution for 
5 min, washed twice in PBS (5 min each) and covered with Strep-HRP solution 
for 30 min at RT.  
After washing twice in PBS (5 min/wash) to remove the Strep- HRP, sections 
were immersed in DAB solution for 3 min at room temperature. The brain 
sections were then counterstained with hematoxylin for 2 min at room 
temperature.  
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Table 2: antibodies used in this study 
Antibody Species Specificity  Use Dilution Source, type 
AT 8 Mouse Tau; 
Ser(P)202/Thr (P)205 
 Pre-tangles; 
Tau marker 
1:1000 Euroclone, mAb 
IgG1 
AT 100 Mouse Tau; 
Thr(P)212/Ser(P)214 
 Tau marker 1:1000 Euroclone, mAb 
IgG1 
NFTs Mouse Neurofilaments  Axonal marker 1:50 Dako, mAb IgG1 
GFAP Rabbit Astrocytes  Astrocytic marker 1:2500 Dako, mAb IgG 
NeuN Mouse Neurons  Neuronal marker 1:1000 Chemicon, mAb 
IgG1 
 
3.4.4 Neuronal  counts  
In the Tauophaty mouse model used in this study, the accumulation of 
pathological Tau species (AT8, AT100), the neuronal loss (NeuN) and the level 
of apoptosis (TUNEL) were quantified in the cerebral cortex and in the 
hippocampus (upon frontal sections). Immunoreactive cells were counted by 
image analysis software in 3 fields using an Olympus Bx51 light microscope 
(Olympus, Italy) equipped with a digital camera (at x400 each field represented a 
tissue section area of about 0.036 mm2). Following manual tracing of the cortex 
and hippocampus at the same stereotactic level in all mice, the number of 
positive cells were manually tagged and counted. Every section was individually 
examined for the presence or absence of visible Tau filaments (AT8 and AT100) 
and for the presence of positive signaling in the neuronal nucleus (NeuN and 
TUNEL reactivities). The observer was not aware of the origin of the sections.  
 
 
3.4.5 Stat i s t i ca l  analys i s  
Statistical analyses were performed using Graph Pad Prism 6 program. Body 
weight data, NOR data, OF data and neuronal counts data were analyzed using 
two-way ANOVA, followed by Tukey’s post hoc test.  Survival ratio was analyzed 
by Log-rank (Mantel-Cox) test. All data were expressed as mean ± SEM with a 
statistical significance given at P< 0.05. 
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3.5 RESULTS 
 
3.5.1 Firs t  exper imental  group:  body weight  and surv iva l  rate   
The increase in body weight was significantly reduced in both male and female 
TG mice in comparison with CTR ones at 7 months (data not shown) and 15 
months (ANOVA, Fgenotype (3,1856) = 163.9, P<0.0001, Fgender (15,1856) = 59.79, 
P<0.0001, Finteraction (45,1856) = 2.750, P<0.0001; Fig. 2A). The effect was more 
pronounced in female animals, as shown by the reduction of 34% of body 
weight in TG female compared to CTR female mice. A reduction of body weight 
in TG male compared to CTR male mice (Fig. 2A) was also evident, but it was 
lesser. The analysis of survival rate showed that both male and female TG mice 
had a significantly reduced survival rate compared to CTR mice (Chi square= 
17.30, P<0.0001, Fig. 2 B and Chi square= 26.24, P<0.0001 Fig. 2C). In order to 
analyze the possible interaction between gender and genotype, the survival rates 
of TG male and female mice were compared, showing a significant reduction of 
percentage of survival in TG female mice (Chi square= 6.150, P<0.05, Fig. 2D).  
 
Figure 2. Body weight and survival rates. A) Significant reduction of body weight gain in male and 
female TG compared to CTR mice all along the experiment (n=30 for each group). TG male vs CTR 
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male mice § P< 0.05, §§ P< 0.01, TG female vs CTR female mice † P< 0.05, †† P< 0.01, TG female vs 
TG male mice # P< 0.05, ## P< 0.01. B, C). Significant decrease of survival rate in TG males and 
females compared to CTR all along the experiment (n=30 for each group), TG male vs CTR male 
mice *** P>0.0001 and TG female vs CTR female mice *** P<0.0001). D) Significant decrease of 
survival rate in female vs male TG mice (* P<0.01). Data were shown as mean ± SEM. 
 
3.5.2 Second exper imenta l  group:  behaviora l  t e s t s   
 
To investigate the cognitive impairment in the mouse model of tauophaty used 
in this study, both male and female TG and CTR mice at 7 and 15 months of age 
were tested in novel object recognition test. In either time points TG mice spent 
less time investigating the novel object compared to CTR mice (Fig. 3A, 3C); a 
significant genotype effect was found for measures of cognitive impairment such 
as discrimination index (7 months F (3,27) = 13.87, P<0.0001) (Fig. 3B), (15 
months (F (3,27) = 13.07, P<0.0001) (Fig. 3D). In order to analyze the interaction 
between gender and genotype, discrimination indexes of TG male and female 
mice were compared. A statistically significant difference between two groups in 
each time point was not identified, but a trend towards a difference at 7 months 
of age (F (3,27) =2.40, P= 0.06) was observed.  
In order to understand if the disease would increase with the age, the possible 
interaction between time and genotype was analyzed:  discrimination indexes of 
TG female mice at 7 and 15 months of age were compared, but a significant 
difference between two groups (P= 0.27) was not evident. The same analysis was 
conducted for TG male mice at 7 and 15 months of age and a significantly 
decreased discriminatory activity was observed in 15 month-old TG mice 
compared to 7-month-old TG mice (P<0.05, data not shown).  
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Figure 3. Discriminatory activity at 7 and 15 months of age in novel object recognition test. A-
C) Histograms indicate percentage of exploration of the familiar and novel objects at 7 (a) and 15 (c) 
months of age. At 7 and 15 months of age tauophaty significantly impaired memory, as shown by the 
inability of the P301L mice both male and female to recognize the familiar object (each experimental 
group n=10). B-D) Histograms show the corresponding discrimination index for the data shown in 
the figure A and in the figure C. Significant relative to control *** P< 0.0001. Data were shown as 
mean ± SEM. 
 
In order to investigate spontaneous locomotor and exploratory activities in the 
mouse model of tauophaty used in this study, both male and female TG and 
CTR mice at 7 months of age were tested in the open field test. A significant 
male gender-genotype effect was found for a locomotor activity measurement 
such as total number of crossing (F (3,27) = 0.0273, P<0.05) (Fig. 4A), but the 
measured value was not significant for the number of internal crossing (F (3,27) = 
1.233, P= 0.3170) (Fig. 4B) and external crossing (F (3,27) = 1.940, P= 0.1470) 
(Fig. 4C). In contrast, no genotype/gender effect was detected for measures of 
exploratory activity such as the time spent in the inner zone (F (3,27) = 1.521, P= 
0.2316) (Suppl. Fig. 2A) and the time spent in the external zone (F (3,27) = 1.589, 
P= 0.2151, Suppl. Fig. 2B).  
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At 15 months of age, a significant female gender-genotype effect was found for 
measures of locomotor activity such as total number of crossing (F (3,27) = 
0.0116, P< 0.05) (Fig. 4D), but the value was not significant for the number of 
internal crossing (F (3,27) = 0.8744, P= 0.4665) (Fig. 4E) and the number of 
external crossing (F (3,27) = 0.8896, P= 0.4591) (Fig. 4F). At 15 months of age 
again, no genotype/gender effect was detected for measures of exploratory 
activity such as the time spent in the inner zone (F (3,27) = 0.1266, P= 0.9460, 
Suppl. Fig. 2C) and the time spent in the external zone (F (3,27) = 0.1490, P= 
0.9294, Suppl. Fig. 2D). With the aim to investigate if the disease signs would 
increase with the age, the interaction between time and genotype was analyzed; 
parameters for measuring locomotor activity of TG female mice at 7 and 15 
months of age were compared, but there was no significant difference between 
two groups (nr total crossing F (3,27) = 0.2554, P= 0.8568, Suppl. Fig. 2E; nr 
internal crossing (F (3,27) = 0.3209, P= 0.8101, Suppl. Fig. 2F; nr external 
crossing (F (3,27) = 0.4815, P= 0.6979, Suppl. Fig. 2G). The same analysis was 
conducted for measures concerning exploratory activity, but no time/genotype 
effect was observed for the time spent in the inner zone (F (3,27) = 1.488, P= 
0.2402, Suppl. Fig. 2H) and the time spent in the external zone (F (3,27) = 1.641, 
P= 0.2032, Suppl. Fig. 2I).  
 
 
 
Figure 4. Locomotor activity at 7 and 15 months of age. A-F) Locomotor activity. Tauophaty 
significantly affected locomotor activity in 7-month TG male mice, as shown by the decrease of the 
number of total crossing performed by TG male mice compared to CTR male mice. Tauophaty 
significantly affected locomotor activity in 15-month TG female mice, as shown by the decrease of the 
number of total crossing performed by TG female mice compared to CTR female mice (each 
experimental group n=10). Significant relative to control * P< 0.05. Data were shown as mean ± SEM. 
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Supplementary Fig. 2. Tauophaty does not affect exploratory activity in P301L TG mice at 7 
and 15 months of age. A-F) Tauophaty didn’t affect significantly the exploratory activity in 7 and 15 
month-old TG male and female mice compared to relative CTR mice (each experimental group n= 
10), as shown by histograms related to time spent in internal and external zone performed by animals. 
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3.5.3 Immunohis to chemis try  
 
Sections of both P301L TG and CTR mice brains were tested with phospho-
specific antibodies for AT8 and AT100 (Fig.5 and Fig.6 respectively). 
Immunostaining applied to cerebral cortex and hippocampus with AT8 and 
AT100 antibodies revealed that in P301L TG mice the phosphorylation of Tau 
was present at both 7 months (data not shown) and 15 months of age (Fig. 5B, 
5D, 5F, 5H and 6B, 6D, 6F, 6H). Abnormal Tau species were also detected in 
the striatum, in the ventral thalamic nuclei, and in the entorhinal cortex (data not 
shown). These brain areas were subsequently quantified by AT8-immunoreactive 
cell counts (Fig. 5I and 5J), and in both the time points a significant genotype-
gender effect in the cortex was detected (ANOVA, Finteraction (3, 40) = 2.857, 
P<0.05; Fgenotype (1,40) = 88.29, P<0.0001; Fgender (3,40) = 6.716, P<0.0001) (Fig. 5I) 
and in the hippocampus (Finteraction (3, 40) = 15.77, P<0.0001; Fgenotype (1,40) = 15.77, 
P<0.0001; Fgender (3,40) = 49.89, P<0.0001) (Fig. 5I-5J). In order to understand if 
the accumulation of pathological Tau species would increase with the age, the 
interaction between time and genotype was investigated too: a significant 
interaction genotype-time was found, as shown by the increase of AT8-
immunopositive cell numbers in 15-month-old female TG mice compared to 7-
month-old female TG mice in the cortex and in the hippocampus (P<0.0001) 
(Fig. 5J).  
The quantification of AT100-immunopositive cells (Fig. 6I and Fig. 6J), in either 
time points revealed a significant genotype-gender effect in the cortex (F interaction 
(3,40)= 16.63, P<0.05; Fgenotype (1,40) = 101.8, P<0.0001 and Fgender (3,40)= 14.05, 
P<0.0001) (Fig. 5I) and in the hippocampus (Finteraction (3,40)= 6.51, P<0.0001; 
Fgenotype (1,40) = 64.18, P<0.0001 and Fgender (3,40)= 10.18, P<0.0001) (Fig. 6J) (but 
the comparison between TG and CTR male mice at 7 months of age was not 
significant). A significant time-genotype interaction was also observed, as shown 
by an increase of AT100-immunopositive cell numbers in 15-month-old TG 
female mice compared to 7-month-old TG female mice both in the cortex and 
hippocampus (P<0.0001) (Fig. 6I-6J). 
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Figure 5. AT8 immunoreactivity and neuronal counts. PSer202–Thr205 (AT8)-stained sections 
revealed the accumulation of abnormal Tau conformation and phosphorylation in 15-month-old males 
and females (P301L TG mice and CTR mice) in cortex (A-D) and in hippocampus (E-H, note the 
arrows pointing to the most representative aspects in TG mice). Representative sections are shown of 
4 animals used per each group. Scale bar: 40 µm. I) Quantification of AT8 immunoreactive cells in the 
cortex showed a significantly increased number of AT8+ cells in TG mice compared to CTR mice 
both at 7 and at 15 months of age. At 15 months of age there was a significant gender effect, as shown 
by a significantly increase of AT8+ cells of female TG mice compared to male TG mice and a 
significant interaction gender-time, as shown by the increase of AT8+ cells of 15-month-old females 
TG mice compared to 7-month-old female TG mice. The same results were obtained in the 
hippocampus (J). Significant relative to control *** P< 0.0001,7 months vs 15 months TG mice *** P< 
0.0001, TG male vs TG female * P< 0.05. Data were shown as mean ± SEM. 
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Figure 6. AT100 immunoreactivity and neuronal counts. PThr212/pSer214 (AT100)-stained 
sections revealed the accumulation of abnormal Tau conformation and phosphorylation in 15-month-
old males and females (P301L TG mice and CTR mice) in cortex (A-D) and in hippocampus (E-H, 
note the arrows pointing to the most representative aspects in TG mice). Representative sections are 
shown of 4 animals used per each group. Scale bar: 40 µm. I-J) Quantification of AT100 
immunoreactive cells in the cortex (I) and in hippocampus (J) showed a significantly increased of the 
number of AT100+ cells in TG mice compared to CTR mice both at 7 and at 15 months of age. At 15 
months of age there was a significant gender effect, as shown by a significantly increase of AT100+ 
cells of female TG mice compared to male TG mice and a significant interaction gender-time, as 
shown by the increase of AT100+ cells of 15-month-old females TG mice compared to 7-month-old 
female TG mice. Significant relative to control *** P< 0.0001,7 months vs 15 months TG mice *** P< 
0.0001, TG male vs TG female * P< 0.05. Data were shown as mean ± SEM. 
 
In order to describe the neurodegeneration aspects, sections of both P301L TG 
and CTR mice brains were treated with neuronal nuclei (NeuN) antibody to 
value the survival of neuronal populations and with TUNEL to value apoptotic 
neurons. Immunostaining of cortex and hippocampus with NeuN revealed a loss 
of neurons in TG mice compared to CTR mice at 7 months of age (data not 
shown), with an abnormal neuronal morphology (Fig. 7A-H).  
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NeuN-immunopositive cells in the cortex and in the hippocampus were 
quantified; at 7 months of age no significant genotype effect was found between 
TG and CTR mice of both sexes in the cortex (F genotype (1,40) = 2.493, P= 0.1223; 
Fig. 7I) and in the hippocampus (Fgenotype (1,40) = 3.366, P= 0.0740; Fig. 7J). At 15 
months of age a significant genotype-gender effect was detected in the cortex of 
TG female mice compared to CTR mice (Finteraction (3,40) = 7.774, P<0.001, Fgender 
(3,40) = 46,58, P< 0.05) (Fig. 7I). A significant genotype-time effect in either time 
points was in addition observed, with an increase of NeuN immunopositive cell 
numbers in 7-month-old TG mice compared to 15-month-old TG mice in the 
cortex and in the hippocampus (Finteraction (3,40) =3.041, P<0.05, Fgender (3,40) =32.88, 
P<0.0001) (Fig. 7J). Immunostaining with TUNEL revealed that at 7 months of 
age some neurons were apoptotic in a larger quantity in TG mice than respective 
CTR mice, with a major density of them in the cortical region compared to the 
hippocampal region (data not shown). Similar data have been shown at 15 
months of age too, with a small increase of apoptotic neurons (Fig. 8A-H). 
Immunoreactivity of TUNEL+ neurons in the cortex and in the hippocampus 
was quantified; in either time points a significant genotype effect was found in 
the cortex (Fgenotype (1,40)= 72,26, P<0.0001; Fgender (3,40)= 7.337, P<0.0001) (Fig. 
8I) and in the hippocampus (Fgenotype (1,40)= 72,26, P<0.0001; Fgender (3,40)= 105.4, 
P<0.0001) (Fig. 8J); no significant genotype-gender-time interaction was 
observed in the cortex (F (3,40)= 2.095, P=0.1162) (Fig. 8I) and in the 
hippocampus (F (3,40)= 0.4845, P=0.6149) (Fig. 8J). 
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Figure 7. NeuN immunoreactivity and neuronal counts. Neuronal nuclei (NeuN) antibody stained 
sections of the cortex (A-D) and hippocampus (E-H) of CTR and P301L TG mice at 15 months of 
age (note the arrows pointing to the most representative dots in TG). Representative sections are 
shown of 4 animals used per each group. Scale bar: 40 µm. I-J). Quantification of NeuN+ cells in the 
cortex (I) and in hippocampus (J) showed a significant decrease of the number of NeuN+ cells in 15-
month-old TG mice compared to 7-month-old TG mice (both males and females). In the cortex at 15 
months of age there was also a significant decrease of the number of NeuN+ cells in TG female mice 
compared to relative CTR. Significant relative to control *** P< 0.0001,7 months vs 15 months TG 
mice * P< 0.05 and ** P< 0. 001. Data were shown as mean ± SEM. 
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Figure 8. Level of apoptosis and quantification of TUNEL+ cells in P301L TG mice. TUNEL 
stained sections of the cortex (A-D) and hippocampus (E-H) of males and females P301L TG mice 
and CTR mice at 15 months of age (note the arrows pointing to the most representative dots in TG). 
Representative sections are shown of 4 animals used per each group. Scale bar: 40 µm. I-J) 
Quantification of TUNEL+ cells in the cortex (I) and in hippocampus (J) showed a significant 
increase of the number of TUNEL+ cells in P301L TG mice compared to relative CTR mice in each 
time point (excluding comparison between TG and CTR male mice at 7 months of age for the cortex 
analysis). Significant relative to control *** P< 0.0001,7 months vs 15 months TG mice * P< 0.05 and 
** P< 0.001. Data were shown as mean ± SEM. 
 
To analyze gliosis coronal sections of both TG and CTR mouse brain were 
immunostained with glial fibrillary acid protein (GFAP) (Suppl. Fig. 2I-2P). 
Immunostaining of cortex and hippocampus with GFAP revealed a state of 
gliosis in TG mice compared to CTR mice at 7 months of age (data not shown), 
with an increase of the number of GFAP+ cells confirmed also at 15 months of 
age (GFAP) (Suppl. Fig. 2I-2P). 
An increase in the number of astroglial GFAP-positive cells was observed in the 
hippocampal area and in the cortex of 15-month-old P301L TG mice compared 
to 7-month-old P301L TG mice (Suppl. Fig. 2I-2P). The number of GFAP-
positive cells increases with age in both CTR and TG mice.  
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Supplementary Fig. 1. Accumulation of neurofibrillary inclusions and gliosis in P301L TG 
mice. A-H) Glial fibrillary acidic protein (GFAP) stained sections of the cortex (A-D) and 
hippocampus (E-H) of males and females P301L TG mice and CTR mice at 15 months of age (note 
the arrows pointing to the most representative dots in TG). Representative sections are shown of 4 
animals used per each group. Scale bar: 40 µm. 
 
 
3.4 DISCUSSION AND CONCLUSION 
 
Alzheimer disease is a complex multifactorial disease with many risk factors such 
as age, sex and stress and many others, the relevance of these risks occur largely 
through unknown mechanisms. 
The pathological mechanisms need to be clarified in order to develop 
therapeutically strategy to slow or spot the Tauopathies. 
In the present study, we consider gender, genotype and age as a relevant risk 
factor for the progression of Tau pathology. 
We characterized a Tau transgenic mutant form (P301L) of human Tau protein 
including four-repeats without amino terminal inserts, and driven by the mouse 
prion promoter 6 (MoPrP). Lewis et al. [17-18] had shown that in the same 
model that motor dysfunction started at as 6.5 months of age in hemizygous 
animals and at 4.5 months in homozygotes with a short lifespan (10 months of 
age). In the brain, NFTs formation was age and gene-dependent and increasing 
insolubility and hyperphosphorylation of Tau paralleled the increasing observed 
NFTs. NFTs and Pick-body-like neuronal lesions were widespread in the brain 
and spinal cord; areas of the brain with the most NFTs also had reactive gliosis.  
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The brain areas most affected by the toxic role of Tau, characterized by the 
presence of aggregates of hyperphosphorylated Tau, deposition of neurofibrillary 
tangles, axonal dilatations, neuronal and synaptic loss, are hippocampus, 
entorhinal cortex, CA1 pyramidal layer and the basal forebrain [33-34-35-36-37]. 
In our experiments P301L model has an onset of Tau pathology starting at 7 
months of age, and all the described features were similar to those ones 
described by Lewis et al. 
Differently for Lewis et al. lifespan of our animals was slightly higher, that is 16-
18 months (instead of 10), with a reduction in weight, grooming and vocalization 
as described by Lewis, and an increase in docility age-dependent. One possible 
explanation for these two different observations is the sub-strain background of 
this transgenic line [39-40]. 
Previous work with JNPL3 mice showed that backcrossing onto C57BL/6 strain 
background significantly delayed the onset of disease and altered the pathological 
presentation of the original model [41-42]. Although JNPL3 mice express the 
same P301L 0N4R Tau as other Tau mouse models, there are several important 
differences between the two models that may explain the disparate effects of the 
C57BL/6 strain on tauophaty in each model. The Tau transgenic integration 
sites in JNPL3 have not been published, but it is likely that the incorporation of 
the human Tau cDNA into the murine genome occurred at different locations 
for each model. Based on the integration site of the transgenes and the 
endogenous activity of that chromosomal region, strain background could 
differentially affect promoter activity in each model [43]. Additionally, the 
C57BL/6 sub-strain utilized in each study could also contribute to the 
difference.  
In this study, we have chosen for our Tau TG model the C57BL/6J sub-strain 
while Lewis et al. crossed Tau-expressing mice to a C57BL/6NTac sub-strain 
(crossed with DBA2 x SW to obtain B6D2F1). The B6/N Tac sub-strain from 
Taconic was originally derived from the B6/J strain from Jackson laboratory, but 
over time genetic and phenotypic differences have developed between the two 
sub-strains [44]. 
Concerning age as a risk factor, we found that tauophaty progresses with age, 
because exploratory locomotor performance was shown to decrease at 15 
months compared to 7 months of age. Accordingly, important motor 
impairment well correlated with the accumulation of hyperphosphorylated Tau 
in the cortex and in the hippocampus and this progress with age from 7 to 15 
months. The neuronal loss is age- dependent too and located mainly in 
hippocampus in this model.  
Analyzing more in details the interaction between cognitive performance and 
brain histology, there is a significant correlation between behavioral performance 
and Tau pathology in our model. 
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A very recent study [45] revealed that environmental stress triggered memory 
impairments in female, but not male, P301L-Tau transgenic mice, and links 
memory deficit with Tau hyperphosphorylation and accumulation.  
Interestingly, in our study poorer “cognitive” performance in the novel object 
recognition test was associated with higher numbers of p-Tau+ (both AT8 and 
AT100) neurons in both cerebral cortex and hippocampus at both 7 and 15 
months of age. Moreover, a greater reduction of discriminatory activity is 
correlated to gender: in female TG mice was associated with higher numbers of 
p-Tau+ neurons in both cerebral cortex and hippocampus compared to male 
TG mice. The P301L mouse develops p-Tau+ stained neuronal cell bodies in 
brainstem and forebrain by 7 months of age, with “pre-tangle” p-Tau+ deposits 
occurring in neocortical and hippocampal cell bodies by that time as well. In 
these areas, we also detected GFAP-positive cells at 7 months of age, with an 
increase of the number of GFAP+ cells age-gender-dependent, revealing a state 
of astrogliosis age-dependent more pronounced in female than in male. Several 
evidences showed that the astrogliosis is a common feature in Tau TG models, 
this is, however, mild compared AD transgenic models [46] or AD brain [47]. A 
key finding of this work is that the interaction between genotype and gender 
triggers a number of mechanisms, Tau aggregation in the cortex and 
hippocampus is mediated by hyperactivation of PP1 and PP2A and the 
hyperphosphorylation of Tau in female is greater than in male P301L-Tau mice. 
Tau aggregation in female mice was also accompanied by altered expression of 
molecular chaperones known to regulate the process of neuronal degeneration 
and loss, inflammation and gliosis, and an important cognitive and locomotor 
impairment compared to male P301L- Tau mice. 
In conclusion, we found an important interaction between gender and pathology 
until now never reported in tauophaty models, in fact we found that female have 
strong cognitive impairment and this is strongly correlated with an increase in P-
Tau, in both cerebral cortex and hippocampus, as well as astrogliosis. 
Although we found a higher attitude in female then in male to develop tauophaty 
we do not correlated this with an increase of neuronal death or 
neurodegeneration in female compare to male (TUNEL labeling). 
Since Tau is a typical hallmark of AD and sex is a well-known etiopathogenic 
factors in AD, this P301L-Tau model could represent a valuable tool to study 
the role and the mechanisms through which gender interacts with 
hyperphosphorylation and Tau aggregation, leading to cognitive and memory 
impairment.  
Moreover, preventing or reducing the accumulation of hyperphosphorylated Tau 
in this model may represent a system to study molecular mechanism of AD like-
disease and could finally lead to the development of potential treatments for 
tauopathies, like AD. 
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4.1 ABSTRACT 
Dietary manipulations are increasingly viewed as possible approaches to treating 
neurodegenerative diseases. Previous studies suggest that an excessive caloric 
intake is associated with an increase of the risk of neurodegenerative disorders, 
while low caloric intake could delay aging and protect the central nervous system 
from neurodegenerative disorders. Low fat-protein diets, widely investigated in 
the treatment and prevention of neurodegenerative diseases, have been 
suggested to reduce the typical hallmarks of tauophaty as hyperphosphorylated 
tau, neurofibrillary tangles and improve cognitive impairment and lifespan. We 
investigate the effects of a low fat-protein diet (diet 14) and a high protein diet 
(diet 18) in a transgenic mouse model of tauophaty (P301L TG). At 3 months of 
age males and females P301L TG mice and B6D2F1 control mice were fed with 
different diets; body weight, food and water intake and survival rate were 
monitored throughout the experiment. Both male and female TG mice weighed 
less than CTR mice, regardless of diets administrated, but male TG and CTR 
mice fed with diet 18 ate and drank more of mice fed with diet 14.  Lifespan of 
TG mice were significantly reduced than CTR mice, but lifespan of female mice 
fed with diet 14 was significantly higher than female mice fed with diet 18. At 7 
and 15 months of age behavioral, exploratory and locomotor testing did not 
show any diet effects. Tissue measures of hyperphosphorylated tau, neuronal 
loss, astroglial and microglial markers in TG and CTR mice showed a strong 
genotype effect, but also an improve of cognitive activity corresponding to a 
decrease of aggregates of hyperphosphorylated tau, an increase of number of live 
neurons (NeuN) and a decrease of death neurons (TUNEL) in the cortex and in 
the hippocampus in TG mice fed with diet 14 compared with TG mice fed with 
diet 18. This effect was more pronounced in female than male TG mice at 7 
months of age, because at 15 months of age pathological conditions of TG 
animals were too severe. These data suggest that a low fat-protein diet may play 
an important role to improve the lifespan and cognitive activity in a mouse 
model of tauophaty, but this type of nutritional formulation have minimal 
impact on the phenotype of this murine model of Tau deposition.  
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Furthermore, these data show the importance of a correct dietary intake that can 
be a useful tool for intervene in early identification of the neurodegenerative 
disease before the cognitive and behavioral impairments are clinically evident, in 
order to delay or even prevent the onset of tauophaty and neurodegenerative 
diseases. 
 
Keywords: 
AD: Alzheimer disease, CTR: control, NFTs: neurofilaments, PUFAs: 
polyunsaturated fatty acids TG: transgenic. 
 
4.2 INTRODUCTION 
Abnormal deposition of the tau protein is the hallmark feature of tauopathies, 
which encompasses a growing list of neurodegenerative diseases, including 
Alzheimer's disease (AD), frontotemporal dementia (FTD), progressive 
supranuclear palsy (PSP), corticobasal degeneration (CBD) and chronic 
traumatic encephalopathy (CTE). Additionally, pathogenic mutations in the 
MAPT gene encoding the tau protein are associated with FTD and Parkinsonism 
linked to chromosome 17 (FTDP-17), indicating that tau dysfunction alone is 
sufficient to cause disease [1-2]. 
Tauophaty is defined by fibrillary and tangled aggregates of phosphorylated 
protein tau, which is normally a very soluble protein that binds to microtubules 
to secure their assembly, stability and spacing [3-4]. Because the underlying 
pathologies may start years before the cognitive and behavioral impairments are 
clinically evident, application of the knowledge on preventive nutritional 
strategies warrants early identification of the disease to be able to intervene and 
delay, or even prevent its onset.	  
Recent epidemiological studies had shown specific associations between 
nutritional components and the risk for neurodegenerative diseases. These 
include the potential protective effects of specific polyunsaturated fats, B-
vitamins and antioxidants [5-6-7]. These macro- and micronutrients are dietary 
components that can influence brain structure and function [8-9].  
Nutritional intake may provide specific nutrients that can be used as building 
blocks for membrane and synapse formation and neurotransmitter production, 
but can also directly influence the availability of nutrients, energy and oxygen to 
the brain. It is well known the importance of nutrition in the onset and 
progression of neurodegenerative diseases, in particular the role of 
polyunsaturated fatty acids (PUFAs) and protein on cognitive and behavioral 
functions. PUFAs are involved not only as structural constituents of the 
membrane lipids of neuronal cells, but also for their neuro-protective, anti-
oxidants and anti-inflammatory effects. 
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The proteins, as the reactive species oxygen, can interact with amino acid 
residues, in particular histidine, arginine and lysine, forming carbonyl functions. 
Some researchers have found that brain levels of these compounds increase with 
aging. Recent studies indicated that different caloric intake might influence 
neuronal function. Excessive caloric intake associated with accelerated aging of 
the brain and increased the risk of neurodegenerative disorders and low caloric 
intake could delay aging, and protect the central nervous system from 
neurodegenerative disorders. 
Excessive caloric intake will easily lead to obesity, so long-term consumption of 
a high-caloric diet is a risk factor that can significantly contribute to the 
development of neurological disease [10].  
An epidemiological study suggested that individuals following diets with high 
caloric intake have a 1.5 times greater risk of AD than those with low caloric 
intake [11]. The availability of transgenic animal models of tauophaty has 
permitted investigations into the impact of nutrients and other compounds 
isolated from foods on disease-related neuropathology, particularly amyloid-beta 
peptide in AD (the major for of tauophaty), and behavioral deficits. 
In our previous study, we demonstrated that the P301L TG mice replicates the 
impairments found in patients affected by tauophaty in a way age-gender-
dependent, with cognitive and behavioral impairment more pronounced in 
female than male P301L TG mice.	  
In this study, young and old male and female transgenic P301L-Tau mice were 
studied in comparison with wild type mice fed with different diets (low fat-
protein diet and high fat-protein diet) to explore the possible mechanisms 
through which diets can contribute to the onset and progress of tauophaty. 
Together, these results add new perspectives to our understanding how dietary 
intake can contribute to the precipitation of AD and other Tau-related 
pathologies, and with the aim to prevent the incidence of neurodegenerative 
diseases with a correct nutrition. 
 
 
4.3 MATERIALS AND METHODS 
4.3.1 Animals  and Diets  
 
Four hundred mice were used in this study. Two hundred were hemizygous tau 
transgenic mice of mixed gender with a mutant form (P301L) of human tau 
protein including four-repeats without amino terminal inserts, and driven by the 
mouse prion promoter 6 (MoPrP) [12]. Two hundred age-compatible wild type 
mice (B6D2F1) of mixed gender served as controls.  
Chapter 4 
	  
	  
77 
	  
Mice originated from Taconic Laboratories, USA, were bred at IRCCS Mario 
Negri Institute of Pharmacological Research in a Specific Pathogen free (SPF) 
facility with a regular 12:12 h light/dark cycle (lights on 07:00 a.m.), at a constant 
room temperature of 22 ± 2 °C, and relative humidity approximately 55 ± 10%. 
Animals were housed (n= 4 per group) in standard mouse cages, until three 
months of ages all animals were fed with standard rodent chow (diet 1: 18% 
protein and 5% fat, Harlan Lab. Tekland global diet), then animals were divided 
into two experimental groups, balanced for body weight and sex.  
The first group was fed with a standard rodent chow (diet 1: 18% protein and 
5% fat, Harlan Lab. Tekland global diet), and the second group was fed with a 
low protein diet (diet 2: 14% protein and 3.5% fat Harlan Lab. Tekland global 
diet).  
Since the animals were bred in a SPF facility, where all materials introduced are 
sterilized, we had to use an autoclavable diet manufactured with high quality 
ingredients and supplemented with additional vitamins to ensure nutritional 
adequacy after autoclaving. 
The diet 1 is a fixed formula, autoclavable diet designed to support gestation, 
lactation, and growth of rodents. This diet does not contain alfalfa, thus lowering 
the occurrence of natural phytoestrogens. Typical isoflavone concentrations 
(daidzein + genistein aglycone equivalents) range from 150 to 250 mg/kg. 
Exclusion of alfalfa reduces chlorophyll, improving optical imaging clarity. 
Absence of animal protein and fishmeal minimizes the presence of nitrosamines 
(Fig. 1).  
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      Figure 1: Composition of diet 1: 18% protein and 5% fat (Harlan Tekland global diet) 
The diet 2 is a fixed formula, autoclavable diet designed to promote longevity 
and normal body weight in rodents. Diet 2 does not contain alfalfa or soybean 
meal, thus minimizing the occurrence of natural phytoestrogens.  
Typical isoflavone concentrations (daidzein + genistein aglycone equivalents) 
range from non-detectable to 20 mg/kg. Exclusion of alfalfa reduces 
chlorophyll, improving optical imaging clarity. Absence of animal protein and 
fishmeal minimizes the presence of nitrosamines (Fig. 2). 
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Figure 2: Composition of diet 2: 14% protein and 3.5% fat (Harlan Tekland global diet) 
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4.3.2 Ethics  Statement 
Procedures involving animals and their care were in accordance to the national 
and international laws and policies (EEC Council Directive 86/609, OJ L 358, 1 
Dec.12, 1987; NIH Guide for the Care and use of Laboratory Animals, U.S. 
National Research Council, 2011). The Mario Negri Institute for 
Pharmacological Research (IRCCS, Milan, Italy) Animal Care and Use 
Committee (IACUC) approved the experiments, which were conducted 
according to the institutional guidelines, which are in compliance with Italian 
laws (D.L. no. 116, G.U. suppl. 40, Feb. 18, 1992, Circular No.8, G.U., Juli14, 
1994). The scientific project was approved by Italian Ministry of Health (Permit 
Number: 71/2014 B). 
 
 
4.3.3 Study Design 
After the characterization of our mouse model of tauophaty, that replicates the 
impairments found in patients affected by tauophaty in a way age-gender-
dependent showing that females were more affected than males, the aim of this 
study was to investigate the interaction between diets and genotype (P301L TG 
and B6D2F1 CTR mice) on the onset and progression of neurodegenerative 
disease in the used TG mouse model. After the weaning, all animals were fed 
with the same diet (diet 1 required for the growth of the mice); at 3 months of 
age the animals were divided into two experimental groups: the first group fed 
with diet 1 and the second group fed with diet 2. Mice were further divided into 
two separate groups for studying either behavior or metabolic profile linked to 
different diets administered; in the first group (n=240) body weight, food and 
water consumption and survival rates were analyzed.  
In the second group (n=160), on the basis of the data from other authors [17-
18], two time points of analysis were defined at 7 and 15 months of age (the first 
time point the symptoms of the disease were evidently expressed, the second 
time point was evidenced as the maximum survival for mice affected by 
tauophaty). 
To investigate the onset and progression of neurodegenerative disease, animals 
were sacrificed after the behavioral tests and the brain were analyzed for 
immunohistochemical (IHC) studies, labeling the neuropathological hallmarks of 
tauophaty such as aggregates of tau and NFTs, neuronal death, inflammation 
aspects and gliosis (Fig. 3).  
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Figure 3: Experimental design of the study. In the study were set three time points: 3 months of 
age related to the administration of two different diets (diet1 anddiet2), 7 and 15 months of age related 
to manifestation of the neurodisease and maximum survival of TG animals (time points for behavioral 
tests). During all experiment were valuated metabolic profile and survival of all animals randomized in 
4 experimental groups related to the strain and type of diet administrated. 
 
4.3.4 Metabol i c  pro f i l e  and surv ival  rate  
Animals were monitored daily for wellbeing welfare-related disease symptoms 
and their body weights, food and water consumption were recorded weekly. 
Based on the daily consumption of food of a mouse (5gr/daily for each mouse), 
it was decided to administer 200 grams of food per cage containing 4 mice (both 
diet 1 both diet 2). A decrease in body weight greater than 15% in two 
consecutive weeks (15% +15%) was considered as humanitary end-point of the 
study and the animal sacrificed. 
During the entire experiment, a large number of data was recorded, so we 
decided to group the values showing the average values for each experimental 
group every 4 weeks, except for the metabolic data collected in the first 12 
weeks. 
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4.4 BEHAVIORAL TESTS  
4.4.1 Nove l -Objec t  Recogni t ion Test  (NORT) 
The novel-object recognition test (NORT) is a memory test relied on 
spontaneous without the need of stressful elements animal behavior [13-14]. In 
the present study, the object recognition task was conducted in an open-field 
arena (40 × 40 × 40 cm) with floor divided into 25 squares by black lines; three 
stimulus objects of similar size were used: a black plastic cylinder (4 × 5 cm), a 
glass vial with a white cup (3 × 6 cm), and a metal cube (3 × 5 cm).  
The task started with a habituation trial during which the animals were placed in 
the empty arena for 5 min, and their movements were recorded as the number 
of line crossings, which provided an indication of both CTR and TG mice 
locomotion motor activities. In the next day, mice were re-placed in the same 
arena containing two identical objects (familiarization phase).  
The objects were randomly selected to avoid bias among animals and between 
groups. Exploration was recorded in a 10 min trial by an investigator blinded to 
the genotype and treatment. Sniffing, touching, and stretching the head toward 
the object at a distance of no more than 2 cm were scored as object 
investigation. Twenty-four hours later (test phase), mice were placed again in the 
arena containing two objects: one already presented during the familiarization 
phase (familiar object) and a new different one (novel object). The time spent 
exploring the two objects was recorded for 10 min. Following each session of 
NORT, the arena and objects were cleaned with 70% ethanol to ensure that the 
animal’s behavior was not guided by odor cues. Results were expressed as 
percentage time of investigation on objects per 10 min or as discrimination index 
(DI), i.e., (seconds spent on novel - seconds spent on familiar)/ (total time spent 
on objects). Animals with no memory impairment spent a longer time 
investigating the novel object, giving a higher DI.  
 
4.4.2 Open Fie ld (OF) and spontaneous locomotor  ac t iv i ty  
The OF test is used to examine the general locomotion, as well as exploration 
activities, and consequent level of anxiety by exposing mice to a novel and open 
space [15-16]. We used a grey Perspex OF box (40 × 40 × 40 cm) with the floor 
divided into 25 (8 × 8 cm) squares. Mice were placed into the center of the floor 
defined as a ‘starting point’ and their behavior video-recorded for 5 min.  
The parameters analyzed as measure of spontaneous locomotor activity, 
exploratory activity and state of anxiety were: the duration of locomotion divided 
into the number of internal (the nine central squares) and external (the sixteen 
peripheral squares) squares crossed, the time spent in the central and external 
area of the open field, the number and duration of rearing (standing on the hind 
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paws), the number and duration of self-grooming (rubbing the body with paws 
or mouth and rubbing the head with paws)[30].  
 
4.4.3 Immunohis tochemistry  
At the end of behavioral tests animals were euthanized by cervical dislocation 
[17-18]; brains were removed and fixed in 10% formalin for 24–48 h with the 
usual procedure and embedded in paraffin. After deparaffinization brain coronal 
sections (3 µm thick; three slices per mouse) were stained for 
immunohistochemistry utilizing different antibodies (see table 1). The sections 
were incubated for 1 h at room temperature with blocking solutions [AT8 and 
AT100: 0.3% Triton X-100 plus 10% NGS; NFTS: 0.4% Triton X-100 plus 3% 
NGS; GFAP: 0.4% Triton X-100 plus 3% NGS; NeuN: 0.1% Triton X-100 plus 
10% NGS] and then overnight at 4°C with the primary antibodies. After 
incubation with the biotinylated secondary antibody (1:200; 1 h at room 
temperature; Vector Laboratories), the sections were then incubated for 30 
minutes at room temperature with the avidin-biotin-peroxidase complex (Vector 
Laboratories, Burlingame, CA) and diaminobenzidine (Sigma).  
The sections were then lightly counterstained with hematoxylin. The specificity 
of the immunostaining was verified by incubating sections with PBS instead of 
the specific primary antibodies. To determine the level of apoptosis in the brain, 
TUNEL assay were performed using Dead-end™ Colorimetric TUNEL System 
(Promega, nr G3250).  
Briefly, after the deparaffinization, sections were immersed at room temperature 
in a 0.85% NaCl solution for 5 minutes, washed twice in PBS (5 min), placed in 
the Proteinase-K solution from the TUNEL assay kit for 10 min at room 
temperature and fixed in 10% buffered formalin solution (5 min). After washing 
in PBS three times (5 min each), sections were immersed in Equilibration buffer 
from the TUNEL assay kit (10 min), and incubated with a rTdT reaction mix 
(from the TUNEL assay kit) in a humidified chamber at 37°C for 1 h.  
To stop the reaction, sections were immersed in stop buffer for 15 min at RT 
and washed twice with PBS (5 min each); for blocking endogenous peroxidases, 
the sections were immersed in 0.3% hydrogen peroxide solution for 5 min, 
washed twice in PBS (5 min each) and covered with Strep-HRP solution for 30 
min at RT. After washing twice in PBS (5 min/wash) to remove the Strep- HRP, 
sections were immersed in DAB solution for 3 min at room temperature. The 
brain sections were then counterstained with hematoxylin for 2 min at room 
temperature. 
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Table 1: primary antibodies 
 
Antibody Species Specificity Use Dilution Source, type 
AT 8 Mouse Tau; 
Ser(P)202/Thr(P)205 
Pre-tangles; 
Tau marker 
1:1000 Euroclone, 
mAb IgG1 
AT 100 Mouse Tau; 
Thr(P)212/Ser(P)214 
Tau marker 1:1000 Euroclone, 
mAb IgG1 
NFTs Mouse Neurofilaments Axonal marker 1:50 Dako, mAb 
IgG1 
GFAP Rabbit Astrocytes Astrocytic 
marker 
1:2500 Dako, mAb 
IgG 
NeuN Mouse Neurons Neuronal 
marker 
1:1000 Chemicon, 
mAb IgG1 
 
4.4.4 Neuronal  Counts  
 
The brain areas most affected by the toxic role of Tau, characterized by the 
presence of aggregates of hyperphosphorylated tau, deposition of neurofibrillary 
tangles, axonal dilatations, neuronal and synaptic loss, are hippocampus, 
entorhinal cortex, CA1 pyramidal layer and the basal forebrain [19-20-21-22-23].  
In our tauophaty mouse model the accumulation of pathological Tau species 
(AT8, AT100), the neuronal loss (NeuN) and the level of apoptosis (TUNEL) 
were quantified in the cortex and in the hippocampus (brain coronal sections). 
Immunoreactive cells were counted by image analysis software in 3 fields using 
an Olympus Bx51light microscope (Olympus, Italy) equipped with a digital 
camera (at x400 each field represented a tissue section area of about 0.036 mm2).  
Following manual tracing of the cortex and hippocampus at the same 
stereotactic level in all mice, the number of positive cells were manually tagged 
and counted. Every section was individually examined for the presence or 
absence of visible Tau filaments (AT8 and AT100) and for the presence of 
positive signaling in the nucleus neuronal (NeuN and TUNEL). The observer 
was not aware of the origin of the sections.  
 
4.4.5 Stat i s t i ca l  Analys i s  
Statistical analyses were performed using Graph Pad Prism 6 program. Body 
weight data, food and water consumption data, NOR data, OF data and 
neuronal counts data were analyzed using two-way ANOVA, followed by 
Tukey’s post hoc test. Survival ratio was analyzed by Log-rank (Mantel-Cox) test. 
All data were expressed as mean ± SEM with a statistical significance given at 
P< 0.05.  
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4.5 RESULTS 
4.5.1 Metabol i c  pro f i l e :  we ight  gain,  food and water  consumption 
During the first 12 weeks of experiment, all animals were fed with diet 1 (18% 
protein and 5% fat). The increase in body weight was significantly reduced in 
female mice compared to male mice both in TG and CTR mice (ANOVA, 
Fgenotype (3, 1392) = 306.8, P<0.0001, Ftime (11, 1392) = 308.9, P<0.0001, Finteraction (33, 1392) 
= 2.623, P<0.0001; Fig. 4A). In correspondence of 10, 11 and 12 weeks of the 
experiment, an increase in body weight was significantly reduced in CTR male 
mice compared to TG male mice (P<0.0001; Fig. 4A). No statistically significant 
difference between experimental groups was identified for food intake (Finteraction 
(11,696) = 1.169, P= 0.4510 Fig. 4B; F interaction (11,696) = 1.044, P= 0.4053 Fig. 4D). 
From 9 to 12 weeks of the experiment, an increase in water consumption was 
significantly reduced in CTR male mice compared to TG male mice (ANOVA, 
Fgenotype (1,696) =43.87, P<0.0001, Ftime (11,696) = 44.77, P<0.0001, Finteraction (11,696) = 
5.941, P<0.0001; Fig. 4C). 
In correspondence of 3 and 4 weeks of the experiment, an increase in water 
consumption was significantly reduced in CTR female mice compared to TG 
female mice (ANOVA, Fgenotype (1,696) = 19.26, P<0.001, Ftime (11,696) = 89.01, 
P<0.0001, Finteraction (11,696) = 2.844, P<0.0001; Fig. 4E). 
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Figure 4. Metabolic profile during 12 weeks of experiment. A) Assessments of body weight and 
B, E) food and water consumption in TG and CTR mice (n=30 for each group). A) Both female TG 
and CTR mice weighed significantly less than male TG and CTR mice. B-D) No significant difference 
in food intake between CTR and TG mice. C-D) Significant reduction of water consumption of TG 
male mice compared to CTR male mice and TG female mice compared to CTR female mice. Data 
were shown as mean ± SEM.CTR female vs CTR male mice # P< 0.05, ## P< 0.001, ### P< 
0.0001, TG male vs CTR male mice § P< 0.05, TG female vs TG male mice * P< 0.05, ** P< 0.001, 
TG female vs CTR female mice † P< 0.05. 
 
At 3 months of age (corresponding to 12 weeks of experiment), mice were 
randomized and divided into 2 experimental groups: one fed with diet 1(18% 
protein and 5% fat) and the second fed with diet 2 (14% protein and 3.5% fat). 
In order to analyze a possible interaction between diets and genotype, body 
weight of TG and CTR mice fed with different diets were compared. No diet 
effects were observed in any genotype (both CTR and TG mice) at 7 months 
(CTR mice P=0.99 and TG mice P= 0.87; Fig. 5A-5C) and 15 months of age 
(CTR mice P=0.99 and TG mice P= 0.8829; Fig. 5B-5D). 
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Figure 5. Body weight gain during 60 weeks of experiment. A,B) Assessments of body weight of 
male and female CTR mice fed with diet 18 and diet 14 at 7 (A) and 15 months of age (B) (n=30 for 
each group). C,D) Assessments of body weight of male and female TG mice fed with diet 18 and diet 
14 at 7 (C) and 15 months of age (D). 
 
An overall main effect of genotype on body weight was observed throughout the 
course of the study; from 36 to 60 weeks, female TG mice had smaller body 
weights, not affected by diet, relative to CTR female mice (ANOVA, P< 0.001 
and P< 0.0001; Fig.6A). From 36 to 60 weeks of experiment, an increase in body 
weight was significantly reduced in male TG mice fed with diet 14compared to 
relative CTR male mice fed with the same diet (ANOVA, P< 0.05, Fig. 6D). 
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Figure 6. Body weight gain during 60 weeks of experiment. A, B) Assessments of body weight of 
female TG and CTR mice fed with diet 18 and diet 14 at 7 (A) and 15 months of age (B) (n=30 for 
each group). Significant reduction of body weight gain in female TG mice compared to CTR mice fed 
with diet 18 and 14 at 32 weeks and from 36 to 60 weeks. C, D) Assessments of body weight gain in 
male TG and CTR mice fed with diet 18 and diet 14 at 7 (C) and 15 months of age (D). Significant 
reduction of body weight gain in male TG mice compared to CTR mice fed with diet 14 from 44 to 60 
weeks, and at 28 weeks in mice fed with diet 18. Data were shown as mean ± SEM. DIET 14: TG 
female vs CTR female mice ** P< 0.001; TG male vs CTR male mice † P< 0.05. DIET 18: TG female 
vs CTR female mice # P< 0.05, ### P< 0.0001; TG male vs CTR male mice. § P< 0.05. 
 
In order to analyze the possible interaction between diets and genotype, food 
and water intake of TG and CTR mice fed with different diets were compared. 
All CTR mice fed with diet 18 presented significantly greater food intake and 
water consumption than TG mice throughout the experiment (ANOVA, P< 
0.0001, Fig. 7A-B); CTR female mice fed with diet 14 presented significantly 
greater food intake than TG female mice (P< 0.0001), but not a significant 
difference in water consumption.  
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The opposite effect was detected in CTR male mice fed with diet 14: it was any 
significant difference in food intake compared to TG male mice fed with the 
same diet, but a significant increase of water consumption of CTR male mice 
respect to TG male mice (Fig. 7A-B). 
 
 
 
Figure 7. Food and water consumption during 60 weeks of experiment. A, B) Assessments of 
food intake (A) and water consumption (B) of TG and CTR mice fed with diet 18 and diet 14 (n=30 
for each group). Significant increase of food and water consumption in CTR mice compared to TG 
mice fed with diet 18. Significant increase of food intake in female CTR mice compared TG mice fed 
with diet 14 and significant increase of water intake in male CTR mice compared TG mice fed with 
diet 14. Data were shown as mean ± SEM. DIET 14: TG female vs CTR female mice *** P< 0.001; 
TG male vs CTR male mice ††† P< 0.0001. DIET 18: TG female vs CTR female mice ### P< 
0.0001; TG male vs CTR male mice §§§ P< 0.0001. 
 
After detected a genotype effect, in order to analyze a possible effect of a 
specific diet within a strain, at 7 and 15 months of age food and water 
consumption of CTR mice fed with diet 18 and diet 14 were compared. At 12, 
20, 28, 32-36 weeks a significant increase of food intake was found in CTR male 
mice fed with diet 18 compared to CTR male mice fed with diet 14 (ANOVA, 
P< 0.0001, Fig. 8A-B). 
At 12, 32 and 48 weeks a significant increase of water intake was found in CTR 
male mice fed with diet 18 compared to CTR male mice fed with diet 14 
(ANOVA, P< 0.0001, Fig. 8C-D). 
A statistically difference in food intake between CTR female mice fed with diet 
18 and 14 in each time point was not identified (except at 60 weeks, P< 0.05, 
Fig. 9A-B). At 12, 24, 48-60 weeks a significant increase of water intake was 
found in CTR female mice fed with diet 18 compared to mice fed with diet 14 
(ANOVA, P< 0.0001, Fig. 9C-D).	  
At 7 and 15 months of age food and water consumption of TG mice fed with 
diet 18 and diet 14 were compared.  
P< 0.001. 
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At 12, 40, 48-60 weeks a significant increase of food intake was found in TG 
male mice fed with diet 18 compared to TG male mice fed with diet 14 
(ANOVA, P< 0.0001, Fig. 10A-B); at 12, 24-32, 40 and 48-56 weeks a significant 
increase of water intake was found in TG male mice fed with diet 18 compared 
to TG male mice fed with diet 14 (ANOVA, P< 0.0001, Fig. 10C-D).  
At 20-32 and 40-48 weeks a significant increase of food intake was found in TG 
female mice fed with diet 18 compared to mice fed with diet 14 (ANOVA, P< 
0.0001, Fig. 11A-B).	  
A statistically difference in water intake between TG female mice fed with diet 
18 and 14 in each time point was not identified (P> 0.05, Fig. 11C-D). 
 
 
Figure 8. Food and water consumption of CTR male mice at 7 and 15 month of age. A, B) Assessments 
of food intake and C, D) water intake at 7 (A) and 15 (B) month of age of CTR male mice fed with diet 18 and 
diet 14(n=30 for each group). Significant increase of food consumption in CTR mice fed with diet 18 compared 
to CTR mice fed with diet 14. C, D) Significant increase of water intake in CTR mice fed with diet 18 compared 
to CTR mice fed with diet 14. Data were shown as mean ± SEM. CTR male diet 18 vs CTR male diet 14 mice §§ 
P< 0.001; §§§ P< 0.0001. 
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Figure 9. Food and water consumption of CTR female mice at 7 and 15 month of age. A, B) 
Assessments of food intake and C, D) water intake at 7 (A) and 15 (B) month of age of CTR female 
mice fed with diet 18 and diet 14 (n=30 for each group). No significant difference of food 
consumption between two groups was found (except at 60 weeks). C, D) Significant increase of water 
intake in CTR mice fed with diet 18 compared to CTR mice fed with diet 14. Data were shown as 
mean ± SEM. CTR female diet 18 vs CTR female diet 14 mice † P< 0.05; †† P< 0.001; ††† P< 0.0001. 
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Figure 10. Food and water consumption of TG male mice at 7 and 15 month of age. A, B) 
Assessments of food intake and C, D) water intake at 7 (A) and 15 (B) month of age of TG male mice 
fed with diet 18 and diet 14 (n=30 for each group). Significant increase of food consumption in TG 
mice fed with diet 18 compared to TG mice fed with diet 14. C, D) Significant increase of water intake 
in TG mice fed with diet 18 compared to TG mice fed with diet 14. Data were shown as mean ± SEM. 
TG male diet 18 vs TG male diet 14 mice #p< 0.05; ## P< 0.001; ### P< 0.0001. 
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Figure 11. Food and water consumption of TG female mice at 7 and 15 month of age. A, B) 
Assessments of food intake and water intake C, D) at 7 (A) and 15 (B) month of age of TG female 
mice fed with diet 18 and diet 14 (n=30 for each group). Significant increase of food intake in TG mice 
fed with diet 18 compared to TG mice fed with diet 14. C, D) No significant difference of water intake 
between two groups was found. Data were shown as mean ± SEM. CTR female diet 18 vs CTR female 
diet 14 mice ** P< 0.001; *** P< 0.0001. 
 
 
4.5.2 Survival  Rate  
The analysis of survival rate showed that both male and female TG mice had a 
significantly reduced survival rate compared to CTR mice, regardless of diet 
administered (Chi square= 37.39, P<0.0001, Fig. 12A, Chi square= 33.50, 
P<0.0001 Fig. 12B, Chi square= 47.44, P<0.0001, Fig. 12C, Chi square= 41.95, 
P<0.0001 Fig. 12D).  
After detected a genotype effect, in order to analyze the possible interaction 
between diets and genotype, the survival rates of CTR male mice fed with 
different diets and females mice fed with different diets were compared, but was 
not significant difference between two groups (P> 0.05, Fig. 13A-B).  
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The same analysis was conducted for TG male and female mice fed with 
different diets, showing a significantly reduction of percentage of survival in TG 
female mice fed with diet 18 compared to mice fed with diet 14 (Chi square= 
11.06, P<0.0001, Fig. 13D). A significant effect of diets was not found for the 
comparison of TG male mice fed with different diets (P> 0.05, Fig. 13C). 
 
 
 
Figure 12. Survival rate of TG and CTR mice fed with different diets. A-D) Significant decrease 
of survival rate in TG males and females compared to CTR all along the experiment (n=30 for each 
group). Data were shown as mean ± SEM. DIET 14: TG male vs CTR male mice ††† P< 0.0001, TG 
female vs CTR female mice *** P< 0.0001. DIET 18: TG male vs CTR male mice §§§ P< 0.0001, TG 
female vs CTR female mice ### P< 0.0001. 
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Figure 13. Survival rate of TG and CTR mice fed with different diets. A, B) No significant 
difference of survival rate between CTR mice fed with diet 18 and 14 (both male and female) was 
found. C, D) Significant decrease of survival rate in TG female mice fed with diet 18 compared to TG 
female mice fed with diet 14 all along the experiment (n=30 for each group). No significant difference 
of survival rate between TG male mice fed with diet 18 and 14 was found. Data were shown as mean 
± SEM. TG female diet 18 vs TG female diet 14 mice *** P< 0.0001.  
 
4.5.3 Behavioral  Tests   
After detected a gender-genotype interaction in the mouse model of tauophaty 
used in this study, it was decided to investigate a possible effect of the diets on 
the cognitive impairment and progression of tauophaty in this mouse model. For 
this purpose, both male and female TG and CTR mice fed with different diets at 
7 and 15 months of age were tested in novel object recognition test.  
In either time points, regardless of diets both male and female TG mice spent 
less time investigating the novel object compared to CTR mice (for male Fig. 
14A, 15A, for female Fig. 14C, 15C). 
A significant genotype effect was found for measures of cognitive impairment 
such as discrimination index (7 months: male F (1, 36) = 10.02, P<0.05; female F 
(1,36) = 33.32, P<0.0001) (Fig. 14B-14D), (15 months: male F (1,36) = 91.19, 
P<0.0001; female F (1, 36) = 91.19, P<0.0001) (Fig. 15B-15D).  
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In either time points any statistically significant effect of diets was found 
(P>0.05).
 
 
Figure 14. Discriminatory activity at 7 months of age in novel object recognition test. A-C) 
Histograms indicate percentage of exploration of the familiar and novel objects at 7 months of age. 
Regardless of diets administrated, at 7 months of age tauophaty significantly impaired memory (each 
experimental group n=10). B-D) Histograms show the corresponding discrimination index for the 
data shown in the figure A and in the figure C. Data were shown as mean ± SEM. DIET 14: TG male 
vs CTR male mice † P< 0.05, TG female vs CTR female mice *** P< 0.0001. DIET 18: TG male vs 
CTR male mice § P< 0.05, TG female vs CTR female mice ### P< 0.0001. 
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Figure 15. Discriminatory activity at 15 months of age in novel object recognition test. A-C) 
Histograms indicate percentage of exploration of the familiar and novel objects at 15 months of age. 
Regardless of diets administrated, at 15 months of age tauophaty significantly impaired memory (each 
experimental group n=10). B-D) Histograms show the corresponding discrimination index for the 
data shown in the figure A and in the figure C. Data were shown as mean ± SEM. DIET 14: TG male 
vs CTR male mice ††† P< 0.0001, TG female vs CTR female mice * P< 0.05. DIET 18: TG male vs 
CTR male mice §§§ P< 0.0001, TG female vs CTR female mice ### P< 0.0001. 
 
After detected in the first work a correlation between time and genotype, a 
possible interaction between time and diets was analyzed; discrimination indexes 
of TG female mice fed with diet 14 and 18 at 7 and 15 months of age were 
compared, but a significant difference between two groups (P= 0.07) was not 
evident (Fig. 16A).  
The same analysis was conducted for TG male mice fed with diet 14 and 18at 7 
and 15 months of age, but only a significant time effect (P< 0.001) and not an 
interaction between time and diets was found (Fig 16B).  
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Figure 16. Discriminatory activity at 7 and 15 months of age in novel object recognition test. A-
B) Histograms show the corresponding discrimination indexes of male and female TG mice fed with 
diet 14 and 18 at 7 and 15 months of age (each experimental group n=10). Any statistically significant 
interaction time-diets was found. 
 
In order to investigate a possible effect of diets correlated to spontaneous 
locomotor and exploratory activities in the mouse model of tauophaty used in 
this study, both male and female TG and CTR mice fed with different diets at 7 
months of age were tested in the open field test. At 7 months of age, any 
significant effect of diets was found for parameters analyzed as total number of 
crossing, number of internal and external crossing (for measures of locomotor 
activity, P> 0.05, Fig. 17A-C), time spent in the inner and external zone (for 
measures of exploratory activity, P> 0.05, Fig. 17D-E) and number of rearing, 
number of grooming, time spent for rearings and time spent for grooming (for 
measures of exploratory activity, P> 0.05, Fig. 17F-I). 
At 15 months of age, any significant effect of diets was detected for parameters 
related to locomotor and exploratory activity (P> 0.05, Fig. 18A-G); a significant 
diet effect was found for measures of number of grooming in male TG mice fed 
with different diets and a significant genotype effect in TG male mice compared 
to CTR male mice fed with diet 14 was found (P< 0.001, Fig. 18H).  
A significant diet effect was found also for the other parameter as time spent for 
grooming in male TG mice fed with different diets and a significant genotype 
effect in TG mice (both male and female) compared to CTR male mice fed with 
diet 14 was found (P< 0.001, Fig. 18I).   
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Figure 17. Locomotor and exploratory activity at 7 months of age in TG and CTR mice fed 
with different diets. A-C) Locomotor activity. Any significant effect of diets was found for 
parameters analyzed as total number of crossing, number of internal and external crossing. D-I) 
Exploratory activity. Any significant effect of diets was found for parameters analyzed as number of 
rearing, number of grooming, time spent for rearings and time spent for grooming. 
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Figure 18. Locomotor and exploratory activity at 15 months of age in TG and CTR mice fed 
with different diets. A-C) Locomotor activity. Any significant effect of diets was found for 
parameters analyzed as total number of crossing, number of internal and external crossing. D-I) 
Exploratory activity. A significant diet effect and genotype effect for measures of number of grooming 
and time spent for grooming in male TG mice fed with different diets was found. Data were shown as 
mean ± SEM. DIET 14: TG male vs CTR male mice †† P< 0.001, DIET 18: TG female vs CTR 
female mice ## P< 0.001. TG male diet 18 vs TG male diet 14 mice αα P< 0.001. 
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4.5.4 Immunohis tochemistry 
Sections of both P301L TG and CTR mice brains were screened with phospho-
specific antibodies for AT8 and AT100 (Fig. 20 and Fig. 22 respectively), in 
order to understand if different diets (diet 18: 18% protein and 5% and diet 14: 
14% protein and 3.5% fat) can improve the progression of tauopathy. 
Immunostaining applied to cortex and hippocampus with AT8 antibody revealed 
that, regardless of diets administrated, in P301L TG mice the phosphorylation of 
Tau was present at both 7 and 15 months of age (diet 14: Fig. 19A-H, 21A-H, 
diet 18: Fig. 19I-P, 21I-P). These brain areas were subsequently quantified by 
AT8-immunoreactive cell counts (Fig. 20A-B and 22A-B). At 7 months of age 
for both male and female mice fed with different diets, a significant genotype 
effect in the cortex was detected (diet 14: TG vs CTR mice P<0.0001, diet 18: 
TG male vs CTR male mice P<0.001, TG female vs CTR female mice 
P<0.0001; Fig. 19A) and in the hippocampus (diet 14: TG vs CTR mice 
P<0.0001, diet 18: TG male vs CTR male mice P<0.0001, TG female vs CTR 
female mice P<0.001; Fig. 19B). A significant diet effect in the cortex of male 
and female TG mice was detected (TG male diet 14 vs TG male diet 18 P<0.001 
and TG female diet 14 vs TG female diet 18 P<0.05; Fig. 19B). 
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Figure 19. AT8 immunoreactivity in TG and CTR mice fed with different diets at 7 month of 
age. PSer202–Thr205 (AT8)-stained sections revealed the accumulation of abnormal Tau 
conformation and phosphorylation in 7-month-old males and females (P301L TG mice and CTR 
mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H,M-P note the arrows 
pointing to the most representative aspects in TG mice). Representative sections are shown of 4 
animals used per each group. Scale bar: 40 µm. 
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Figure 20. Quantification of AT8 immunoreactive cell counts in TG and CTR mice fed with 
different diets at 7 month of age. A-B) Quantification of AT8 immunoreactive cells in hippocampus 
and in the cortex showed a significantly increased number of AT8+ cells in TG mice compared to 
CTR mice at 7 months of age. A significant diet effect in the cortex of male and female TG mice was 
detected, as shown by a significantly increase of AT8+ cells TG mice fed with diet 18 compared to TG 
mice fed with diet 14. Data were shown as mean ± SEM.DIET 14: TG male vs CTR male mice ††† 
P< 0.0001, TG female vs CTR female mice *** P< 0.0001. DIET 18: TG male vs CTR male mice §§ 
P< 0.001, §§§ P< 0.0001, TG female vs CTR female mice ## P< 0.001, ### P< 0.0001. TG male 
diet 18 vs TG male diet 14 ¥¥ P< 0.001, TG female diet 18 vs TG female diet 14 ¥ P< 0.05. 
At 15 months of age for both male and female mice fed with different diets a 
significant genotype effect in the cortex was detected (diet 14: TG vs CTR mice 
P<0.0001, diet 18: TG vs CTR mice P<0.0001; Fig. 22A) and in the 
hippocampus (diet 14: TG vs CTR mice P<0.0001, diet 18: TG male vs CTR 
male mice P<0.0001, TG female vs CTR female mice P<0.001; Fig. 22B). Any 
significant diet effect in the cortex and in hippocampus of TG mice fed with 
different diets was detected (P>0.05, Fig. 22A-B). 
Chapter 4 
	  
	  
106 
	  
 
Figure 21. AT8 immunoreactivity in TG and CTR mice fed with different diets at 15 month of 
age. PSer202–Thr205 (AT8)-stained sections revealed the accumulation of abnormal Tau 
conformation and phosphorylation in 15-month-old males and females (P301L TG mice and CTR 
mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P note the arrows 
pointing to the most representative aspects in TG mice). Representative sections are shown of 4 
animals used per each group. Scale bar: 40 µm. 
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Figure 22. Quantification of AT8 immunoreactive cell counts in TG and CTR mice fed with 
different diets at 15 month of age. A-B) Quantification of AT8 immunoreactive cells in 
hippocampus and in the cortex showed a significantly increased number of AT8+ cells in TG mice 
compared to CTR mice at 15 months of age. Data were shown as mean ± SEM. DIET 14: TG male vs 
CTR male mice ††† P< 0.0001, TG female vs CTR female mice *** P< 0.0001. DIET 18: TG male vs 
CTR male mice, §§§ P< 0.0001, TG female vs CTR female mice ### P< 0.0001.  
Immunostaining applied to cortex and hippocampus with AT100 antibody 
revealed that, regardless of diets administrated, in P301L TG mice the 
phosphorylation of Tau was present at both 7 and 15 months of age (diet 14: 
Fig. 23A-H, 25A-H, diet 18: Fig. 23I-P, 25I-P). These brain areas were 
subsequently quantified by AT100-immunoreactive cell counts (Fig. 24A-B and 
26A-B). At 7 months of age for both male and female mice fed with different 
diets a significant genotype effect in the cortex was detected (diet 14: TG vs 
CTR mice P<0.0001, diet 18: TG male vs CTR male mice P<0.001, TG female 
vs CTR female mice P<0.0001; Fig. 24A) and in the hippocampus (both male 
and female mice diet 14: TG vs CTR mice P<0.0001, diet 18: TG vs CTR mice 
P<0.0001; Fig. 24B). A significant diet effect in the hippocampus of male TG 
mice was detected (TG male diet 14 vs diet 18 P<0.0001; Fig. 24B). 
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Figure 23. AT100 immunoreactivity in TG and CTR mice fed with different diets at 7 month of 
age. PThr212-PSer214 (AT100)-stained sections revealed the accumulation of abnormal Tau 
conformation and phosphorylation in 7-month-old males and females (P301L TG mice and CTR 
mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P note the arrows 
pointing to the most representative aspects in TG mice). Representative sections are shown of 4 
animals used per each group. Scale bar: 40 µm. 
Chapter 4 
	  
	  
109 
	  
 
Figure 24. Quantification of AT100 immunoreactive cell counts in TG and CTR mice fed with 
different diets at 7 month of age. A-B) Quantification of AT100 immunoreactive cells in 
hippocampus and in the cortex showed a significantly increased number of AT100+ cells in TG mice 
compared to CTR mice at 7 months of age. A significant diet effect in the hippocampus of male TG 
mice was detected, as shown by a significantly increase of AT100+ cells TG mice fed with diet 14 
compared to TG mice fed with diet 18. Data were shown as mean ± SEM. DIET 14: TG male vs CTR 
male mice ††† P< 0.0001, TG female vs CTR female mice *** P< 0.0001. DIET 18: TG male vs CTR 
male mice §§ P< 0.001, §§§ P< 0.0001, TG female vs CTR female mice ### P< 0.0001. TG male diet 
18 vs diet 14 ¥¥¥ P< 0.0001. 
At 15 months of age for both male and female mice fed with different diets a 
significant genotype effect in the cortex was detected (diet 14: TG vs CTR mice 
P<0.0001, diet 18: TG male vs CTR male mice P<0.001, TG female vs CTR 
female mice P<0.0001; Fig. 26A) and in the hippocampus (both male and female 
mice diet 14: TG vs CTR mice P<0.0001, diet 18: TG vs CTR mice P<0.0001; 
Fig. 26B). A significant diet effect in the cortex and in the hippocampus of 
female TG mice was detected (TG female diet 14 vs diet 18 P<0.0001; Fig. 26B). 
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Figure 25. AT100 immunoreactivity in TG and CTR mice fed with different diets at 15 month 
of age. PThr212-PSer214 (AT100)-stained sections revealed the accumulation of abnormal Tau 
conformation and phosphorylation in 15-month-old males and females (P301L TG mice and CTR 
mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P note the arrows 
pointing to the most representative aspects in TG mice). Representative sections are shown of 4 
animals used per each group. Scale bar: 40 µm. 
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Figure 26. Quantification of AT100 immunoreactive cell counts in TG and CTR mice fed with 
different diets at 15 month of age. A-B) Quantification of AT100 immunoreactive cells in 
hippocampus and in the cortex showed a significantly increased number of AT100+ cells in TG mice 
compared to CTR mice at 15 months of age. A significant diet effect in the cortex and in the 
hippocampus of female TG mice was detected, as shown by a significantly increase of AT100+ cells 
TG mice fed with diet 18 compared to TG mice fed with diet 14. Data were shown as mean ± SEM. 
DIET 14: TG male vs CTR male mice ††† P< 0.0001, TG female vs CTR female mice *** P< 0.0001. 
DIET 18: TG male vs CTR male mice §§§ P< 0.0001, TG female vs CTR female mice ### P< 
0.0001. TG female diet 18 vs diet 14 ¥¥¥ P< 0.0001. 
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In order to describe the neurodegeneration aspects, sections of both P301L TG 
and CTR mice brains fed with different diets were treated with neuronal nuclei 
(NeuN) antibody to value the survival of neuronal populations and with 
TUNEL to value apoptotic neurons. Immunostaining of cortex and 
hippocampus with NeuN revealed, regardless of diets administrated, a loss of 
neurons in TG mice compared to CTR mice at 7 months of age, with an 
abnormal neuronal morphology and a decrease in cell size confirmed also at 15 
months of age (Fig. 27A-H, 29A-H). The NeuN+ cells were stained by the 
brown color of immunostochemystry (Fig. 27A-H).  
NeuN-immunopositive cells in the cortex and in the hippocampus were 
quantified; at 7 months of age a significant genotype effect was found between 
female TG and CTR mice fed with different diets in the cortex (diet 14: P< 
0.0001; diet 18: P< 0.0001, Fig. 28A) and in the hippocampus (diet 14: P< 
0.0001; diet 18: P< 0.0001, Fig. 28B). A significant diet effect in the cortex of 
female TG mice was detected (TG female diet 14 vs diet 18 P<0.0001; Fig. 
28A). At 15 months of age a significant genotype effect was found between 
female TG and CTR mice fed with different diets in the cortex (diet 14: P< 
0.001; diet 18: P< 0.0001, Fig. 30A) and in the hippocampus (diet 18: P< 0.001, 
Fig. 30B). Any significant diet effect in the cortex and hippocampus of TG and 
CTR mice was detected (Fig. 30A-B). 
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Figure 27. NeuN immunoreactivity in TG and CTR mice fed with different diets at 7 month of 
age. NeuN-stained sections revealed the accumulation of abnormal tau conformation and 
phosphorylation in 7-month-old males and females (P301L TG mice and CTR mice) fed with diet 14 
and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P note the arrows pointing to the most 
representative aspects in TG mice). Representative sections are shown of 4 animals used per each 
group. Scale bar: 40 µm. 
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Figure 28. Quantification of NeuN immunoreactive cell counts in TG and CTR mice fed with 
different diets at 7 month of age. A-B) Quantification of NeuN immunoreactive cells in 
hippocampus and in the cortex showed a significantly decreased number of NeuN+ cells in TG female 
mice compared to relative CTR mice at 7 months of age. A significant diet effect in the cortex of 
female TG mice was detected, as shown by a significantly increase of NeuN+ cells TG mice fed with 
diet 14 compared to TG mice fed with diet 18. Data were shown as mean ± SEM. DIET 14: TG 
female vs CTR female mice * P< 0.05. DIET 18: TG female vs CTR female mice ## P< 0.001, ### 
P< 0.0001. TG female diet 18 vs diet 14 ¥¥¥ P< 0.0001. 
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Figure 29. NeuN immunoreactivity in TG and CTR mice fed with different diets at 15 month 
of age. NeuN-stained sections revealed the accumulation of abnormal tau conformation and 
phosphorylation in 15-month-old males and females (P301L TG mice and CTR mice) fed with diet 14 
and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P note the arrows pointing to the most 
representative aspects in TG mice). Representative sections are shown of 4 animals used per each 
group. Scale bar: 40 µm. 
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Figure 30. Quantification of NeuN immunoreactive cell counts in TG and CTR mice fed with 
different diets at 15 month of age. A-B) Quantification of NeuN immunoreactive cells in 
hippocampus and in the cortex showed a significantly decreased number of NeuN+ cells in TG female 
mice compared to relative CTR mice at 15 months of age. Any significant diet effect was detected. 
Data were shown as mean ± SEM. DIET 14: TG female vs CTR female mice ** P< 0.0001. DIET 18: 
TG female vs CTR female mice ## P< 0.001, ### P< 0.0001.  
Immunostaining of cortex and hippocampus with TUNEL revealed, regardless 
of diets administrated, an increase of neurons in TG mice compared to CTR 
mice at 7 months of age, with an abnormal neuronal morphology and a decrease 
in cell size confirmed also at 15 months of age (Fig. 31A-H, 33A-H). At 7 
months of age a significant genotype effect was detected in the cortex of TG 
female mice compared to relative CTR mice (diet 14: P<0.0001, diet 18: P< 
0.0001; Fig. 32A) and in hippocampus (diet 14: P<0.001, diet 18: P< 0.001; Fig. 
32B). Any significant diet effect in the cortex and hippocampus of TG and CTR 
mice was detected (Fig. 32A-B).	   At 15 months of age a significant genotype 
effect was found both male and female TG and CTR mice fed with different 
diets in the cortex (male diet 14: P< 0.001; diet 18: P< 0.001; female diet 14: P< 
0.0001; diet 18: P< 0.0001; Fig. 34A) and in the hippocampus (male diet 14: P< 
0.001; diet 18: P< 0.001; female diet 14: P< 0.0001; diet 18: P< 0.0001 Fig. 34B). 
A significant diet effect in the cortex of female TG mice was detected (TG 
female diet 14 vs diet 18 P<0.05; Fig. 34A).	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Immunostaining of cortex and hippocampus with TUNEL revealed, regardless 
of diets administrated, an increase of neurons in TG mice compared to CTR 
mice at 7 months of age, with an abnormal neuronal morphology and a decrease 
in cell size confirmed also at 15 months of age (Fig. 31A-H, 33A-H). At 7 
months of age a significant genotype effect was detected in the cortex of TG 
female mice compared to relative CTR mice (diet 14: P< 0.0001, diet 18: P< 
0.0001; Fig. 32A) and in hippocampus (diet 14: P< 0.001, diet 18: P< 0.001; Fig. 
32B). Any significant diet effect in the cortex and hippocampus of TG and CTR 
mice was detected (Fig. 32A-B). At 15 months of age a significant genotype 
effect was found both male and female TG and CTR mice fed with different 
diets in the cortex (male diet 14: P< 0.001; diet 18: P<0.001; female diet 14: P< 
0.0001; diet 18: P< 0.0001; Fig. 34A) and in the hippocampus (male diet 14: P< 
0.001; diet 18: P< 0.001; female diet 14: P< 0.0001; diet 18: P< 0.0001; Fig. 
34B). A significant diet effect in the cortex of female TG mice was detected (TG 
female diet 14 vs diet 18 P< 0.05; Fig. 34A). 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
 
 
118 
 
 
Figure 31. TUNEL immunoreactivity in TG and CTR mice fed with different diets at 7 month 
of age. TUNEL stained sections revealed the accumulation of abnormal Tau conformation and 
phosphorylation in 7-month-old males and females (P301L TG mice and CTR mice) fed with diet 14 
and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P note the arrows pointing to the most 
representative aspects in TG mice). Representative sections are shown of 4 animals used per each 
group. Scale bar: 40 µm. 
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Figure 32. Quantification of TUNEL immunoreactive cell counts in TG and CTR mice fed 
with different diets at 7 month of age. A-B) Quantification of TUNEL immunoreactive cells in 
hippocampus and in the cortex showed a significantly increased number of TUNEL+ cells in TG mice 
compared to CTR mice at 7 months of age. Any significant diet effect in the cortex and hippocampus 
of TG and CTR mice was detected. DIET 14: TG female vs CTR female mice ** P< 0.001, *** P< 
0.0001. DIET 18: TG female vs CTR female mice ## P< 0.001, ### P< 0.0001. Data were shown as 
mean ± SEM. 
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Figure 33. TUNEL immunoreactivity in TG and CTR mice fed with different diets at 15 
month of age. TUNEL stained sections revealed the accumulation of abnormal Tau conformation 
and phosphorylation in 15-month-old males and females (P301L TG mice and CTR mice) fed with 
diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P note the arrows pointing to the 
most representative aspects in TG mice). Representative sections are shown of 4 animals used per each 
group. Scale bar: 40 µm. 
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Figure 34. Quantification of TUNEL immunoreactive cell counts in TG and CTR mice fed 
with different diets at 15 month of age. A-B) Quantification of TUNEL immunoreactive cells in 
hippocampus and in the cortex showed a significantly increased number of TUNEL+ cells in TG mice 
compared to CTR mice at 15 months of age. A significant diet effect in the hippocampus of female 
TG mice was detected, as shown by a significantly increase of TUNEL+ cells TG mice fed with diet 
18 compared to TG mice fed with diet 14. DIET 14: TG male vs CTR male mice †† P< 0.001, ††† P< 
0.0001, TG female vs CTR female mice *** P< 0.0001. DIET 18: TG male vs CTR male mice §§ P< 
0.001, §§§ P< 0.0001, TG female vs CTR female mice ### P< 0.0001. TG female diet 18 vs diet 14 ¥ 
P< 0.05. Data were shown as mean ± SEM. 
In order to analyze the neurodegeneration aspects correlated to 
hyperphosphorylation of Tau, sections of P301L TG and CTR mice brain fed 
with different diets were immunostained with neurofilaments (NFTs), aggregates 
of actin filaments that in the physiological state are needed to support the 
organization and function of cytoskeleton, but in pathological conditions are 
enriched in hyperphosphorylated Tau and beta amyloid forming the so-called 
neurofibrillary tangles, typical hallmarks of neurodegenerative diseases. 
Immunostaining of cortex and hippocampus with NFTs revealed a pathological 
state in TG mice compared to CTR mice at 7 months of age (Fig. 35), with an 
increase of the number of NFTs+ cells confirmed also at 15 months of age (Fig. 
36). 
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From the qualitative point of view, no significant effect of diets between TG and 
CTR was detected. 
 
Figure 35. NFTs immunoreactivity in TG and CTR mice fed with different diets at 7 month of 
age. NFTs stained sections revealed the accumulation of neurofilaments in 7-month-old males and 
females (P301L TG mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in 
hippocampus (E-H, M-P note the arrows pointing to the most representative aspects in TG mice). 
Representative sections are shown of 4 animals used per each group. Scale bar: 40 µm. 
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Figure 36. NFTs immunoreactivity in TG and CTR mice fed with different diets at 15 month 
of age. NFTs stained sections revealed the accumulation of neurofilaments in 15-month-old males and 
females (P301L TG mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in 
hippocampus (E-H, M-P note the arrows pointing to the most representative aspects in TG mice). 
Representative sections are shown of 4 animals used per each group. Scale bar: 40 µm. 
To analyze gliosis coronal sections of P301L TG and CTR mice brain fed with 
different diets were immunostained with glial fibrillary acid protein (GFAP) (Fig. 
37-38). Immunostaining of cortex and hippocampus with GFAP revealed a state 
of gliosis in TG mice compared to CTR mice at 7 months of age (Fig. 37), with 
an increase of the number of GFAP+ cells confirmed also at 15 months of age 
(GFAP) (Fig. 38).  
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An increase in the number of astroglial GFAP-positive cells was observed in the 
hippocampal area and in the cortex of 15-month-oldP301L TG mice compared 
to 7-month-oldP301L TG mice. The number of GFAP-positive cells increases 
with age in both CTR and TG mice.  
 
Figure 37. GFAP immunoreactivity in TG and CTR mice fed with different diets at 7 month of 
age. GFAP stained sections revealed a state of gliosis in 7-month-old males and females (P301L TG 
mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P 
note the arrows pointing that show an increase state of gliosis in TG mice). Representative sections are 
shown of 4 animals used per each group. Scale bar: 40 µm.  
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Figure 38. GFAP immunoreactivity in TG and CTR mice fed with different diets at 15 month 
of age. GFAP stained sections revealed a state of gliosis in 15-month-old males and females (P301L 
TG mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P 
note the arrows pointing that show an increase state of gliosis in TG mice). Representative sections are 
shown of 4 animals used per each group. Scale bar: 40 µm.   
Chapter 4 
 
 
126 
 
4.6 DISCUSSION 
Neurodegenerative diseases are complex diseases often caused by a combination 
of genetic and environmental risk factors, as age, sex and nutrition. The 
pathological mechanisms need to be clarified in order to develop therapeutically 
strategy to slow or spot the tauopathies. Because the underlying pathologies may 
start years before the cognitive and behavioral impairments are clinically evident, 
application of the knowledge on preventive nutritional strategies warrants early 
identification of the disease to be able to intervene and delay, or even prevent its 
onset. 
In the present study, we evaluated how two different diets (low protein-fat diet 
and high protein-fat diet) can interact with genotype, sex and age of P301L TG 
mice model of tauophaty and can reduce the progression of Tau pathology. In 
our previous work, we characterized P301L model that replicates the 
impairments found in patients affected by tauophaty in a way age-gender-
dependent, founding that females had strong cognitive impairment and this was 
strongly correlated with an increase in P-Tau, in both cerebral cortex and 
hippocampus, as well as astrogliosis. 
In this work, using P301L model, administrating the same diet (growth diet) to 
P301L TG and CTR mice until 12 weeks of age, we confirmed a gender-
genotype interaction with a significantly decrease of body weight gain in female 
TG mice compared to CTR mice. Analyzing food and water consumptions, any 
difference between TG and CTR mice was detected for food consumption, 
while water consumption was significantly increased in TG than CTR mice. 
From 12 weeks of age, mice were randomized and fed with different diets (diet 
18 high protein-fat diet and diet 14 low protein-fat diet), but a genotype effect 
overbeared diet effects. CTR mice, regardless of diets administrated, significantly 
ate and drank more than TG mice; male TG and CTR mice fed with diet 18 ate 
and drank more of mice fed with diet 14. Concerning nutrition as preventive 
care of tauophaty, lifespan of TG mice was significantly reduced than CTR mice; 
lifespan of female mice fed with diet 14 was significantly higher than female mice 
fed with diet 18. 
Several evidences show that nutrition profoundly influences lifespan [24]; dietary 
restriction has been the central focus of most research, with numerous studies 
showing that caloric restriction can improve age-related health and prolong 
lifespan across a wide range of taxa ranging from yeasts to humans. More 
recently, the “constitutive tradeoff” models have been superseded by the idea 
that macronutrients differentially facilitate survival and give rise to life-history 
tradeoffs that constrain trait evolution [25-26]. 
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Experiments in Drosophila have shown that the balance of macronutrients, 
rather than total calorie intake, is a key nutritional factor that influences lifespan, 
and the appearance of a resource-based tradeoff arises because of the different 
nutritional requirements of this biological function. Such experiments have 
shown that intake of total calories per se is not responsible for prolonging life, 
but, rather, the restriction of protein relative to carbohydrate may be the key 
under ad libitum feeding conditions [27-28]. 
In order to investigate the correlation between nutrition-cognitive impairment 
and exploratory locomotor performance, we found a highly significantly 
genotype effect that overbeared diet effects on cognitive and locomotor 
performances, with a further decrease at 15 months compared to 7 months of 
age, more pronounced in female than male TG mice. This strong genotype 
effect was also confirmed with the accumulation of hyperphosphorylated Tau in 
the cortex and in the hippocampus and correlated with a significantly decrease of 
aggregates of Tau in TG mice fed with diet 14 compared with TG mice fed with 
diet 18 at 7 months of age. This genotype effect was also found in the increase 
of distribution of neurofilaments in TG mice compared to CTR mice at 7 and 15 
months of age, but any significant diet effect was found. Recent study suggests 
that the high-fat diet in Alzheimer's disease background induces the expression 
and exon 10 inclusion of Tau in the brain of female mice [29]; the excessive 
incorporation of fatty acids in the neuronal membrane increases fluidity of 
neuronal membranes and herewith improves neurotransmission and signaling via 
increased receptor binding and enhancement of the number and affinity of 
receptors and function of ion channels [30-31-32-33].  
We also detected a major water consumption of water in mice fed with diet 18 
(high protein-fat diet), more increased in TG than CTR mice. One mechanism 
linking the intake of high total fat and saturated fat intake to cognitive 
impairment may be through the development of insulin resistance characterized 
by growth body weight and excessive consumption of water [34-35]. Insulin 
resistance leads to deficiencies in energy metabolism and increased oxidative 
stress, correlated in our mouse model with a high state of astrogliosis [36]. For 
the neuronal loss we found a female-genotype effect located in the cortex and 
hippocampus of TG mice, with a significantly increase of number of neurons in 
TG mice fed with diet 14 compared with TG mice fed with diet 18 at 7 months 
of age and a correlated decrease of number of death neurons in TG mice fed 
with diet 14 compared with TG mice fed with diet 18 at 15 months of age. In 
the cortex and hippocampus, we also detected GFAP-positive cells at 7 months 
of age, with an increase of the number of GFAP+ cells age-gender-dependent, 
revealing a state of astrogliosis age-dependent more pronounced in females than 
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in males, with a qualitative increase of GFAP+ cells in TG mice compared to 
CTR mice, not yet identified.  
In summary, we found an improvement of pathological conditions associated 
with our mouse model of tauophaty administrating a low fat-protein diet, 
occurred with an increased lifespan, a reduction of food and water consumption, 
a reduction of aggregates of hyperphosphorylated Tau and neuronal loss, more 
pronounced in female than male TG mice at 7 months of age, since 15 months 
of age a time point which pathological conditions are too severe. The 
importance of a correct dietary intake can be a useful tool for intervene in early 
identification of the neurodegenerative disease before the cognitive and 
behavioral impairments are clinically evident, in order to delay or even prevent 
the onset of tauophaty and neurodegenerative diseases. 
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5.1 ABSTRACT 
Accumulating evidence shows nutritional factors influence the risk of developing 
and progression of neurodegenerative diseases. A greater understanding of these 
mechanisms is showed by studies of oxidative stress,	   a prominent and early 
feature in Tau pathology. Several studies showed as a high fat diets induce 
oxidative stress, which may be involved in neurodegenerative diseases as 
tauophaty. In this study, young and old male and female transgenic P301L-Tau 
mice were studied in comparison with CTR mice fed with different diets (low 
fat-protein diet and high fat-protein diet) to investigate the oxidative damage and 
to investigate how diets can interact and improve a possible condition of 
oxidative stress. Immunostaining with oxidative stress markers (acrolein, 
nitrotyrosine, NOS2 and NOS3) in the cortex and hippocampus of TG and 
CTR mice revealed a significant interaction genotype-oxidative stress in TG 
mice, regardless of diets administrated, more pronounced at 15 months of age 
compared to 7 months of age. This effect was also confirmed with the 
quantification of immunoreactive cell counts for each oxidative stress markers 
that revealed a significant increase of number of immunoreactive cell counts in 
TG mice compared to CTR mice.	  At 15 months of age, immunohistochemical 
analysis and quantification cell counts correlated to oxidative marker used, had 
shown a significant diet effect in the cortex and hippocampus of TG mice, 
highlighted by a decrease of immunopositive cells in TG mice fed with low fat-
protein diet (diet 14) compared to TG mice fed with high fat-protein diet (diet 
18). This diet effect was more pronounced in female TG mice compared to male 
TG mice. We demonstrated an oxidative damage associated with P301LTG 
model in a way age-gender-dependent and an improvement of oxidative damage 
in TG mice fed with a low fat-protein diet, more pronounced in female than 
male TG mice. Results suggests that nutritional factors may have protective 
effects in the onset and development of tauopathies by reducing oxidative stress, 
leading to the development of preventive treatments for tauopathies. 
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Keywords: 
AD: Alzheimer disease, AGEs: glycation end products, CTR: control, DHA: 
docosahexaenoic acid, GSK-3b: glycogen synthase kinase-3b, NFTs: 
neurofilaments, PUFAs:	  Polyunsaturated fatty acids, ROS: reactive oxygen, RNS: 
reactive nitrogen, TG: transgenic. 
	  
5.2 INTRODUCTION 
A greater understanding of the mechanisms involved in nutritional influences on 
neurodegenerative risk and progression could help to better inform possible 
interventional strategies. Among the mechanisms most studied as a contributory 
cause of neurodegenerative diseases, oxidative stress plays a key role. Oxidative 
stress occurs when the intracellular capacity for removing free radicals is 
exceeded, leading to modification of DNA, lipids, polysaccharides, and proteins, 
and to changes in redox homeostatic balance. Oxidative stress is a prominent 
and early feature in tauopathies, in particular in AD pathology [1]. 
Tauopathies are currently considered to be groups of neurodegenerative diseases 
presenting in adults with aggregates of abnormal Tau in neurons and glial cells. 
Tau is a neuronal protein that stabilizes microtubules and axoplasmic transport, 
establishes neuronal polarity, mediates axonal outgrowth and dendritic 
positioning, and protects DNA from heat damage and oxidative stress [2]. A 
pathological hallmark of tauopathies is the deposition of excessive amounts of 
hyperphosphorylated Tau in neurons and glial cells in affected brain areas, as 
temporal cortex, hippocampus and cerebellum. Hyperphosphorylation of Tau is 
thought to suppress its ability to stabilize microtubules, resulting in axonal 
degeneration and eventual cell death [3]. Several transgenic animal models of 
tauopathies have been generated in order to understand the effects of Tau not 
only on Tau phosphorylation and aggregation and their effects on cytoskeletal 
stability and axonal transport, but also to learn about putative alterations of 
metabolic pathways the defects of which underlie cellular malfunction and 
eventual neuronal death in tauopathies. Increased inflammatory responses, 
increased oxidative stress, abnormal mitochondrial function, and abnormal 
autophagy have been described in P301S transgenic mice [4-5-6]. A number of 
reports have established damage from reactive oxygen species (ROS) not only in 
the lesions of AD, but also in neuronal populations affected in the 
neurodegenerative disease [7-8-9].	   
Persistent oxidative stress leads to reactive oxygen (ROS) and reactive nitrogen 
(RNS) species formation, as occur in AD [10]. ROS and RNS exacerbate 
oxidative stress by attacking organelles such as mitochondria.  
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Their molecular attacks result in formation of stable adducts with DNA, RNA, 
lipids, and proteins, still further compromising neuronal integrity [11]. Oxidation 
of amino acids leads to formation of advanced glycation end products (AGEs) 
or advanced oxidation protein products, and protein unfolding, rendering them 
inactive and vulnerable to cleavage. Oxidation of aliphatic side-chains yields 
peroxides and carbonyls (aldehydes and ketone) that can attack other molecules 
and generate radicals, as well as AGE accumulation. Oxidative stress and its 
responses can activate pro- inflammatory networks that exacerbate organelle 
dysfunction and pro-apoptosis mechanisms and activate or dis-inhibit GSK-3b, 
which promotes Tau phosphorylation. Interestingly, many of the pathogenic 
factors such as oxidative damage, mitochondrial dysfunction, and accumulation 
of hyperphosphorylated Tau are found at synaptic terminals in AD brain and 
models, and are associated with synaptic dysfunction. This is important because 
synaptic damage is a critical factor in cognitive decline during aging and 
progression of tauopathies as AD [12]. 
There is good evidence linking oxidative stress with synaptic dysfunction and 
loss [12-13-14]. A mouse model of AD showed loss of postsynaptic proteins was 
associated with increased oxidation [14]. This effect may involve loss of the 
omega-3 fatty acid docosahexaenoic acid (DHA), which is highly vulnerable to 
oxidative damage, showing as a dietary deficiency of DHA may be a relevant and 
modifiable risk factor in AD and emphasizing the importance of a healthy diet 
regime as a preventive therapy for neurodegenerative disease [14]. Several 
nutrients are of special interest in tauopathies, particularly those required for the 
maintenance of neuronal integrity, including antioxidants and fatty acids; changes 
in the composition and levels of fatty acids also have important implications on 
neuronal integrity during the development of neurodegenerative diseases. 
Polyunsaturated fatty acids (PUFAs), such as DHA, are essential to support 
neuronal integrity and brain function; an excess of these nutrients supplied by a 
high fat diet could support the development of neurodegenerative disease [15]. 
Accumulating evidence suggests that diet and nutrition status influence neuronal 
membrane integrity, oxidative status and risk for tauopathies; maintaining a 
healthy diet, designed to support neuronal membrane integrity and to reduce the 
oxidative damage, may reduce the risk of developing neurodegenerative diseases. 
In our first study, we demonstrated that the P301L TG mice replicates the 
impairments found in patients affected by Tauophaty in a way age-gender-
dependent, with cognitive and behavioral impairment more pronounced in 
female than male P301L TG mice. In our previous study, we demonstrated that 
a low fat-protein diet might play an important role to improve the lifespan and 
cognitive activity in a transgenic mouse model of Tauophaty (P301L), with a 
major improvement in female than male P301L TG mice. 
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In this study, young and old male and female transgenic P301L-Tau mice were 
studied in comparison with CTR mice fed with different diets (low fat-protein 
diet and high fat-protein diet) to investigate the oxidative damage in this model 
of Tauophaty and to explore the possible mechanisms through which diets can 
interact and improve a possible condition of oxidative stress. Together, these 
results add new perspectives to our understanding how dietary intake can delay 
or even prevent the oxidative damage in AD and other Tau-related pathologies, 
in order to prevent tauophaty and neurodegenerative diseases with a correct 
nutrition. 
5.3 MATERIALS AND METHODS 
5.3.1 Animals  and Diets  
Four hundred mice were used in this study. Two hundred were hemizygous Tau 
transgenic mice of mixed gender with a mutant form (P301L) of human Tau 
protein including four-repeats without amino terminal inserts, and driven by the 
mouse prion promoter 6 (MoPrP) [16]. Two hundred age-compatible wild type 
mice (B6D2F1) of mixed gender served as controls. Mice originated from 
Taconic Laboratories, USA, were bred at IRCCS Mario Negri Institute of 
Pharmacological Research in a Specific Pathogen free (SPF) facility with a 
regular 12:12 h light/dark cycle (lights on 07:00 a.m.), at a constant room 
temperature of 22 ± 2 °C, and relative humidity approximately 55 ± 10%. 
Animals were housed (n= 4 per group) in standard mouse cages, until three 
months of ages all animals were fed with standard rodent chow (diet 1: 18% 
protein and 5% fat, Harlan Lab. Tekland global diet), then animals were divided 
into two experimental groups, balanced for body weight and sex. The first group 
was fed with a standard rodent chow (diet 1: 18% protein and 5% fat, Harlan 
Lab. Tekland global diet), and the second group was fed with a low protein diet 
(diet 2: 14% protein and 3.5% fat Harlan Lab. Tekland global diet). Since the 
animals were bred in a SPF facility, where all materials introduced are sterilized, 
we had to use an autoclavable diet manufactured with high quality ingredients 
and supplemented with additional vitamins to ensure nutritional adequacy after 
autoclaving.  
The diet 1 is a fixed formula, autoclavable diet designed to support gestation, 
lactation, and growth of rodents. This diet does not contain alfalfa, thus lowering 
the occurrence of natural phytoestrogens. Typical isoflavone concentrations 
(daidzein + genistein aglycone equivalents) range from 150 to 250 mg/kg. 
Exclusion of alfalfa reduces chlorophyll, improving optical imaging clarity. 
Absence of animal protein and fishmeal minimizes the presence of nitrosamines 
(Fig. 1). 
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Figure 1: Composition of diet 1: 18% protein and 5% fat (Harlan Tekland global diet) 
The diet 2 is a fixed formula, autoclavable diet designed to promote longevity 
and normal body weight in rodents. Diet 2 does not contain alfalfa or soybean 
meal, thus minimizing the occurrence of natural phytoestrogens. Typical 
isoflavone concentrations (daidzein + genistein aglycone equivalents) range from 
non-detectable to 20 mg/kg.  
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Exclusion of alfalfa reduces chlorophyll, improving optical imaging clarity. 
Absence of animal protein and fishmeal minimizes the presence of nitrosamines 
(Fig. 2). 
 
Figure 2: Composition of diet 2: 14% protein and 3.5% fat (Harlan Tekland global diet) 
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5.3.2 Ethics  Statement 
Procedures involving animals and their care were in accordance to the national 
and international laws and policies (EEC Council Directive 86/609, OJ L 358, 1 
Dec.12, 1987; NIH Guide for the Care and use of Laboratory Animals, U.S. 
National Research Council, 2011). The Mario Negri Institute for 
Pharmacological Research (IRCCS, Milan, Italy) Animal Care and Use 
Committee (IACUC) approved the experiments, which were conducted 
according to the institutional guidelines, which are in compliance with Italian 
laws (D.L. no. 116, G.U. suppl. 40, Feb. 18, 1992, Circular No.8, G.U., Juli14, 
1994). The scientific project was approved by Italian Ministry of Health (Permit 
Number: 71/2014 B). 
 
5.3.3 Study Design 
The first point of our study was to characterize the transgenic mouse model of 
tauophaty that replicates the impairments found in patients affected by 
tauophaty in a way age-gender-dependent showing that females were more 
affected than males. Subsequently we investigated the effect of two different 
diets (high fat-protein and low fat-protein diets) on the onset and progression of 
tauophaty, finding that a low fat-protein diet may play an important role to 
improve the lifespan and cognitive activity in a transgenic mouse model of 
tauophaty (P301L), with a major improvement in female than male P301L TG 
mice. 
The aim of this study was to investigate the oxidative damage in this model of 
tauophaty and to explore the possible mechanisms through which diets can 
interact and improve a possible condition of oxidative stress. After the weaning, 
all animals were fed with the same diet (diet 1 required for the growth of the 
mice); at 3 months of age the animals were divided into two experimental 
groups: the first group fed with diet 1 and the second group fed with diet 2. Mice 
were further divided into two separate groups for studying either behavior or 
metabolic profile linked to different diets administered; in the first group 
(n=240) body weight, food and water consumption and survival rates were 
analyzed (data shown previously). 
In the second group (n=160), based on data in the literature [17-18], two time 
points were defined at 7 and 15 months of age (the first time point the 
symptoms of the disease were evident expressed, the second time point: 
maximum survival for mice affected by tauophaty), cognitive and locomotor 
aspects were evaluated utilizing behavioral tests.  
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To investigate the possible condition of oxidative stress and to investigate the 
possible mechanisms through which diets can interact and improve a possible 
condition of oxidative stress, animals were sacrificed after the behavioral tests 
and the brain were analyzed for immunohistochemical (IHC) studies, labeling 
the oxidative stress assessments as acrolein (alpha, beta-unsaturated aldehyde 
byproduct of lipid peroxidation), nitrotyrosine (marker for peroxynitrite 
formation in vivo), NOS2 and NOS3 (nitric oxide synthases the enzymes 
responsible for synthesis of NO identified the first in neurons and the second in 
endothelial cells).  
At both time points (7 and 15 months) n=12 animals were sacrificed for IHC 
analyses as described below. 
 
Figure 3: Experimental design of the study. In the study were set three time points: 3 months of 
age related to the administration of two different diets (diet 1 and diet 2), 7 and 15 months of age 
related to manifestation of the neurodisease and maximum survival of TG animals (time points for 
behavioral tests). After behavioral tests, HIC analysis and neuronal counts were conducted to value a 
condition of oxidative damage. 
 
5.3.4 Immunohis tochemistry  
 
At the end of behavioral tests animals were euthanized by cervical dislocation 
[17-18]; brains were removed and fixed in 10% formalin for 24–48 h with the 
usual procedure and embedded in paraffin.  
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After deparaffinization, brain coronal sections (3 µm thick; three slices per 
mouse) were stained for immunohistochemistry utilizing different antibodies: 
acrolein, nitrotyrosine, NOS2 and NOS3 (see table 1). Acrolein, a reactive alpha, 
beta-unsaturated aldehyde, is a common environmental pollutant, a metabolite 
of the anticancer drug cyclophosphamide, and a byproduct of lipid peroxidation.  
An increase in acrolein production has been proposed as a marker for 
Alzheimer's disease, diabetic glomerular lesions, and atherosclerosis.  
Acrolein is a potent inhibitor of cell proliferation at nonlethal doses and may act 
through effects on redox-regulated transcription factors.  
Nitric oxide (NO) is a product of the enzymatic conversion of arginine to 
citrulline by nitric oxide synthase. NO reacts rapidly with superoxide to form 
peroxynitrite. At physiological pH and in the presence of transition metals, 
peroxynitrite undergoes heterolytic cleavage to form hydroxyl anion and 
nitronium ion, the latter of which nitrates protein tyrosine residues. Thus, the 
presence of nitrotyrosine on proteins can be used as a marker for peroxynitrite 
formation in vivo. The presence of nitrotyrosine has been detected in various 
inflammatory processes including atherosclerotic plaques. 
Nitric oxide (NO) has a broad range of biological activities and has been 
implicated in signaling pathways in phylogenetically different species. Nitric 
oxide synthases (NOSs), the enzymes responsible for synthesis of NO, contain 
an N-terminal oxygenase domain and a C-terminal reductase domain. NOS 
activity requires homodimerization as well as three cosubstrates (L-arginine, 
NADPH and O2) and five cofactors or prosthetic groups (FAD, FMN, 
calmodulin, tetrahydrobiopterin and heme).  
Several distinct NOS isoforms have been described and been shown to represent 
the products of three distinct genes. These include two constitutive Ca2+/CaM-
dependent forms of NOS, including NOS1 (also designated ncNOS) whose 
activity was first identified in neurons, and NOS3 (also designated ecNOS), first 
identified in endothelial cells. The inducible form of NOS, NOS2 (also 
designated iNOS), is Ca2+-independent and is expressed in a broad range of cell 
types. The sections were incubated for 1 h at room temperature with blocking 
solutions [NITRO TYROSINE and ACROLEIN: 3% Triton X-100 plus 1% 
NGS; NOS2 and NOS3: before antigen unmasking with citrate buffer PH 6 for 
15 min in microwave; 0.1% Triton X-100 plus 1.5% NGS] and then overnight at 
4°C with the primary antibodies.  
After incubation with the biotinylated secondary antibody (1:200; 1 h at room 
temperature; Vector Laboratories, Burlingame, CA), the sections were then 
incubated for 30 minutes at room temperature with the avidin-biotin-peroxidase 
complex (Vector Laboratories) and diaminobenzidine (Sigma).  
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The sections were then lightly counterstained with hematoxylin. The specificity 
of the immunostaining was verified by incubating sections with PBS instead of 
the specific primary antibodies. 
 
Table 1: primary antibodies 
 
Antibody Species Specificity  Use Dilution Source, type 
Acrolein Mouse Neurons  Oxidative 
damage 
1:500 ABCam, mAb 
IgG1 
Nitrotyrosine Mouse Neurons  Oxidative 
damage 
1:500 ABCam, mAb 
IgG1 
NOS2 Mouse Neurons  Oxidative 
damage 
1:50 Genetex, 
mAbIgG1 
NOS3 Rabbit Neurons  Oxidative 
damage 
1:50 Genetex, 
mAbIgG 
 
5.3.4 Neuronal  Counts 
The brain areas most affected by the toxic role of Tau, characterized by the 
presence of aggregates of hyperphosphorylated Tau, deposition of neurofibrillary 
tangles, axonal dilatations, neuronal and synaptic loss, are hippocampus, 
entorhinal cortex, CA1 pyramidal layer and the basal forebrain [19-20-21-22-23]. 
In our tauophaty mouse model the accumulation of oxidative species were 
quantified in the cortex and in the hippocampus (brain coronal sections). 
Immunoreactive cells were counted by image analysis software in 3 fields using 
an Olympus Bx51 light microscope (Olympus, Italy) equipped with a digital 
camera (at x400 each field represented a tissue section area of about 0.036 mm2). 
Following manual tracing of the cortex and hippocampus at the same 
stereotactic level in all mice, the number of positive cells were manually tagged, 
counted and oxidative damage scoring system was used. Grading is based on 
quantification of immunoreactive positive cells. 
Oxidative damage scoring (histological) was as follows: 
0=normal (no oxidative damage) 
1=mild presence of oxidative damage (corresponding to 25% of immunoreactive 
positive cells) 
2=moderate presence of oxidative damage (corresponding to 50% of 
immunoreactive positive cells) 
3=severe presence of oxidative damage (corresponding to 75% of 
immunoreactive positive cells) 
4=total presence of oxidative damage (corresponding to 100% of 
immunoreactive positive cells). 
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Every section was individually examined for the presence or absence of positive 
signaling in the nucleus neuronal (acrolein, nitrotyrosine, NOS2 and NOS3). The 
observer was not aware of the origin of the sections.  
5.3.5 Stat i s t i ca l  Analys i s  
Statistical analyses were performed using Graph Pad Prism 6 program. Neuronal 
counts data were analyzed using two-way ANOVA, followed by Tukey’s post hoc 
test.  
 
5.4 RESULTS 
5.4.1 Immunohis tochemistry  and Neuronal  Counts  
Sections of both P301L TG and CTR mice brains were screened with acrolein, 
nitrotyrosine, NOS2 and NOS3 (Fig.4-6-8-10-12 respectively), in order to 
understand if oxidative damage was present and if different diets (diet 18: 18% 
protein and 5% and diet 14: 14% protein and 3.5% fat) can improve a 
hypothetical condition of oxidative status and progression of tauophaty. 
Immunostaining applied to cortex and hippocampus with acrolein antibody 
revealed that, regardless of diets administrated, in P301L TG mice the oxidative 
status was present at both 7 and 15 months of age (diet 14: Fig. 4B-F-D-H, Fig. 
6B-F-D-H, diet 18: Fig. 4J-N-L-P,Fig. 6J-N-L-P).  
These brain areas were subsequently quantified by acrolein immunoreactive cell 
counts (Fig. 5A-B and 7A-B).  At 7 months of age for both male and female 
mice fed with different diets, a significant genotype effect in the cortex was 
detected (diet 14: TG female vs CTR female mice P<0.0001, diet 18: TG female 
vs CTR female mice P<0.001; Fig. 5A) and in the hippocampus (diet 18: TG 
male vs CTR male mice P<0.0001, TG female vs CTR female mice P<0.0001; 
Fig. 5B). At 7 month of age, any significant diet effect in the cortex of male and 
female TG mice was detected (P>0.05). At 15 months of age for both male and 
female mice fed with different diets, a significant genotype effect in the cortex 
was detected (diet 14: TG male vs CTR male mice P<0.05, TG female vs CTR 
female mice P<0.0001, diet 18: TG male vs CTR male mice P<0.0001, TG 
female vs CTR female mice P<0.0001; Fig. 7A) and in the hippocampus (diet 14: 
TG male vs CTR male mice P<0.05, TG female vs CTR female mice P<0.0001; 
diet 18: TG male vs CTR male mice P<0.0001, TG female vs CTR female mice 
P<0.0001Fig. 6B). A significant diet effect in the cortex and hippocampus of 
female TG mice was detected (cortex: TG diet 14 vs TG diet 18 P<0.05; 
hippocampus: TG diet 14 vs TG diet 18 P<0.00001; Fig. 6B).  
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Also in the hippocampus of CTR female mice a significant diet effect was 
detected (CTR diet 14 vs CTR diet 18 P<0.05; Fig. 6B). 
 
Figure 4. Acrolein immunoreactivity in TG and CTR mice fed with different diets at 7 month 
of age. Acrolein stained sections revealed the positive signal in 7-month-old males and females (P301L 
TG mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P 
note the arrows pointing to the most representative aspects in TG mice). Representative sections are 
shown of 4 animals used per each group. Scale bar: 40 µm. 
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Figure 5. Quantification of Acrolein immunoreactive cell counts in TG and CTR mice fed with 
different diets at 7 month of age. A-B) Quantification of Acrolein immunoreactive cells in the 
cortex and in hippocampus showed a significantly increased number of Acrolein+ cells in TG mice 
compared to CTR mice, regardless of diet administrated, at 7 months of age. Any significant diet effect 
in the cortex and hippocampus of male and female TG mice was detected. Data were shown as mean 
± SEM.DIET 14: TG female vs CTR female mice ** P< 0.001. DIET 18: TG male vs CTR male mice 
†† P< 0.001, TG female vs CTR female mice ### P< 0.0001.  
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Figure 6. Acrolein immunoreactivity in TG and CTR mice fed with different diets at 15 month 
of age. Acrolein stained sections revealed the positive signal in 7-month-old males and females (P301L 
TG mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P 
note the arrows pointing to the most representative aspects in TG mice). Representative sections are 
shown of 4 animals used per each group. Scale bar: 40 µm. 
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Figure 7. Quantification of Acrolein immunoreactive cell counts in TG and CTR mice fed with 
different diets at 15 month of age. A-B) Quantification of acrolein immunoreactive cells in 
hippocampus and in the cortex showed a significantly increased number of acrolein+ cells in TG mice 
compared to CTR mice at 15 months of age. A significant diet effect in the cortex and hippocampus of 
female TG mice was detected, as shown by a significantly increase of acrolein+ cells TG mice fed with 
diet 18 compared to TG mice fed with diet 14. DIET 18: TG male vs CTR male mice ††† P< 0.0001, 
TG female vs CTR female mice ### P< 0.0001. DIET 14: TG male vs CTR male mice ¤ P< 0.05, 
TG female vs CTR female mice *** P< 0.0001. TG female diet 18 vs TG female diet 14 § P< 0.05, §§§ 
P< 0.0001; CTR female diet 18 vs CTR female diet 14 α P< 0.05. Data were shown as mean ± SEM. 
 
 
 
A 
B 
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Immunostaining applied to cortex and hippocampus with nitrotyrosine antibody 
revealed that, regardless of diets administrated, in P301L TG mice the oxidative 
status was present at both 7 and 15 months of age (diet 14: Fig. 8B-F-D-H, Fig. 
10B-F-D-H, diet 18: Fig. 8J-N-L-P, Fig. 10J-N-L-P).  
These brain areas were subsequently quantified by nitrotyrosine immunoreactive 
cell counts (Fig. 9A-B and 11A-B).  At 7 months of age for both male and 
female mice, regardless of diets administrated, a significant genotype effect in the 
cortex was detected (diet 14: TG female vs CTR female mice P<0.05, diet 18: 
TG female vs CTR female mice P<0.0001; Fig. 9A) and in the hippocampus 
(diet 18: TG male vs CTR male mice P<0.0001, Fig. 9B). At 7 month of age, in 
the hippocampus of TG male mice a significant diet effect was detected (TG diet 
14 vs TG diet 18 P<0.05; Fig. 9B).  
At 15 months of age for both male and female mice fed with different diets, a 
significant genotype effect in the cortex was detected (diet 14: TG male vs CTR 
male mice P<0.001, diet 18: TG female vs CTR female mice P<0.0001, Fig. 
11A) and in the hippocampus (diet 14: TG female vs CTR female mice 
P<0.0001; diet 18: TG male vs CTR male mice P<0.0001, TG female vs CTR 
female mice P<0.0001; Fig. 11B).  
A significant diet effect in the cortex and hippocampus of TG mice was detected 
(cortex: TG male mice diet 14 vs diet 18 P<0.05, TG female mice diet 14 vs diet 
18 P<0.0001; hippocampus: TG male mice diet 14 vs TG diet 18 P<0.0001; Fig. 
11B). 
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Figure 8. Nitrotyrosine immunoreactivity in TG and CTR mice fed with different diets at 7 
month of age. Nitrotyrosine stained sections revealed the positive signal in 7-month-old males and 
females (P301L TG mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in 
hippocampus (E-H, M-P note the arrows pointing to the most representative aspects in TG mice). 
Representative sections are shown of 4 animals used per each group. Scale bar: 40 µm. 
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Figure 9. Quantification of nitrotyrosine immunoreactive cell counts in TG and CTR mice fed 
with different diets at 7 month of age. A-B) Quantification of nitrotyrosine immunoreactive cells in 
the cortex and in hippocampus showed a significantly increased number of nitrotyrosine+ cells in TG 
mice compared to CTR mice, regardless of diets administrated, at 7 months of age. A significant diet 
effect in hippocampus of male TG mice was detected, as shown by a significantly increase of 
nitrotyrosine+ cells TG mice fed with diet 18 compared to TG mice fed with diet 14. DIET 18: TG 
male vs CTR male mice ††† P< 0.0001, TG female vs CTR female mice ## P< 0.001. DIET 14: TG 
female vs CTR female mice * P< 0.05. TG male diet 18 vs TG male diet 14 ¥ P< 0.05. Data were 
shown as mean ± SEM. 
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Figure 10. Nitrotyrosine immunoreactivity in TG and CTR mice fed with different diets at 15 
month of age. Nitrotyrosine stained sections revealed the positive signal in 15-month-old males and 
females (P301L TG mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in 
hippocampus (E-H, M-P note the arrows pointing to the most representative aspects in TG mice). 
Representative sections are shown of 4 animals used per each group. Scale bar: 40 µm. 
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Figure 11. Quantification of nitrotyrosine immunoreactive cell counts in TG and CTR mice fed 
with different diets at 15 month of age. A-B) Quantification of nitrotyrosine immunoreactive cells 
in the cortex and in hippocampus showed a significantly increased number of nitrotyrosine+ cells in 
TG mice compared to CTR mice, regardless of diets administrated, at 15 months of age. A significant 
diet effect in the cortex and in hippocampus of male and female TG mice was detected, as shown by a 
significantly increase of nitrotyrosine+ cells TG mice fed with diet 18 compared to TG mice fed with 
diet 14. DIET 18: TG male vs CTR male mice ¤¤¤ P< 0.0001, TG female vs CTR female mice ### 
P< 0.0001. DIET 14: TG male vs CTR male mice ††† P< 0.0001, TG female vs CTR female mice *** 
P< 0.0001. TG male diet 18 vs TG male diet 14 ¥ P< 0.05, ¥¥ P<0.001. TG female diet 18 vs TG 
female diet 14 §§§ P< 0.0001 Data were shown as mean ± SEM. 
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Immunostaining applied to cortex and hippocampus with NOS2 antibody 
revealed that, regardless of diets administrated, in P301L TG mice the oxidative 
status was present at 15, but not at 7 months of age (diet 14: Fig. 12B-F-D-H, 
Fig. 14B-F-D-H, diet 18: Fig. 12J-N-L-P, Fig. 14J-N-L-P). These brain areas 
were subsequently quantified by NOS2 immunoreactive cell counts (Fig. 13A-B 
and 15A-B). At 7 months of age for both male and female mice fed with 
different diets, any significant genotype and diet effect in the cortex and in 
hippocampus was detected (P>0.05).  
At 15 months of age for both male and female mice fed with different diets, a 
significant genotype effect in the cortex was detected (diet 14: TG male vs CTR 
male mice P<0.0001, TG female vs CTR female mice P<0.0001; diet 18: TG 
male vs CTR male mice P<0.0001, TG female vs CTR female mice P<0.0001, 
Fig. 15A) and in the hippocampus (diet 14: TG male vs CTR male mice 
P<0.0001, TG female vs CTR female mice P<0.0001; diet 18: TG male vs CTR 
male mice P<0.0001, TG female vs CTR female mice P<0.0001, Fig. 15B). A 
significant diet effect in the cortex of TG female mice (TG female mice diet 14 
vs diet 18 P<0.0001) and in the hippocampus of TG male mice (TG male mice 
diet 14 vs TG diet 18 P<0.05; Fig. 15B) was detected. 
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Figure 12. NOS2 immunoreactivity in TG and CTR mice fed with different diets at 7 month of 
age. NOS2 stained sections revealed the positive signal in 7-month-old males and females (P301L TG 
mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P 
note the arrows pointing to the most representative aspects in TG mice). Representative sections are 
shown of 4 animals used per each group. Scale bar: 40 µm. 
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Figure 13. Quantification of NOS2 immunoreactive cell counts in TG and CTR mice fed with 
different diets at 7 month of age. A-B) Quantification of NOS2 immunoreactive cells in the cortex 
and in hippocampus showed any significant difference between TG and CTR mice fed with different 
diets. 
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Figure 14. NOS2 immunoreactivity in TG and CTR mice fed with different diets at 15 month 
of age. NOS2 stained sections revealed the positive signal in 15-month-old males and females (P301L 
TG mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P 
note the arrows pointing to the most representative aspects in TG mice). Representative sections are 
shown of 4 animals used per each group. Scale bar: 40 µm. 
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Figure 15. Quantification of NOS2 immunoreactive cell counts in TG and CTR mice fed with 
different diets at 15 month of age. A-B) Quantification of Nos2 immunoreactive cells in the cortex 
and in hippocampus showed a significantly increased number of NOS2+ cells in TG mice compared 
to CTR mice, regardless of diets administrated, at 15 months of age. A significant diet effect in the 
cortex and in hippocampus of female and male TG mice was detected, as shown by a significantly 
increase of Nos2+ cells TG mice fed with diet 18 compared to TG mice fed with diet 14. DIET 18: 
TG male vs CTR male mice ††† P< 0.0001, TG female vs CTR female mice ### P< 0.0001. DIET 
14: TG male vs CTR male mice ¤¤¤ P< 0.0001, TG female vs CTR female mice *** P< 0.0001. TG 
male diet 18 vs TG male diet 14 ¥ P< 0.05; TG female diet 18 vs TG female diet 14 §§§ P< 0.0001 
Data were shown as mean ± SEM. 
Immunostaining applied to cortex and hippocampus with NOS3 antibody 
revealed that, regardless of diets administrated, in P301L TG mice the oxidative 
status was present both at 7 and 15months of age (diet 14: Fig. 16B-F-D-H, Fig. 
18B-F-D-H, diet 18: Fig. 16J-N-L-P,Fig. 18J-N-L-P).  
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These brain areas were subsequently quantified by NOS3 immunoreactive cell 
counts (Fig. 17A-B and 19A-B).  At 7 months of age for both male and female 
mice, regardless diets administrated, a significant genotype effect in the cortex 
was detected (diet 14: TG female vs CTR female mice P<0.0001; diet 18: TG 
male vs CTR male mice P<0.0001, TG female vs CTR female mice P<0.0001, 
Fig. 17A) and in the hippocampus (diet 14: TG male vs CTR male mice 
P<0.0001, TG female vs CTR female mice P<0.0001; diet 18: TG male vs CTR 
male mice P<0.05, TG female vs CTR female mice P<0.0001, Fig. 17B).  
A significant diet effect in the cortex of TG mice (TG female mice diet 14 vs 
diet 18 P<0.001, TG male mice diet 14 vs TG diet 18 P<0.05; Fig. 17B) was 
detected. At 15 months of age for both male and female mice fed with different 
diets, a significant genotype effect in the cortex was detected (diet 14: TG male 
vs CTR male mice P<0.0001, TG female vs CTR female mice P<0.0001; diet 18: 
TG male vs CTR male mice P<0.0001, TG female vs CTR female mice 
P<0.0001, Fig. 19A) and in the hippocampus (diet 14: TG female vs CTR female 
mice P<0.0001; diet 18: TG male vs CTR male mice P<0.0001, TG female vs 
CTR female mice P<0.0001, Fig. 19B). A significant diet effect in the cortex and 
hippocampus of TG female mice (cortex: TG mice diet 14 vs diet 18 P<0.0001, 
hippocampus: TG mice diet 14 vs diet 18 P<0.05; Fig. 19B) was detected. 
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Figure 16. NOS3 immunoreactivity in TG and CTR mice fed with different diets at 7 month of 
age. NOS3 stained sections revealed the positive signal in 7-month-old males and females (P301L TG 
mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P 
note the arrows pointing to the most representative aspects in TG mice). Representative sections are 
shown of 4 animals used per each group. Scale bar: 40 µm. 
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Figure 17. Quantification of NOS3 immunoreactive cell counts in TG and CTR mice fed with 
different diets at 7 month of age. A-B) Quantification of NOS3 immunoreactive cells in the cortex 
and in hippocampus showed a significantly increased number of NOS3+ cells in TG mice compared 
to CTR mice, regardless of diets administrated, at 7 months of age. A significant diet effect in the 
cortex of male and female TG mice was detected, as shown by a significantly increase of NOS3+ cells 
TG mice fed with diet 18 compared to TG mice fed with diet 14. DIET 18: TG male vs CTR male 
mice ††† P< 0.0001, TG female vs CTR female mice ### P< 0.0001. DIET 14: TG male vs CTR 
male mice ¤¤ P< 0.001, TG female vs CTR female mice *** P< 0.0001. TG male diet 18 vs TG male 
diet 14 ¥ P< 0.05; TG female diet 18 vs TG female diet 14 §§ P< 0.001. Data were shown as mean ± 
SEM. 
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Figure 18. NOS3 immunoreactivity in TG and CTR mice fed with different diets at 15 month 
of age. NOS3 stained sections revealed the positive signal in 15-month-old males and females (P301L 
TG mice and CTR mice) fed with diet 14 and 18 in cortex (A-D, I-L) and in hippocampus (E-H, M-P 
note the arrows pointing to the most representative aspects in TG mice). Representative sections are 
shown of 4 animals used per each group. Scale bar: 40 µm. 
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Figure 19. Quantification of NOS3 immunoreactive cell counts in TG and CTR mice fed with 
different diets at 15 month of age. A-B) Quantification of Nos3 immunoreactive cells in the cortex 
and in hippocampus showed a significantly increased number of NOS3+ cells in TG mice compared 
to CTR mice, regardless of diets administrated, at 15 months of age. A significant diet effect in the 
cortex and hippocampus of female TG mice was detected, as shown by a significantly increase of 
Nos3+ cells TG mice fed with diet 18 compared to TG mice fed with diet 14. DIET 18: TG male vs 
CTR male mice †† P< 0.001, ††† P< 0.0001, TG female vs CTR female mice ### P< 0.0001. DIET 
14: TG male vs CTR male mice ¤¤¤ P< 0.0001, TG female vs CTR female mice *** P< 0.0001. TG 
female diet 18 vs TG female diet 14 § P< 0.05; TG female diet 18 vs TG female diet 14 §§§ P< 0.0001. 
Data were shown as mean ± SEM. 
After detected an oxidative damage in the mouse model of tauophaty used in 
this study, confirming a greater increase of oxidative damage in females than 
males TG mice (as described in the first article on the characterization of P301L 
line used in this project), a possible correlation increase of age- oxidative damage 
was investigated too.  
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The cortex and hippocampus of male and female TG mice fed with different 
diets at 7 and 15 months of age were quantified by acrolein, nitrotyrosine, NOS2 
and NOS3 immunoreactive cell counts; for each antibody used, a significant 
interaction oxidative damage-time was found, regardless of diet administrated, as 
shown by the increase of antibody-immunopositive cells numbers in 15-month-
old TG mice (both male and female) compared to 7-month-old TG mice in the 
cortex and in the hippocampus (P<0.0001; Fig. 20A-B, 21A-B, 22A-B,23 A-B). 
For each antibody used, also a significant interaction diet-oxidative damage-time 
was found, as shown by the increase of antibody-immunopositive cells numbers 
in 15-month-old TG mice (both male and female) fed with diet 18 compared to 
7-month-old TG mice fed with diet 14 in the cortex and in the hippocampus 
(P<0.0001,Fig. 20A-B, 21A-B, 22A-B, 23 A-B). 
 
Figure 20. Quantification of acrolein immunoreactive cell counts in TG mice fed with different 
diets at 7 and 15 month of age. A-B) Quantification of acrolein immunoreactive cells in the cortex 
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and in hippocampus showed a significantly interaction oxidative damage-time shown by an increase of 
number of acrolein+ cells in 15-months-old TG mice compared to 7-months-old TG mice, regardless 
of diets administrated. A significant diet-oxidative damage-time interaction in the cortex and 
hippocampus of TG mice was detected, as shown by a significantly increase of acrolein+ cells 15-
months-old TG mice fed with diet 18 compared to 7-months-old TG mice fed with diet 14. DIET 18: 
7-month-old vs 15-month-old TG male mice *** P< 0.0001, 7-month-old vs 15-month-old TG female 
mice ††† P< 0.0001. DIET 14: 7-month-old vs 15-month-old TG male mice ## P<0.001, 7-month-
old vs 15-month-old TG female mice §§§ P< 0.0001.15-month-old TG mice diet 18 vs 7-month-old 
TG mice diet 14 male ααα P< 0.0001, female ¥¥¥ P< 0.0001. Data were shown as mean ± SEM.	  
 
Figure 21. Quantification of nitrotyrosine immunoreactive cell counts in TG mice fed with 
different diets at 7 and 15 month of age. A-B) Quantification of nitrotyrosine immunoreactive cells 
in the cortex and in hippocampus showed a significantly interaction oxidative damage-time shown by 
an increase of number of nitrotyrosine+ cells in 15-months-old TG mice compared to 7-months-old 
TG mice, regardless of diets administrated. A significant diet-oxidative damage-time interaction in the 
cortex and hippocampus of TG mice was detected, as shown by a significantly increase of acrolein+ 
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cells 15-months-old TG mice fed with diet 18 compared to 7-months-old TG mice fed with diet 14. 
DIET 18: 7-month-old vs 15-month-old TG male mice *** P< 0.0001, 7-month-old vs 15-month-old 
TG female mice ††† P< 0.0001. DIET 14: 7-month-old vs 15-month-old TG male mice # P< 0.05, 7-
month-old vs 15-month-old TG female mice §§ P< 0.001. 15-month-old TG mice diet 18 vs 7-month-
old TG mice diet 14 male ααα P< 0.0001, female ¥¥¥ P< 0.0001. Data were shown as mean ± SEM. 
 
Figure 22. Quantification of NOS2 immunoreactive cell counts in TG mice fed with different 
diets at 7 and 15 month of age. A-B) Quantification of NOS2 immunoreactive cells in the cortex 
and in hippocampus showed a significantly interaction oxidative damage-time shown by an increase of 
number of NOS2+ cells in 15-months-old TG mice compared to 7-months-old TG mice, regardless 
of diets administrated. A significant diet-oxidative damage-time interaction in the cortex and 
hippocampus of TG mice was detected, as shown by a significantly increase of acrolein+ cells 15-
months-old TG mice fed with diet 18 compared to 7-months-old TG mice fed with diet 14. DIET 18: 
7-month-old vs 15-month-old TG male mice *** P< 0.0001, 7-month-old vs 15-month-old TG female 
mice ††† P< 0.0001. DIET 14: 7-month-old vs 15-month-old TG male mice ### P< 0.0001, 7-
month-old vs 15-month-old TG female mice §§§ P< 0.0001. 15-month-old TG mice diet 18 vs 7-
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month-old TG mice diet 14 male ααα P< 0.0001, female ¥¥¥ P< 0.0001. Data were shown as mean 
± SEM. 
 
Figure 23. Quantification of NOS3 immunoreactive cell counts in TG mice fed with different 
diets at 7 and 15 month of age. A-B) Quantification of NOS3 immunoreactive cells in the cortex 
and in hippocampus showed a significantly interaction oxidative damage-time shown by an increase of 
number of NOS3+ cells in 15-months-old TG mice compared to 7-months-old TG mice, regardless 
of diets administrated. A significant diet-oxidative damage-time interaction in the cortex and 
hippocampus of TG mice was detected, as shown by a significantly increase of acrolein+ cells 15-
months-old TG mice fed with diet 18 compared to 7-months-old TG mice fed with diet 14. DIET 18: 
7-month-old vs 15-month-old TG female mice ††† P< 0.0001. DIET 14: 7-month-old vs 15-month-
old TG male mice ## P< 0.001. 15-month-old TG mice diet 18 vs 7-month-old TG mice diet 14 male 
ααα P< 0.0001, female ¥¥¥ P< 0.0001. Data were shown as mean ± SEM. 
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5.5 DISCUSSION 
Tauopathies are neurodegenerative disease characterized by agglomerates of 
hyperphosphorylated Tau and neurofibrillary tangles, typical hallmarks of most 
neurodegenerative disease, as AD. Although the pathological mechanisms 
driving Tau to hyperphosphorylation and oligomerization in vivo are poorly 
understood [19], the oxidative stress is an important player in the pathogenesis 
of neurodegenerative diseases [20]. Increased oxidative stress has been 
implicated in the process of aging, thus is a major contributing risk factor in the 
progression of neurodegeneration. The brain is highly susceptible to oxidative 
imbalance due to its high-energy demand, high oxygen consumption, rich 
abundance of easily peroxidable polyunsaturated fatty acids, high level of potent 
ROS catalyst iron, and relative paucity of antioxidants and related enzymes [21]. 
Hippocampus, basal forebrain and cortex are the brain areas that are involved in 
learning and memory formation and are the most vulnerable areas susceptible to 
oxidative stress [22-23]. Thus, in an obvious way oxidative imbalance 
subsequently leads to oxidative stress mediated damage to the biomolecules that 
is widely reported in pathogenesis of various neurodegenerative disorders, as 
tauopathies.  
In our previous works, we characterized P301L model that replicates the 
impairments found in patients affected by tauophaty in a way age-gender-
dependent, we investigated the effects of two different diets (high fat-protein 
diet and low fat-protein diet) on cognitive and behavioral impairments in this 
mouse model of tauophaty, founding an improvement of pathological conditions 
administrating a low fat-protein diet, occurred with an increased lifespan, a 
reduction of food and water consumption, a reduction of aggregates of 
hyperphosphorylated Tau and neuronal loss. 
In this study, young and old male and female transgenic P301L-Tau mice fed 
with different diets (low fat-protein diet and high fat-protein diet) were studied 
in comparison with CTR mice to investigate the oxidative damage in this model 
of Tauophaty and to explore the possible mechanisms through which diets can 
interact and improve a possible condition of oxidative damage. All oxidative 
stress markers used in this project for brain immunohistochemical studies 
(acrolein, nitrotyrosine, NOS2 and NOS3) revealed a significant interaction 
genotype-oxidative damage in TG mice, regardless of diets administrated, more 
pronounced at 15 months of age compared to 7 months of age. This effect was 
also confirmed with the quantification of immunoreactive cell counts for each 
oxidative stress markers that revealed a significant increase of number of 
immunoreactive cell counts in TG mice compared to CTR mice. In particular, 
immunostaining of acrolein, a byproduct of lipid peroxidation, reveled a higher 
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increase of immunopositive cells in TG mice compared to CTR mice at 7 
months of age that was found to be doubled at 15 months of age.  
Several studies had shown as oxidative damage has an important role in the 
development of many tauopathies [24-25-26], but very little is known about 
oxidative stress in FTLD (disease which has affected the animal model used in 
this study). A study carried out on human patients affected by FTLD had 
revealed,	   using anti-HNE (4-Hydroxynonenal) antibodies and MS (Mowse 
scores), an increased lipoxidative damage in the frontal cortex, identifying 
astrocytes as targets of lipoxidative damage, GFAP as a target of lipoxidation, 
and that astrocytes were crucial elements of oxidative stress responses in FTLD 
[27]. After detected an oxidative damage in the mouse model of Tauophaty used 
in this study, we investigated a possible interaction between diets and oxidative 
damage, valuating if diets can improve this pathological condition.  
At 7 months of age, immunostaining applied to cortex and hippocampus of CTR 
and TG mice with acrolein and NOS2 antibodies revealed any significant 
interaction diet- oxidative damage. In the same brain areas, immunostaining with 
nitrotyrosine antibody revealed in the hippocampus of TG male mice a 
significant diet effect, highlighted by a decrease of nitrotyrosine+ cells in TG 
mice fed with low fat-protein diet (diet 14) compared to TG mice fed with high 
fat-protein diet (diet 18). Immunostaining with NOS3 antibody revealed in the 
cortex of TG mice (both males and females) a significant diet effect, highlighted 
by a decrease of NOS3+ cells in TG mice fed with low fat-protein diet (diet 14) 
compared to TG mice fed with high fat-protein diet (diet 18). 
At 15 months of age, for each oxidative marker used for immunohistochemistry 
in this study, a significant diet effect in the cortex and hippocampus of TG mice 
was detected, highlighted by a decrease of immunopositive cells in TG mice fed 
with low fat-protein diet (diet 14) compared to TG mice fed with high fat-
protein diet (diet 18). This diet effect was more pronounced in female TG mice 
compared to male TG mice, confirming a genotype-gender effect showed in 
previous works. 
After detected an oxidative damage in the mouse model of Tauophaty used in 
this study, found an improvement of oxidative status in TG mice fed with low 
fat-protein diet, a possible correlation increase of age- oxidative damage was 
investigated too. The cortex and hippocampus of male and female TG mice fed 
with different diets at 7 and 15 months of age were quantified by acrolein, 
nitrotyrosine, NOS2 and NOS3 immunoreactive cell counts; for each antibody 
used, a significant interaction oxidative damage-time was found, regardless of 
diet administrated, as shown by the increase of antibody-immunopositive cells 
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numbers in 15-month-old TG mice (both male and female) compared to 7-
month-old TG mice in the cortex and in the hippocampus. 
For each oxidative marker used, also a significant interaction diet-oxidative 
damage-time was found, as shown by the increase of antibody-immunopositive 
cells numbers in 15-month-old TG mice (both male and female) fed with diet 18 
compared to 7-month-old TG mice fed with diet 14 in the cortex and in the 
hippocampus. 
Several studies showed as high fat diets induce oxidative stress that may be 
involved in neurodegenerative diseases, in particular the hippocampus is the 
primary region of the brain for spatial learning and memory, as well as for 
neurogenesis that continues into adulthood, and it is susceptible to the effects of 
high-fat diets [28]. Previous research has clarified that a high-fat diet can impair 
hippocampal synaptic plasticity as well as hippocampus-dependent learning and 
memory [29]. The central role of lipids in maintaining neuronal integrity has clear 
implications for dietary management for neurodegenerative diseases prevention 
and management. A high ratio of saturated/unsaturated fatty acids in the diet 
leads to an increase in LDL and a decrease in high-density lipoprotein 
cholesterol; this change may significantly alter the oxidative status in the brain, 
and consequently oxidative stress causes increased Tau phosphorylation, 
facilitates the conformational conversion and assembly of Tau fibrils, and 
impairs the proteasomal and lysosomal activity that may lead to progressive 
accumulation of protein deposits [30-31]. 
In summary, we found an oxidative damage associated with our mouse model of 
Tauophaty in a way age-gender-dependent, confirming that female TG mice 
were more affected by Tauophaty then male TG mice. Administering different 
diets to TG and CTR mice, we found an improvement of oxidative damage 
associated with our mouse model of tauophaty administrating a low fat-protein 
diet, occurred with a decreased of immunopositive cells numbers correlated to 
oxidative markers used for immunohistochemistry (acrolein, nitrotyrosine, 
NOS2 and NOS3), more pronounced in female than male TG mice. Oxidative 
stress plays a central role in the development of neurodegenerative disease, 
contributing to loss of neuronal integrity in tauopathies as AD.  
A correct dietary intake, consisting of nutrients with antioxidant properties, low 
fat and protein, may have protective effects in the onset and development of 
tauopathies by reducing oxidative stress, particularly when used in combination.	  	  
Moreover, preventing or reducing the oxidative damage with a low fat-protein 
diet in this model, may represent a system to study the correlation between 
nutrition and pathological mechanisms underlying tauopathies and could finally 
lead to the development of preventive treatments for tauopathies, like AD. 
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Chapter 6: A high fat-protein diet induces nonalcoholic fatty liver 
disease (NAFLD) in young and aged P301L TG mice model of 
tauophaty 
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6.1 ABSTRACT 
Growing evidence supports the concept that insulin resistance and metabolic 
dysfunction are mediators of tauopathies as AD, and tauopathies could be 
regarded as a metabolic disease mediated by brain insulin and IGF resistance. In 
particular, a crosslink between insulin resistance-dysregulates lipid metabolism 
and oxidative stress seems to be the cause of hepatic dysfunctions as fibrosis or 
steatosis including nonalcoholic fatty liver disease (NAFLD). In this study we 
investigated in males and females P301L TG mice and B6D2F1 control mice at 
7 and 15 months of age fed with different diets a possible condition of 
nonalcoholic fatty liver disease (NAFLD) valuating macroscopy, histology and 
immunohistochemical profiles (H&E and Sirius Red) of liver and spleen 
removed from each experimental group. We also evaluated the concentration of 
molecules and enzymes related to hepatic activity as cholesterol, triglycerides, 
alanine aminotransferase and aspartate aminotransferase in plasma of TG and 
CTR mice at 7 and 15 months of age. Macroscopy analysis revealed a significant 
difference in the aspect, size and weight in liver and spleen removed from TG 
mice compared to CTR mice, regardless of diet administrated, in a way age-
dependent. At 15 months of age, these alterations were also correlated to a 
significant diet effect showed by significative increase of size and weight of 
tissues removed from TG mice fed with high fat-protein diet compared to TG 
mice fed with low fat-protein diet. Immunohistochemical analysis (H&E 
immunostaining and Sirius red) of liver and spleen removed from TG and CTR 
mice replicated the previous results revealing an age-dependent lobular 
inflammatory infiltrate with increased vascularity and a state of fibrosis in P301L 
TG mice, more pronounced in TG mice fed with high fat-protein diet. These 
results were confirmed by biochemical analysis on plasma that showed, except 
for the measurement of total cholesterol (which values were included into 
reference intervals of values for biochemical analytes), a high increase of the 
median levels of triglycerides, AST and ALT in TG mice, more pronounced in 
TG mice fed with high fat-protein diet. In summary, in this study we 
demonstrated a correlation between hyperphosphorylated Tau, insulin/IGF 
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resistance and high fat-protein diet consumption in P301L TG mice expressed 
on peripheral organs as hepatic insulin resistance and fatty accumulation in the 
liver, which induced nonalcoholic fatty liver disease.  
Keywords: 
AD: Alzheimer disease, ALT: alanine aminotransferase, AST: aspartate 
aminotransferase CTR: control, FFA: free fatty acid, NAFLD: nonalcoholic fatty 
liver disease, NFTs: neurofilaments, IGF: insulin growth factor, ROS: reactive 
oxygen, RNS: reactive nitrogen, TG: transgenic. 
 
6.2 BACKGROUND 
During necropsy analysis performed after the behavioral tests in P301L TG and 
B6D2F1 CTR mice fed with different diets (diet 18: high fat-protein diet and 
diet 14: low fat-protein diet), we observed an alteration of the size of the liver 
and spleen in TG mice fed with a high fat-protein diet at 7 and 15 months of 
age. This apparent condition of hepatomegaly was associated to an increase of 
body weight, food and water consumption in TG mice fed with high fat-protein 
diet. Based on data obtained in our previous works, the mouse model of 
tauophaty used in this study showed:  
1) a gender-genotype interaction, with a strong cognitive impairment in 
female than male mice, strongly correlated with an increase in P-Tau, in 
both cerebral cortex and hippocampus, as well as astrogliosis; 
2) an improvement of pathological conditions administrating a low fat-
protein diet, occurred with an increased lifespan, a reduction of food and 
water consumption, a reduction of aggregates of hyperphosphorylated tau 
and neuronal loss in both cerebral cortex and hippocampus, more 
pronounced in female than male TG mice; 
3) a strong oxidative damage associated to tauophaty in a way age-gender-
dependent, with a strong oxidative damage in female than male mice; an 
improvement of oxidative damage administrating a low fat-protein diet 
was also detected, with a decreased of oxidative markers in both cerebral 
cortex and hippocampus, more pronounced in female than male TG mice. 
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6.3 INTRODUCTION 
Growing evidence supports the concept that insulin resistance and metabolic 
dysfunction are mediators of tauopathies as AD [1-2], and tauopathies could be 
regarded as a metabolic disease mediated by brain insulin and IGF resistance [3-
4]. In fact, AD shares many features in common with systemic insulin resistance 
diseases including, reduced insulin-stimulated growth and survival signaling, 
increased oxidative stress, pro-inflammatory cytokine activation, mitochondrial 
dysfunction, and impaired energy metabolism [5-6-7]. Human postmortem 
studies showed that brain insulin resistance with reduced insulin receptor 
expression and insulin receptor binding were consistently present in AD brains 
and worsen with disease progression [3-4], and that insulin signaling impairments 
were associated with deficits in IGF-1 and IGF-2 networks [4].  
Tau gene expression [8] and phosphorylation [9] are regulated by insulin and 
IGF, and impairments in insulin/IGF signaling contribute to tau hyper-
phosphorylation due to over activation of specific kinases, e.g. GSK-3b [9-10] 
and reductions in tau gene expression [7-8-11]. Attendant failure to generate 
sufficient normal tau protein, vis-a-vis accumulation of hyperphosphorylated 
insoluble fibrillary tau likely promotes cytoskeletal collapse, neurite retraction, 
and synaptic disconnection. Moreover, decreased signaling through 
phosphoinositol-3-kinase (PI3K), Akt [9], and increased activation of GSK-3β 
correlate with brain insulin and IGF resistance. Therefore, impairments in 
signaling through these pathways could account for the reductions in neuronal 
survival, myelin maintenance, synaptic integrity, neuronal plasticity, 
mitochondrial function, and cellular stress management in AD.	  
Insulin stimulates lipogenesis, which results in increased triglyceride storage in 
the liver [12-13]. Independent studies have shown that cognitive impairment and 
neuropsychiatric dysfunction occur with steatohepatitis and hepatic insulin 
resistance of various etiologies [14-15-16]. Mechanistically, inflammation in the 
setting of hepatic steatosis increases ER stress, oxidative damage, mitochondrial 
dysfunction, and lipid peroxidation, which together drive hepatic insulin 
resistance. Insulin resistance dysregulates lipid metabolism and promotes 
lipolysis [17-18], which increases production of toxic lipids, including ceramides, 
which further impair insulin signaling, mitochondrial function, and cell viability 
[18-19]. Liver disease worsens because ER stress and mitochondrial dysfunction 
exacerbate insulin resistance, lipolysis, and ceramide accumulation [81–83], 
generating nonalcoholic fatty liver disease (NAFLD). Nonalcoholic fatty liver 
disease (NAFLD) is characterized by insulin resistance, which results in elevated 
serum concentration of free fatty acids (FFAs). Circulating FFAs provide the 
substrate for triacylglycerol formation in the liver, and may be directly cytotoxic.  
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Hepatocyte apoptosis is a key histologic feature of NAFLD, and correlates with 
progressive inflammation and fibrosis. The hallmark in the pathogenesis of the 
NAFDL is the accumulation of triglycerides (TGs) in hepatocytes, which is 
followed by increased susceptibility to hepatocyte injury. The pathogenesis is 
thought to involve the “two‑hits” hypothesis [20]; the “first hit” is characterized 
by accumulation of TGs derived from the esterification of free fatty acid (FFA) 
and glycerol. The latter arises from an imbalance of supply, formation, 
consumption and hepatic oxidation and disposal of TG [21]. The sources of 
FFAs are diet, adipose tissue lipolysis, and de novo lipogenesis. Donnely et al. 
[22] demonstrated that in NAFLD, the major sources of FFA are adipose tissue 
lipolysis (59%) and de novo lipogenesis (26%) and less so from diet (15%). The 
increased influx of FFA from adipose tissue in NAFLD is attributed to impaired 
suppression of lipolysis in adipose tissue by insulin due to insulin resistance [21-
22]. Following accumulation of TG in hepatocytes, there is increased 
susceptibility to inflammatory injury, and this constitutes the “second hit” in the 
pathogenetic pathway. The injury is mediated by increased expression of 
inflammatory cytokines and adipokines, oxidative stress and mitochondrial 
dysfunction, endoplasmic reticulum stress and gut‑derived endotoxemia from 
bacterial overgrowth among others [8-9]. Fibrosis is the final stage or the “third 
hit” resulting from an imbalance between the rate of hepatocyte death and 
hepatocyte regeneration. There is inhibition of hepatocyte proliferation due to 
oxidative stress. 
Metabolic syndrome is a cluster of disease processes centered on insulin 
resistance, visceral obesity, hypertension, and dyslipidemia [23]. Metabolic 
syndrome is frequently associated with NAFLD/NASH, pro-inflammatory and 
pro-thrombotic states [23]. Studies have linked peripheral insulin resistance [24], 
visceral obesity [25], and metabolic syndrome [26-27-28] to brain atrophy, 
cognitive impairment, and impaired executive function [29]. The aggregate 
findings in humans and experimental models suggest that peripheral/systemic 
insulin resistance disease states serve as cofactors in the pathogenesis and 
progression of neurodegeneration.  
Based on the data in the literature, we decided to investigate a possible condition 
of nonalcoholic fatty liver disease (NAFLD) in mouse model of tauophaty used 
in this study evaluating:  macroscopy and histology of various tissues such as 
liver and spleen, the concentration of molecules and enzymes related to hepatic 
activity as cholesterol, triglycerides, alanine aminotransferase and aspartate 
aminotransferase in plasma of males and females P301L TG mice and B6D2F1 
CTR mice at 7 and 15 months of age fed with different diets. 
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6.3 MATERIALS AND METHODS 
6.3.1 Animals  and Diets  
Four hundred mice were used in this study. Two hundred were hemizygous tau 
transgenic mice of mixed gender with a mutant form (P301L) of human tau 
protein including four-repeats without amino terminal inserts, and driven by the 
mouse prion promoter 6 (MoPrP) [30]. Two hundred age-compatible wild type 
mice (B6D2F1) of mixed gender served as controls. Mice originated from 
Taconic Laboratories, USA, were bred at IRCCS Mario Negri Institute of 
Pharmacological Research in a Specific Pathogen free (SPF) facility with a 
regular 12:12 h light/dark cycle (lights on 07:00 a.m.), at a constant room 
temperature of 22 ± 2 °C, and relative humidity approximately 55 ± 10%. 
Animals were housed (n= 4 per group) in standard mouse cages, until three 
months of ages all animals were fed with standard rodent chow (diet 1: 18% 
protein and 5% fat, Harlan Lab. Tekland global diet), then animals were divided 
into two experimental groups, balanced for body weight and sex.  
The first group was fed with a standard rodent chow (diet 1: 18% protein and 
5% fat, Harlan Lab. Tekland global diet), and the second group was fed with a 
low protein diet (diet 2: 14% protein and 3.5% fat Harlan Lab. Tekland global 
diet). Since the animals were bred in a SPF facility, where all materials introduced 
are sterilized, we had to use an autoclavable diet manufactured with high quality 
ingredients and supplemented with additional vitamins to ensure nutritional 
adequacy after autoclaving (Fig. 1-2). 
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     Figure 1: Composition of diet 1: 18% protein and 5% fat (Harlan Tekland global diet) 
Chapter 6 
	  
	  
184	  
	  
     Figure 2: Composition of diet 2: 14% protein and 3.5% fat (Harlan Tekland global diet) 
6.3.2 Ethics  Statement 
Procedures involving animals and their care were in accordance to the national, 
international laws and policies (EEC Council Directive 86/609, OJ L 358, 1 
Dec.12, 1987; NIH Guide for the Care and use of Laboratory Animals, U.S. 
National Research Council, 2011). The Mario Negri Institute for 
Pharmacological Research (IRCCS, Milan, Italy) Animal Care and Use 
Committee (IACUC) approved the experiments, which were conducted 
according to the institutional guidelines, which are in compliance with Italian 
laws (D.L. no. 116, G.U. suppl. 40, Feb. 18, 1992, Circular No.8, G.U., Juli14, 
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1994). The scientific project was approved by Italian Ministry of Health (Permit 
Number: 71/2014 B). 
6.3.3 Study Design 
The first point of our study was to characterize the transgenic mouse model of 
tauophaty, that replicates the impairments found in patients affected by 
tauophaty in a way age-gender-dependent showing that females were more 
affected than males, and subsequently investigate the effect of two different diets 
(high fat-protein and low fat-protein diets) on the onset and progression of 
tauophaty, finding that a low fat-protein diet may play an important role to 
improve the lifespan and cognitive activity in a transgenic mouse model of 
tauophaty (P301L), with a major improvement in female than male P301L TG 
mice.  
The aim of this study was to investigate a possible condition of nonalcoholic 
fatty liver disease (NAFLD) due to alteration of insulin signaling in this model of 
tauophaty and to explore the possible mechanisms through which diets can 
interact and improve this pathological condition. After the weaning, all animals 
were fed with the same diet (diet 1 required for the growth of the mice); at 3 
months of age the animals were divided into two experimental groups: the first 
group fed with diet 1 and the second group fed with diet 2.  
Based on data in the literature [17-18], two time points were defined at 7 and 15 
months of age (the first time point the symptoms of the disease were evident 
expressed, the second time point: maximum survival for mice affected by 
tauophaty); in the previous works we evaluated metabolic profiles and cognitive 
and locomotor aspects utilizing behavioral tests. To investigate the possible 
condition of nonalcoholic fatty liver disease (NAFLD) and to investigate the 
possible mechanisms through which diets can interact and improve a possible 
condition of oxidative stress, animals were sacrificed after the behavioral tests 
and different tissues were used for morphometry and immunohistochemistry 
(H&E and Sirius red). Blood samples were collected for biochemical analysis. At 
both time points (7 and 15 months) n=5 animals for each experimental group 
were sacrificed for IHC and biochemical analyses as described below. 
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Figure 3: Experimental design of the study. In the study were set three time points: 3 months of 
age related to the administration of two different diets (diet 1 and diet 2), 7 and 15 months of age 
related to manifestation of the neuro disease and maximum survival of TG animals (time points for 
behavioral tests After behavioral tests HIC and biochemical analysis were conducted to value a 
condition of nonalcoholic fatty liver disease (NAFLD). 
6.3.4 Histopathology :  co l l e c t ion o f  mouse t i s sue and sera 
At the end of behavioral tests (7 and 15 months of age) TG and CTR mice fed 
with different diets were euthanized by cervical dislocation [31-32]; the 
peripheral blood samples were collected from mice under isoflurane inhalation 
anesthesia by sterile cardiac puncture. Intestine, stomach, kidney, liver and 
spleen were promptly dissected from the animals and measured after removal. 
The spleen and the left hepatic lobe was divided into sections for fixation in 10% 
buffered formalin, embedded in paraffin and used for different staining (Sirius 
red Staining and hematoxylin and eosin staining). 
6.3.5 Sir ius Red Staining 
After deparaffinization, spleen and liver sections (3 µm thick; three slices per 
mouse) were stained with Sirius Red. Sections were stained in Wiegert’s 
hematoxylin for 8 minutes, and then washed for 10 minutes in running tap 
water. The sections were incubated for 1 h at room temperature with in picro-
sirius red (0.5 gr/500 ml) and washed in two changes of acidified water, 
removing the water from the slides by vigorous shaking.  
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The sections were dehydrated in three changes of 100% ethanol, cleared in 
xylene and mounted in a resinous medium. 
 
6.3.6 Hematoxyl in and Eosin (H&E) Staining 
After deparaffinization, spleen and liver sections (3 µm thick; three slices per 
mouse) were stained with Hematoxylin and Eosin using this protocol. Sections 
were stained within Harris hematoxylin solution for 8 minutes then were washed 
in running tap water for 5 minutes. Sections were differentiated in 1% acid 
alcohol for 30 seconds, washed in running tap water for 1 minute and bluinged 
in 0.2% ammonia water or saturated lithium carbonate solution for 30 seconds 
to 1 minute. Sections were washed in running tap water for 5 minutes, rinsed in 
95% alcohol (10 dips) and counterstained in eosin-phloxine solution for 30 
seconds to 1 minute. Finally, the sections were dehydrated in three changes of 
100% ethanol, cleared in xylene and mounted in a resinous medium. 
 
6.3.7 Choles t ero l ,  Trig ly cer ides ,  Alanine Aminotrans ferase  And Aspartate  
Aminotrans ferase  Measurements   
Plasma of CTR and TG mice fed with different diets at 7 and 15 months of age 
(n=5 animals per each experimental group) were collected to value the 
concentration of cholesterol, triglycerides, alanine aminotransferase and aspartate 
aminotransferase using specific kit of Biochemicals System (for Triglycerides 
cod. TG383, for ALAT GPT cod. ALO20XL, for ASAT GOT cod. ASO70XL 
and for cholesterol total cod. C20TS).  
 
6.3.8 Stat i s t i ca l  Analys i s  
Statistical analyses were performed using Graph Pad Prism 6 program. 
Biochemical data (cholesterol, triglycerides, ALT, AST) were analyzed using two-
way ANOVA, followed by Tukey’s post hoc test. 
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6.4 RESULTS  
6.4.1 Histopathology 
At 7 and 15 months of age intestine (duodenum), stomach, kidney, liver and 
spleen of TG and CTR mice fed with different diets were dissected from the 
animals and measured after removal. At 7 months of age macroscopy analysis 
revealed a difference both in the aspect and size in liver and spleen of TG mice 
compared to CTR mice, regardless of diet administrated (Fig.4 and table 1). The 
assessment of the weight of tissues removed revealed a difference in the weight 
of liver and spleen between TG and CTR mice (P= 0.06, Fig. 5A-B; Fig. 6A-B), 
but any statistically significant effect of diet was found (P> 0.05, Fig. 5C-D).  
Based on these data, we decided to investigate in terms of immunohistochemical 
analysis, liver and spleen of animals for each experimental group at 7 months of 
age. Sections of both P301L TG and CTR mice liver and spleen were staining 
with hematoxylin and eosin and Sirius red (Fig.7-8), in order to understand if 
inflammation was present and if different diets (diet 18: 18% protein and 5% 
and diet 14: 14% protein and 3.5% fat) can improve the pathological condition. 
H&E immunostaining applied to liver and spleen revealed that, regardless of 
diets administrated, in P301L TG mice the inflammation with increased 
vascularity and an initial state of fibrosis was present at 7 months of age (liver: 
Fig. 7B-D-F-H, spleen: Fig. 7J-L-N-P).  
This result was also confirmed with Sirius red immunostaining applied to liver 
and spleen of TG and CTR mice, showing a strong positive signal of collagen 
presence in TG mice compare to CTR mice (liver: Fig. 8B-D-F-H, spleen: Fig. 
8J-L-N-P). 
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Figure 4. Gross anatomy of mouse liver and spleen in TG and CTR mice fed with different 
diets at 7 month of age. Detailed front (A-D) view of excised liver and spleen (E-H) in TG and 
CTR mice fed with different diets. I-J) Detailed view of excised tissues (liver, intestine, stomach, 
kidney and spleen) removed from CTR mice (I) and TG mice (J) fed with high fat-protein diet (diet 
18). 
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  Diet 18    Diet 14   
 CTR 
male 
CTR 
female 
TG 
male 
TG 
female 
CTR 
male 
CTR 
female 
TG 
male 
TG 
female 
Liver (cm) 2 x 1.3 1.9 x 1.3 3 x 2.2 2.5 x 1.8 1.8 x 1.5 2 x 1.2 2.6 x 2 2.6 x 2 
Intestine (cm) 1 1.1 1.1 1.2 1.3 1 1.1 1.2 
Stomach (cm) 
1.2 x 1 1.3 x 1.2 1.6 x 1.2 1.4 x 1.2 1.4 x 1.3 1.1 x 
1.3 
1.8 x 1.3 1.2 x 
1.3 
Kidney (cm) 
0.7 x 0.9 0.9 x 0.8 1 x 0.9 1 x 0.8 0.7 x 0.8 0.8 x 
0.9 
1 x 0.9 1 x 1.2 
Spleen (cm) 
1.2 x 1 0.9 x 1 1.8 x 1 1.9 x 1.1 1.3 x 1.2 1.1 x 
1.3 
1.4 x 1 1.6 x 1 
 
Table 1: Valuation of size tissues in TG and CTR mice fed with different diets at 7 months of 
age. Valuation of intestine, stomach, kidney, liver and spleen size in male and female CTR and TG 
mice at 7 months of age. Values are mean of size of 5 animals for each experimental groups. 
 
 
Figure 5: Valuation of weight tissues in TG and CTR mice fed with different diets at 7 months 
of age. A-B) Valuation of intestine, stomach, kidney, liver and spleen weights in male and female CTR 
and TG mice fed with different diets at 7 months of age. C-D) Valuation of intestine, stomach, kidney, 
liver and spleen weights only in male and female TG mice fed with different diets showed any diet 
effect (n= 5 mice per each experimental group). 
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Figure 6: Valuation of weight tissues in TG and CTR mice fed with different diets at 7 months 
of age. A) Valuation of intestine, stomach, kidney, liver and spleen weight in male and female CTR 
and B) TG mice revealed any diet effect at 7 months of age. 
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Figure 7. Hematoxylin and Eosin (H&E) staining of liver and spleen in TG and CTR mice fed 
with different diets at 7 month of age. H&E stained sections revealed a condition of inflammation 
in 7-month-old males and females (P301L TG mice) fed with diet 14 and 18 in liver (A-H) and in 
spleen (I-P note the arrows pointing to the most representative aspects in TG mice). Representative 
sections are shown of 5 animals used per each group. Scale bar: 40 µm. 
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Figure 8. Sirius red staining of liver and spleen in TG and CTR mice fed with different diets at 
7 month of age. Sirius red stained sections revealed the positive signal in 7-month-old males and 
females (P301L TG mice and CTR mice) fed with diet 14 and 18 in liver (A-H) and in spleen (I-P note 
the arrows pointing to the most representative aspects in TG mice). Representative sections are shown 
of 5 animals used per each group. Scale bar: 40 µm. 
At 15 months of age macroscopy analysis revealed a strong difference both in 
the aspect and size in liver and spleen of TG mice compared to CTR mice, with 
a strong diet effect showing by an increase of size and alteration of aspect of 
tissues in TG mice fed with high fat-protein diet (Fig. 9 and table 2).  
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The assessment of the weight of tissues removed revealed a significant genotype 
effect, showing by an increase in the weight of liver and intestine in TG mice 
compared to CTR mice (P<0.0001, Fig. 10A-B), and a significant diet effect 
showing by an increase in the weight of liver and intestine in TG mice fed with 
high fat-protein diet compared to TG mice fed with low fat-protein diet 
(P<0.0001, Fig. 10C-D). Consequently, we decided to investigate in terms of 
immunohistochemical analysis, liver and spleen of animals for each experimental 
group at 15 months of age. Sections of both P301L TG and CTR mice liver and 
spleen were staining with hematoxylin and eosin and Sirius red (Fig. 12-13), in 
order to understand if inflammation was present and if different diets (diet 18: 
18% protein and 5% and diet 14: 14% protein and 3.5% fat) can improve the 
pathological condition. H&E immunostaining applied to liver and spleen 
revealed that in P301L TG mice a severe inflammation with increased vascularity 
and an advanced state of fibrosis was present at 15 months of age (liver: Fig. 
12B-D-F-H, spleen: Fig. 12J-L-N-P).  
This effect was more pronounced in TG mice fed with high fat-protein diet 
compared to TG mice fed with low fat-protein diet; an initial state of 
inflammation was also detected in CTR mice fed with high fat-protein diet. 
These results were also confirmed with Sirius red immunostaining applied to 
liver and spleen of TG and CTR mice, revealing a strong positive signal of 
collagen presence in TG mice compare to CTR mice (liver: Fig. 13B-D-F-H, 
spleen: Fig. 13J-L-N-P). Comparing the images of TG mice fed with different 
diets, an increase of collagen aggregates in TG mice fed with high fat-protein 
diet compared to TG mice fed with low fat-protein diet was detected. 
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Figure 9. Gross anatomy of mouse liver, spleen, stomach and kidney in TG and CTR mice fed 
with different diets at 15 month of age. A-D) Detailed view of excised tissues (liver, spleen, stomach 
and kidney) in TG and CTR mice fed with different diets (diet 18 A-B, diet 14. E) Detailed view of 
liver removed from TG mice fed with high fat- protein diet that shows a strong state of fibrosis. 
 
  Diet 18    Diet 14   
 CTR 
male 
CTR 
female 
TG 
male 
TG 
female 
CTR 
male 
CTR 
female 
TG 
male 
TG 
female 
Liver (cm) 4 x 3.4 3.7 x 3 7 x 4.5 4.5 x 3.2 2.6 x 2.2 2 x 1.2 6 x 3.5 2.6 x 4 
Intestine (cm) 1 1.1 1.2 1.1 1.1 1 1.3 1.2 
Stomach (cm) 1.7 x 1.1 1.3 x 1.2 2 x 1.8 2.4 x 1.2 1.9 x 2 
1.5 x 
1.3 2.3 x 1.5 
2.5 x 
1.8 
Kidney (cm) 1.2 x 0.8 0.9 x 0.8 1.5 x 1 1.3 x 0.8 1.2 x 1 1.2 x 1 1.6 x 1.2 
1.2 x 
0.8 
Spleen (cm) 0.5 x 1.3 0.9 x 1 
1.9 x 
1.5 1.9 x 1.2 0.8 x 1.2 
0.5 x 
1.2 1.4 x 1.9 
0.9 x 
1.4 
Table 2: Valuation of size tissues in TG and CTR mice fed with different diets at 15 months of 
age. Valuation of intestine, stomach, kidney, liver and spleen size in male and female CTR and TG 
mice at 15 months of age. Values are mean of size of 5 animals for each experimental group. 
Chapter 6 
	  
	  
196	  
	  
 
 
Figure 10: Valuation of weight tissues in TG and CTR mice fed with different diets at 15 
months of age. A-B) Valuation of intestine, stomach, kidney, liver and spleen weights in male and 
female CTR and TG mice fed with different diets at 15 months of age showed a significant genotype 
effect for the weight measurements of liver and intestine. C-D) Valuation of intestine, stomach, 
kidney, liver and spleen weights only in male and female TG mice fed with different diets revealed a 
significant diet effect for the weight measurements of liver and intestine, showing by an increase of 
weight in TG mice fed with high fat- protein diet (diet 18). DIET 18: TG vs CTR mice *** P< 0.0001.  
DIET 14: TG vs CTR mice ## P< 0.001, ### P< 0.0001. Liver: TG mice diet 18 vs TG mice diet 14 
¥¥¥ P< 0.0001; intestine: TG mice diet 18 vs TG mice diet 14 ααα P< 0.0001 (n= 5 mice per each 
experimental group). 
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Figure 11: Valuation of weight tissues in TG and CTR mice fed with different diets at 15 
months of age. A) Valuation of intestine, stomach, kidney, liver and spleen weight in male and female 
CTR and B) TG mice revealed a significant diet for the weight measurements of liver and intestine, 
showing by an increase of weight in TG mice fed with high fat- protein diet (diet 18) at 15 months of 
age. Liver: CTR mice diet 18 vs CTR mice diet 14 ¥ P< 0.05, ¥¥ P< 0.001; TG mice diet 18 vs TG 
mice diet 14 ¥¥¥ P< 0.0001; intestine: CTR mice diet 18 vs CTR mice diet 14 α P< 0.05, αα P< 
0.001; TG mice diet 18 vs TG mice diet 14 ααα P< 0.0001 (n= 5 mice per each experimental group). 
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Figure 12. Hematoxylin and Eosin (H&E) staining of liver and spleen in TG and CTR mice 
fed with different diets at 15 month of age. H&E stained sections revealed the positive signal in 15-
month-old males and females (P301L TG mice and CTR mice) fed with diet 14 and 18 in liver (A-H) 
and in spleen (I-P note the arrows pointing to the most representative aspects in TG mice). 
Representative sections are shown of 5 animals used per each group. Scale bar: 40 µm. 
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Figure 13. Sirius red staining of liver and spleen in TG and CTR mice fed with different diets 
at 15 month of age. Sirius red stained sections revealed the positive signal in 15-month-old males and 
females (P301L TG mice and CTR mice) fed with diet 14 and 18 in liver (A-H) and in spleen (I-P note 
the arrows pointing to the most representative aspects in TG mice). Representative sections are shown 
of 5 animals used per each group. Scale bar: 40 µm 
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6.4.2 Choles t ero l ,  Trig ly cer ides ,  Alanine Aminotrans ferase  and Aspartate  
Aminotrans ferase  Measurements 
Based on previous data related to histopathology analysis, plasma of TG and 
CTR mice fed with different diets (n=5 animals per each experimental group) 
were collected to value the concentration of total cholesterol, triglycerides, 
alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in order 
to explore tauophaty-related metabolic modifications in mouse model used in 
this study and to understand if diets can interact with this metabolic syndrome. 
The measurement of concentration of cholesterol total had shown any 
significant difference between TG mice fed with different diets at 7 and 15 
months of age (Fig. 14). Median levels of total cholesterol measured in both TG 
and CTR mice, regardless of diet administrated, were included in age-related 
reference intervals (median and 2.5th–97.5th percentiles ranges) for biochemical 
analytes published in literature (see table 3) [33]. 
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Table 3. Serum biochemical analytes (median and 2.5th–97.5th percentiles interval) measured in 
aged 4–8 months C57BL/6J, 129SV/EV and C3H/HeJ mouse strains. [1] 
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Figure 14: Biochemical median values of total cholesterol in TG and CTR mice at 7 and 15 
months of age. A) Total cholesterol median values calculated in TG and CTR mice fed with different 
diets at 7 and B) 15 months of age showed any significant difference between experimental groups. 
The measurement of concentration of triglycerides had shown at 7 months of 
age a significant genotype effect between TG and CTR male mice fed with diet 
14 (P< 0.05, Fig. 15A) and a significant diet effect between TG male mice fed 
with diet 14 and diet 18 (P< 0.0001, Fig. 15A). At 15 months of age any 
significant difference between TG and CTR mice were detected (P > 0.05, Fig. 
15B), but median levels of triglycerides measured in TG mice, regardless of diet 
administrated, were higher compared to value included in reference intervals for 
biochemical analytes (table 3), revealing an altered metabolic condition 
associated to tauophaty in mouse model used in this study. 
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Figure 15: Biochemical median values of triglycerides in TG and CTR mice at 7 and 15 months 
of age. A) Triglycerides median values calculated in TG and CTR mice fed with different diets at 7 
and B) 15 months of age showed a significant difference between TG and CTR male mice fed with 
diet 14 and a significant diet effect between TG male mice fed with diet 14 and diet 18. TG male mice 
diet 14 vs CTR male mice diet 14 ¥¥¥ P< 0.0001; TG male mice diet 18 vs TG male mice diet 14 * 
P< 0.05. Data were shown as mean ± SEM (n= 5 mice per each experimental group). 
The measurement of concentration of ALT had shown at 7 months of age a 
significant genotype effect between TG and CTR male mice fed with diet 14 (P< 
0.05, Fig. 16A) and a significant diet effect between TG male mice fed with diet 
14 and diet 18 (P< 0.0001, Fig. 16A). At 15 months of age a significant diet 
effect between TG and CTR mice fed with different diets were detected (TG 
male mice fed with diet 14 vs diet 18 and CTR male mice fed with diet 14 vs diet 
18 P< 0.05, Fig. 16B), but median levels of ALT measured in TG mice, 
regardless of diet administrated, were higher compared to value included in 
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reference intervals for biochemical analytes (table 3), revealing an altered 
metabolic condition associated to tauophaty in mouse model used in this study. 
 
Figure 16: Biochemical median values of ALT in TG and CTR mice at 7 and 15 months of age. 
A) ALT median values calculated in TG and CTR mice fed with different diets at 7 and B) 15 months 
of age showed a significant difference between TG and CTR male mice fed with diet 14 and a 
significant diet effect between TG male mice fed with diet 14 and diet 18. 7 months: TG male mice 
diet 14 vs CTR male mice diet 14 ¥¥¥ P< 0.0001; TG mice diet 18 vs TG mice diet 14 * P< 0.05. 15 
months:  TG male mice diet 18 vs TG mice diet 14 α P< 0.05; CTR male mice diet 14 vs CTR male 
mice diet 18 ¥ P< 0.05. Data were shown as mean ± SEM (n= 5 mice per each experimental group). 
The measurement of concentration of AST had shown at 7 months of age a 
significant genotype effect between male and female TG and CTR male mice fed 
with diet 14 (P< 0.05, Fig. 17A) and any significant diet effect between 
experimental group (P> 0.05, Fig. 17A). At 15 months of age a significant diet 
effect between TG and CTR mice fed with different diets were detected (TG 
male mice fed with diet 14 vs diet 18 and CTR male mice fed with diet 14 vs diet 
18 P< 0.05, Fig. 16B), and a significant genotype effect between female TG and 
Chapter 6 
	  
	  
205	  
	  
CTR male mice fed with diet 18 (P< 0.05, Fig. 17B). Median levels of AST 
measured in TG mice, regardless of diet administrated, were higher compared to 
value included in reference intervals for biochemical analytes (table 3), revealing 
an altered metabolic condition associated to tauophaty in mouse model used in 
this study. 
 
Figure 17: Biochemical median values of AST in TG and CTR mice at 7 and 15 months of age. 
A) ALT median values calculated in TG and CTR mice fed with different diets at 7 and B) 15 months 
of age showed a significant difference between male and female TG and CTR mice fed with diet 14 
and a significant diet effect between TG male mice fed with diet 14 and diet 18 and CTR male mice 
fed with diet 14 and diet 18. 7 months: TG male mice diet 14 vs CTR male mice diet 14 * P< 0.05; TG 
female mice diet 14 vs CTR female mice diet 14 § P< 0.05. 15 months:  TG mice diet 18 vs TG mice 
diet 14 α P< 0.05. TG female mice diet 18 vs CTR female mice diet 18 # P< 0.05; CTR male mice diet 
14 vs CTR male mice diet 18 ¥ P< 0.05. Data were shown as mean ± SEM (n= 5 mice per each 
experimental group). 
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6.5 DISCUSSION 
Growing evidence supports the concept that insulin resistance and metabolic 
dysfunction are mediators of tauopathies as AD [1-2], and tauopathies could be 
regarded as a metabolic disease mediated by brain insulin and IGF resistance [3-
4]. In particular, a crosslink between insulin resistance-dysregulates lipid 
metabolism and oxidative stress seems to be the cause of hepatic dysfunctions as 
fibrosis or steatosis including nonalcoholic fatty liver disease (NAFLD). 
In our previous works we characterized P301LTG line, a mouse model of 
tauophaty used in our studies, that replicate both cognitive and behavioral 
impairment found in patient affected by tauophaty, strongly correlated with an 
increase in P-Tau, astrogliosis and oxidative damage in both cerebral cortex and 
hippocampus, more pronounced in female than male TG mice at 7 and 15 
months of age. Investigating the effects of different diets (high and low fat-
protein diets) on neurodegeneration aspects of this mouse model, we found an 
improvement of pathological conditions administrating a low fat-protein diet, 
occurred with an increased lifespan, a reduction of food and water consumption, 
a reduction of aggregates of P-Tau and neuronal loss in both cerebral cortex and 
hippocampus, more pronounced in female than male TG mice. During necropsy 
analysis performed after the behavioral tests in TG and CTR mice, we observed 
an alteration of the size of the liver and spleen in TG mice fed with a high fat-
protein diet at 7 and 15 months of age. This apparent condition of hepatomegaly 
was associated to an increase of body weight, food and water consumption in 
TG mice fed with high fat-protein diet. Consequently, in this study we decided 
to investigate this pathological condition, assuming it can be nonalcoholic fatty 
liver disease (NAFLD), in P301L TG and CTR mice at 7 and 15 months of age 
fed with different diets evaluating:  macroscopy and histopathology of various 
tissues such as liver and spleen, the concentration of cholesterol, triglycerides, 
alanine aminotransferase and aspartate aminotransferase in plasma of TG and 
CTR mice. 
At 7 and 15 months of age macroscopy analysis revealed a difference both in the 
aspect and size in tissues (in particular liver, spleen and intestine) removed from 
TG mice compared to CTR mice, regardless of diet administrated, most 
pronounced at 15 months of age. In the second time point, these alterations 
were also correlated to a significant diet effect showed by an increase of size and 
alterations of tissues removed from TG mice fed with high fat-protein diet 
compared to TG mice fed with low fat-protein diet. Macroscopy results were 
confirmed by the assessment of the weight of tissues removed from TG and 
CTR mice fed with different diets both at 7 and 15 months of age.  
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In particular, at 15 months of age, a significant genotype effect and diet effect 
for the weight of liver and intestine removed from TG mice fed with high fat-
protein diet was found, replicating previous results obtained. 
Immunohistochemical analysis (H&E immunostaining and Sirius red) of liver 
and spleen removed from TG and CTR mice at 7 and 15 months of age revealed 
that, regardless of diets administrated, in P301L TG mice a lobular inflammatory 
infiltrate with increased vascularity and an initial state of fibrosis correlated to 
collagen infiltration was present at 7 months of age. At 15 months of age, a 
severe lobular inflammatory infiltrate and fibrosis in TG mice was found. This 
pathological state was more pronounced in TG mice fed with high fat-protein 
diet compared to TG mice fed with low fat-protein diet and an initial state of 
inflammation was also detected in CTR mice fed with high fat-protein diet.  
In order to understand the causes that have generated these alterations in the 
liver and spleen of mouse model used in this study, plasma of TG and CTR mice 
were collected to value the concentration of molecules and enzymes related to 
hepatic activity as total cholesterol, triglycerides, alanine aminotransferase (ALT) 
and aspartate aminotransferase (AST) at 7 and 15 months of age. The 
measurement of concentration of cholesterol total had shown any significant 
difference between TG mice fed with different diets at 7 and 15 months of age. 
The measurement of concentration of triglycerides had shown at 7 months of 
age a significant genotype effect between TG and CTR male mice fed with diet 
14, showing by an increase of triglycerides concentration in plasma of TG mice 
compared to CTR mice, and a significant diet effect showing by an increase of 
triglycerides concentration in TG mice fed with diet 18 compared to TG mice 
fed with diet 14. At 15 months of age any significant difference between TG and 
CTR mice were detected, but median levels of triglycerides measured in plasma 
of TG mice were higher compared to value included in reference intervals for 
biochemical analytes published in literature. 
The measurement of concentration of ALT and AST had shown at 7 months of 
age a significant genotype effect between TG and CTR mice fed with diet 14 and 
a significant diet effect showing by an increase of ALT concentration in TG 
mice fed with diet 18 compared to TG mice fed with diet 14. At 15 months of 
age a significant diet effect in both CTR and TG mice was detected, showing by 
an increase of ALT and AST concentration in mice fed with diet 18 compared to 
mice fed with diet 14 and a significant genotype effect between female TG and 
CTR mice fed with diet 18 for AST analysis.  
Therefore the biochemical results obtained showed that, except for the 
measurement of total cholesterol (which values were included into reference 
intervals of values for biochemical analytes), the median levels of triglycerides, 
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AST and ALT measured in plasma of TG mice were higher compared both to 
median levels measured in CTR mice both to values included in reference 
intervals for biochemical analytes, revealing a pathological condition in the liver 
associated to tauophaty in mouse model used in this study. This hepatic 
pathological condition was more severe in TG mice fed with high fat-protein 
diet, assuming an interaction between tauophaty and an excessive consumption 
of fats that could lead to lipotoxicity, resulting in accumulation of fats in the 
liver, hepatic inflammation and fibrosis. Several studies in literature described 
this pathological condition as nonalcoholic fatty liver disease (NAFLD), a 
metabolic syndrome (of which fatty liver disease is considered the hepatic 
manifestation) overloads tissues with lipids, leading to toxic effects such as 
apoptosis, insulin resistance, maladaptive autophagy, and oxidative stress [34].  
NAFLD is considered a “collateral pathology” in neurodegenerative diseases, 
AD in particular, being the result of hepatic insulin resistance caused by deficits 
in brain insulin/IGF signaling due to the combined effects of insulin/IGF 
resistance and deficiency [35-36]. P301L TG line is used in literature for the 
study of its main features, as neurofibrillary tangles and hyperphosphorylated 
Tau, and for the study of diet effects in the brain and mitochondrial functions, 
not on peripheral organs [37-38]. 
In summary, in this study we demonstrated a correlation between 
hyperphosphorylated Tau, insulin/IGF resistance and high fat-protein diet 
consumption in P301L TG mice expressed on peripheral organs as hepatic 
insulin resistance and fatty accumulation in the liver, which induced nonalcoholic 
fatty liver disease. This correlation was confirmed by a condition of 
hepatomegaly characterized by the presence of lobular inflammatory infiltrate 
and deposits of collagen in liver and spleen, an increase of weight and size of 
liver and spleen, an increase of body weight due to hepatomegaly and not for the 
accumulation of adipose tissue, the excessive water consumption, the highest 
increase of median levels of triglycerides, AST and ALT in P301L TG mice fed 
with high-fat protein diet.  
Since tauophaty defined a metabolic disease mediated by brain insulin and IGF 
resistance, the mouse model P301L TG used in this study could represent a 
valuable tool to study not only the eziopathogenesis of tauophaty, but also 
metabolic dysfunctions that occurred in peripheral organs neurodegenerative 
diseases. Moreover, preventing or reducing IGF resistance and consequently the 
accumulation of fats in the liver in this model may represent a system to study 
molecular mechanism of metabolic syndrome related to neurodegenerative 
disease and could finally lead to the development of potential treatments not 
only for tauophaty, but also for its collateral pathology as NAFLD. 
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7.1 GENERAL DISCUSSION 
The aim of this study, during three years of my PhD, was to investigate the 
effects of two different diets in a mouse model of neurodegenerative disease. 
The mouse model chosen for this study is P301L TG affected by tauophaty, a 
rare disease that manifests the typical hallmarks of Alzheimer disease, a 
pathology that affects 60% of the human population.  
The hallmarks of tauophaty are neurofibrillary tangles consist of 
hyperphosphorylated tau, neurofilaments and beta amyloid in the brain, causing 
alteration of axonal transport, synaptic dysfunctions and neuronal loss leading to 
cognitive and behavioral impairments. We decided to use two different diets 
characterized by the different protein and fat content (diet 1: 18% protein and 
5% fat, diet 2: 14% protein and 3.5% fat) based on data in literature that 
underling the adverse effects of a high fat-protein diet on brain functionality, 
influence neuronal membrane integrity, oxidative status and risk for tauopathies. 
Based on the manifestation of symptoms of disease described by Lewis et al. in 
this mouse model, we established two experimental time points at 7 and 15 
months of age (the first time point the symptoms of the disease were evident 
expressed, the second time point: maximum survival for mice affected by 
tauophaty).  
In this study we investigated at 7 and 15 months of age the effects of different 
diets on P301L TG and CTR mice valuating metabolic, behavioral and cognitive 
activities; for the metabolic activities we analyzed survival rate, body weight gain 
and food and water consumption of animals. For behavioral activities we 
valuated mnemonic, locomotor and exploratory performances of animals; for 
cognitive activities we investigated the cognitive impairment (identifying 
agglomerates of hyperphosphorylated tau, neuronal loss, astrogliosis and 
oxidative damage) using immunohistochemical analysis and neuronal counts. 
We started the study characterizing P301L TG mouse model that replicated the 
impairments found in patients affected by tauophaty in a way age-gender-
dependent underling an important interaction between gender and pathology 
until now yet never reported in tauophaty models. Female TG mice had strong 
cognitive impairment strongly correlated with an increase in P-Tau, in both 
cerebral cortex and hippocampus, as well as astrogliosis.	  After characterization of 
P301L TG model, we evaluated how two different diets (low protein-fat diet and 
high protein-fat diet) can interact with genotype, sex and age of P301L TG mice 
and can improve Tau pathology.  
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Administrating a low fat-protein diet we found an improvement of pathological 
conditions associated with our mouse model of tauophaty, occurred with an 
increased lifespan, a reduction of food and water consumption, a reduction of 
aggregates of hyperphosphorylated tau and neuronal loss, more pronounced in 
female than male TG mice at 7 months of age, since 15 months of age a time 
point which pathological conditions are too severe.  
Since oxidative damage is a neuropathological hallmark of tauopathies and 
strictly correlated to nutrition, we decided to investigate the oxidative damage in 
this model of tauophaty and to explore the possible mechanisms through which 
diets can interact and improve a possible condition of oxidative stress. We found 
an oxidative damage associated with our mouse model of tauophaty in a way 
age-gender-dependent, confirming an increase of oxidative damage in female TG 
mice. Administrating a low fat-protein diet we found an improvement of 
oxidative damage in TG mice, occurred with a decreased of immunopositive 
cells numbers correlated to oxidative markers used for immunohistochemistry, 
more pronounced in female than male TG mice.	   During necropsy analysis 
performed after the behavioral tests in TG and CTR mice fed with different 
diets, we observed an alteration of the size of the liver and spleen in TG mice 
fed with a high fat-protein diet at 7 and 15 months of age. This apparent 
condition of hepatomegaly was associated to an increase of body weight, food 
and water consumption in TG mice fed with high fat-protein diet. 
Based on our previous data and literature, we assumed that P301L mice could be 
affected by nonalcoholic fatty liver disease (NAFLD), a metabolic syndrome 
correlated to neurodegenerative disease caused by insulin/IGF resistance, 
accumulation of fats in liver, hepatic inflammation and fibrosis. So we decided to 
investigate this pathological condition in TG and CTR mice at 7 and 15 months 
of age fed with different diets evaluating:  macroscopy and histopathology of 
various tissues such as liver and spleen, the concentration of cholesterol, 
triglycerides, alanine aminotransferase and aspartate aminotransferase in plasma 
of these animals.	   We found a correlation between hyperphosphorylated Tau, 
insulin/IGF resistance and high fat-protein diet consumption in TG mice fed 
with a high fat-protein diet at 7 and 15 months of age expressed on peripheral 
organs as hepatic insulin resistance and fatty accumulation in the liver, which 
induced nonalcoholic fatty liver disease.  
This correlation was confirmed by a condition of hepatomegaly characterized by 
the presence of lobular inflammatory infiltrate and deposits of collagen in liver 
and spleen, an increase of weight and size of liver and spleen, an increase of 
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body weight due to hepatomegaly and not for the accumulation of adipose 
tissue, the excessive water consumption, the highest increase of median levels of 
triglycerides, AST and ALT in P301L TG mice fed with high-fat protein diet. 
   
7.2 CONCLUDING REMARKS AND FUTURE 
PROSPECTIVES                                        
In conclusion, in this study we demonstrated the importance of interaction 
between nutrition and neurodegeneration and the role that different diets can 
have on the onset and development of tauophaty, obtaining an improvement of 
pathological conditions administrating a low fat-protein diet. Also an 
improvement of welfare, represented by an increase in survival, both in control 
and transgenic animals fed with	  a low fat-protein diet was detected. We found an 
important interaction between tauophaty and consumption of high fat-protein 
diet that lead to the onset of metabolic syndrome as nonalcoholic fatty liver 
disease. 
Since this important interaction	  between tauophaty and consumption of high fat-
protein until now yet never reported in tauophaty models, a more detailed 
investigation on the possible mechanisms of action that leading to metabolic 
syndrome will be performed. In particular, we will investigate the insulin/IGF 
signaling on brain and peripheral organs, valuating the concentration of 
insulin/glucagon on plasma and in liver and pancreas of P301L TG mice. 
Results obtained in this study suggest that P301L-Tau model could represent a 
valuable tool to study the role and the mechanisms through 
hyperphosphorylation and Tau aggregation leading to cognitive and memory 
impairment. Using the influence of nutrition for preventing or reducing the 
accumulation of hyperphosphorylated tau in this model could finally lead to the 
development of preventive potential treatments for tauopathies. 
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Effects of different diets in a mouse model of 
neurodegeneration 
 
Abstrac t  
Tauopathies are neurodegenerative disorders characterized by the accumulation 
of abnormal Tau protein leading to cognitive and/or motor dysfunction; several 
studies suggest that dietary manipulations are increasingly viewed as possible 
approaches to treating neurodegenerative diseases. The mouse model chosen for 
this study was P301L; mice expressing P301L mutant Tau mimics features of 
human tauopathies and provides a model for investigating the 
neuropathogenesis of diseases. In this study we investigate at 7 and 15 months 
of age the effects of different diets (high fat-protein diet and low fat-protein diet) 
on P301L TG and CTR mice valuating metabolic, behavioral and cognitive 
activities; for the metabolic activities we analyzed survival rate, body weight gain 
and food and water consumption of animals. For behavioral activities we 
valuated mnemonic, locomotor and exploratory performances of animals; for 
cognitive activities we investigated the cognitive impairment (identifying 
agglomerates of hyperphosphorylated tau, neuronal loss, astrogliosis and 
oxidative damage) using immunohistochemical analysis and neuronal counts. We 
characterized P301L TG mouse model (trial 1-3) that replicated the impairments 
found in patients affected by tauophaty in a way age-gender-dependent showing 
in female TG mice a strong cognitive impairment strictly correlated with an 
increase in P-Tau, in both cerebral cortex and hippocampus, as well as 
astrogliosis and oxidative damage.	   We found an improvement of pathological 
conditions in TG mice administrating a low fat-protein diet in a way age-gender-
dependent (trial 2-3), occurred with an increased lifespan, a reduction of food 
and water consumption, a reduction of aggregates of P-Tau, neuronal loss, 
astrogliosis and oxidative damage. We found an interaction between tauophaty 
and consumption of high fat-protein expressed on peripheral organs as hepatic 
insulin resistance and fatty accumulation in the liver, which induced nonalcoholic 
fatty liver disease in TG mice (trial 4). The correlation between P-Tau, 
insulin/IGF resistance and high fat-protein diet consumption was expressed by a 
condition of hepatomegaly characterized by the presence of lobular 
inflammatory infiltrate and deposits of collagen in liver and spleen, an increase 
of weight and size of liver and spleen, the highest increase of median levels of 
triglycerides, AST and ALT in P301L TG mice fed with high-fat protein diet in a 
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way age-gender-dependent. In summary, we demonstrated the importance of 
interaction between nutrition and neurodegeneration and the role that different 
diets can have on the onset and development of tauophaty, obtaining an 
improvement of pathological conditions administrating a low fat-protein diet. 
Results obtained in this study suggest that P301L-Tau model could represent a 
valuable tool to study the role and the mechanisms through 
hyperphosphorylation and Tau aggregation leading to cognitive and memory 
impairment. Using the influence of nutrition for preventing or reducing the 
accumulation of hyperphosphorylated tau in this model could finally lead to the 
development of preventive potential treatments for tauopathies.	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10.1 ABSTRACT 
Oxygen concentration in an Individually Ventilated Caging systems (IVCs) was 
recently found to be slightly lower than optimal for an ideal microenvironment 
to house laboratory mice. Given the substantial technical differences between 
IVCs of different designs, which may yield dissimilar intra-cage environmental 
conditions, it was decided to monitor the micro-environment of an Individually 
Ventilated Cage (IVC) system and an open cage system and compare the impact 
on Red Blood Cell (RBC) count and related parameters in C57Bl/6J mice 
housed either in ventilated or open cages. 
A small decrease in the intra-cage oxygen level was detected in both cage systems 
when approaching the cage change procedure (performed every two weeks). No 
differences in the hematological parameters were detectable after 6 weeks 
conditioning of mice in either of the two systems. 
The IVC microenvironment was shown to be free from any impact on the 
hematological parameters taken into consideration in this trial when compared to 
the “open cage” set-up. 
 
10.2 INTRODUCTION 
There are a number of parameters used to assess the welfare of animals used in 
research, each contributing to the description of the physical and psychological 
health status. From a simple evaluation of appearance, coat condition, body 
weight, gait, posture, feeding and drinking behavior, urination and defecation to 
faecal or blood cortisol, the list of welfare indicators can be very long.  
The choice of the most appropriate indicator is mainly down to the potential 
effect caused by the “factor” under investigation and hematological parameters 
are certainly very good indicators of state of animal health. Red Blood Cell 
count, total hemoglobin (Hgb) and hematocrit (HCT) are potential indicators 
when studying the environmental “fresh air” availability in terms of gas 
composition in Individually Ventilated caging systems.   
The impact on the above mentioned blood parameters might be due to a 
reduced quality of the air because a decreased percentage of oxygen, lower than 
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20.9% or an increased CO2 concentration. If alterations of intra-cage atmosphere 
are accepted when an IVC is not ventilated (static), it is not acceptable to detect 
a constant modification of its microenvironment, in terms of oxygen reduction, 
during standard operations.   
Removal of pollutants like ammonia (NH3) and CO2 from a ventilated 
environment, stability of desired temperature and relative humidity is achieved 
through an efficient ventilation, an acceptable concentration of oxygen (O2) is 
also maintained, provided that at room level the same parameters are controlled 
and within regulatory acceptable ranges. 
Intra-cage microenvironment has been widely investigated especially in 
Individually Ventilated Cages due to their confined environmental condition. 
Consistent differences between IVC systems operating at different air changes 
per hour and mode of air distribution have been shown to create diversity in the 
microenvironment: ammonia, CO2 and oxygen with possible impact on breeding 
performances1. 
Some authors failed to find a relation between different concentrations of 
NH3 in the cage and respiratory tract lesions
2, whereas more recently others have 
described the connection between cumulative pollutants (NH3) and nasal 
histological identifiable lesions3; nevertheless, intra-cage oxygen concentration 
was not reported by these investigators.  
Oxygen concentration was taken into consideration when a disposable cage was 
tested under static conditions up to six hours, showing consistent reduction of 
O2 in relation with cage occupancy and time
4. 
A recently published scientific paper5 describes the impact due to reduced 
oxygen concentration on mouse Red Blood Cells count, hemoglobin and 
hematocrit, all of which increased when mice are maintained in a ventilated 
caging system operated at 60 Air Changes per Hour (ACH) and the air is injected 
at animal level vs the open cage control group. 
Individually ventilated caging systems vary considerably in terms of solutions 
found to move the air inside the cages and the flow rate suggested by the 
manufacturer. The main consequence of the two mentioned substantial 
differences is the efficiency of ventilation responsible for the quality of the 
microenvironment in the cage6. 
Owing to these differences in design and performances, it was decided to test an 
IVC system with technical and operating solutions very different from 
that tested by York et al5, to understand if the problem identified by the authors 
can be generalized to IVCs or is specific of that equipment. 
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10.3 MATERIALS AND METHODS 
 
10.3.1 Animals  and housing 
A total of 24 Male C57Bl/6J (Harlan Laboratories, Italy), Specified Pathogen 
Free mice, 4 weeks old at arrival, weaned and maintained in open cages were 
randomly distributed 4 to a cage, three cages x 2 groups (open and IVC).  
In addition, four mice were distributed two to a cage (one cage x group, two 
mice each). Prior to distribution to the assigned caging group, all mice were 
maintained at the same density in open cages for one week.  
Each cage was filled with 150 g of autoclaved corncob bedding. Autoclaved diet 
was distributed and weighed on a weekly basis.  
Autoclaved filtered water was provided by bottles (270 ml capacity); bottles were 
singly weighed when filled and after one week during change.  
All mice were weighed after the random distribution to each cage. Cages were 
GM500 (Tecniplast S.p.a VA, Italy) 500 cm2 each of usable surface with wire top 
cage lids that were either open to the environment or connected to a positive 
pressure mode Air Handling Unit set at 75 Air Changes Hour (ACH) in positive 
pressure according to the manufacturer's specification. The Air Handling Unit is 
connected to the rack by flexible hoses and HEPA filtered air enters and exits 
the cages from the rear of the plastic cage cover. 
 
10.3.2 Oxygen,  Carbon dioxide ,  ammonia,  humidi ty  and temperature 
Intra-cage air oxygen, CO2 and ammonia were measured using a Dragger X-Am 
7000 inserting a flexible probe alternatively through the flap used for the bottle 
nipple in the IVC configuration or through the bar lids in the open one, to a 
distance from the bedding of approximately 2.5 cm.  
Temperature and Relative Humidity (RH) were monitored by means of Data 
Loggers USB 502 (Measurement Computing, Norton MA, USA) positioned on 
top of the wire bar lid of the cages and set to record the two parameters every 30 
minutes. One Data Logger was also positioned on top of the rack to monitor the 
environment. 
 
10.3.3 Treatments  and tes t ing 
IVC mice were 11 weeks old at testing and had spent almost 6 weeks in IVC or 
open cages. Open cages mice were 11 weeks old either at testing and had spent 
all their life in open cages. 
 
10.3.4 Hematology  
All mice were euthanized by carbon dioxide at ten weeks of age and blood was 
drawn by cardiac puncture. The approximate volume of blood was 0.4 to 0.6 ml. 
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A maximum volume of 0.5 ml was placed in EDTA coated microtainer tubes 
(Becton & Dickinson, Franklin Lakes, NJ USA). 
Analysis for Red Blood Cells count (RBC), total hemoglobin content (Hgb), 
hematocrit (HCT), Mean Corpuscular volume (MCV), Mean Cell Hemoglobin 
(MCH), Mean Cell Hemoglobin Concentration (MCHC), Red Blood Cell 
Distribution width (RBCw) and Platelets (PLT) were performed on an Abacus 
Junior Vet (Diatron Messtechnik GmbH, Austria), set for mice profile. 
 
10.4 RESULTS 
 
10.4.1 Air oxygen and other  gases  
Oxygen was maintained at a concentration of 20.9% throughout the trial in both 
systems with minor fluctuations, down to 20.6% two days before cage change 
(day 14) in both open cages and IVCs. 
Ammonia concentration was not detected in either system during the first 12 
days before change but increased up to 3 p.p.m in the IVC system and 5 p.p.m 
in the open cages during the last few days before cage cleaning. 
Carbon dioxide (CO2) on day 14 (day of cage change) was 0.067 % and 0.037% 
respectively in both IVCs and open cages. 
 
10.4.2 Body Weight ,  Feed and Water  intake 
Mean body weight of mice in the two groups were comparable and respectively: 
in IVC 26.77±0.68; in open 27.01±0.45 group (95% C.I of difference -1.154 to 
1.639; two-tailed Student’s t test, t=0.357; DF=26; p=0,723). 
The mean food intake during the last two weeks of the trial was 3.68 g (±0.21) 
and 3.54 g (±0.18) respectively in IVCs and open cages. 
Daily water intake was 4.21 g (±0.1) and 4.43 g (±0.18) respectively in IVCs and 
open cages. 
  
10.4.3 Temperature  and Relat ive  humidi ty  
All cages with 4 mice were equipped with a Data Logger. An additional Data 
Logger was positioned on top of the rack to record temperature and Relative 
Humidity in the room. One IVC cage had a mean value of RH outside the 
acceptable field of variation 40 to 70% (Table 1). 
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      IVC GM500 Open GM500 
P 
values* 
total n 
 
14 14 
 Red Blood Cells (109/L) 9.08±0.25 9.08±0.11 P=0.991 
      Haemoglobin (g/dl) 
 
15.22±0,29 15.22±0.16 P=0.982 
      Haematocrit (%) 
 
40.82±0.82 40.26±0.42 P=0.551 
      Mean Cell Volume (FL) 44.71±0.24 44.5±0.20 P=0.505 
      Mean Cell Haemoglobin (pg) 16.67±0.14 16.82±0.14 P=0.445 
      Mean Cell Haemoglobin  37.15±0.25 37.73±0.31 P=0.469 
Concentration (g/dl) 
          RBC distribution width (%) 18.15±0.22 18.28±0.14 P=0.628 
Platelets (K/µL) 1481.9±210.8 1434.9±173.4 P=0.864 
* t-Student test, two-tailed probability 
 
  Table 1. Red Blood Cell (RBC) count and related RBC parameters from groups housed 
(4 and 2/ group) 
 
10.4.4 Hematology  
A preliminary statistical evaluation for differences between the means of RBC 
count and related parameters in mice housed at a density of 2 and 4 to a cage in 
their respective groups (IVC and open) was performed. Since no statistical 
significant difference between the means was detected it was decided to pool the 
results (14 mice from IVC vs 14 mice from open cages). Table 2, shows that no 
differences were detected between the mean values of the hematological 
parameters tested for the two housing systems. 
 
 
Temperature Relative humidity 
 
 Mean (SD) Mean (SD) 
Room  21.0 (0.1) 64.4 (2.9) 
Cage 1 IVC  22.9 (0.7) 68.3 (3.3) 
Cage 2 Open  22.9 (0.7) 64.7 (2.9) 
Cage 3 IVC  23.6 (0.6) 70.5 (4.3) 
Cage 4 Open  22.7 (0.7) 65.4 (2.9) 
Cage 5 IVC  22.9 (0.6) 75.4 (4.4) 
Cage 6 Open  21.5 (0.4) 67.0 (3.3) 
  
Table 2. Intra-cage and Room Temperature and Rel. Humidity were sampled by means of 
data loggers during the last 4 weeks of the trial every 30 minutes 
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10.5 DISCUSSION 
 
The trial was carried out in the area of Milano (Italy) located at a mean altitude 
of 122 m above sea level. It is important to note that IVCs pressurized 
environment is not capable of modifying the normobaric condition (760 mm 
Hg). The conditioning period of approximately 6 weeks is sufficient to 
determine the complete turn-over of RBC in mice7, 8, 9 which allows possible 
modifications due to altered environmental conditions to be expressed. In our 
trial the differences were found to be limited to an expected slightly higher 
relative humidity and temperature in IVCs vs Open cages and the room. Both 
RH and temperature can alter the reading of O2 concentration in air, 
nevertheless recording instruments are able to maintain a linear reading in a 
range of temperature that includes values close to 0 °C and up to 50°C.  
On the other hand, as the humidity in air increases, water vapor molecules 
displace O2 molecules causing the output of the sensor to decrease. Of course 
the effect is larger at higher temperatures because there is more water vapor in 
the air.  
Relative humidity in the test room was unfortunately constantly close to the 
upper acceptable limit stated by international guidelines/regulation (field of 
variation 45 to 65%) and was consequently unavoidable to find mean RH above 
65% in the cages.  
During the last two days before the cage change (procedural interval was 14 
days), RH in some IVCs was definitely different and higher than in room and 
open cages. This might have played a minor role in the minor fluctuations of 
O2 concentration detected in that very short phase.  
However, no significant differences in mean Red Blood Cell (RBC) count and 
related RBC parameters, body weight, feed and water consumption were seen 
between mice from the two systems (ventilated and open) confirming that the 
concentration of O2 in the cages of both groups was comparable and optimal for 
the physiological process of hematopoiesis. Differences in the design and 
performance of IVCs, such as the number of Air Changes per Hour (75) and air 
delivery point is probably the key point for the interpretation of the differences 
between our results and those described in York et al.5 as an efficient turn-over 
of air in the cage makes its microenvironment similar to the outside macro 
environment, minimizing differences in the atmosphere and any impact on mice 
physiology. 
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10.1 ABSTRACT 
The environment in which a laboratory animal is housed can significantly 
influence its behavior and welfare, acting as a potential confounding factor for 
those studies in which it is utilized. This study investigated the impact of two 
Individually Ventilated Cage (IVC) housing systems on anxiety-related behavior 
and welfare indicators in two common strains of laboratory mice. Subjects were 
juvenile female C57BL/6J and BALB/c mice (N = 128) housed in groups of 
four in two different IVC systems for 7 weeks. System One had air delivery at 
the cage ‘cover’ level at 75 ACH (Air Changes/Hour) and System Two had air 
delivery at the ‘animal’ level at 50 ACH. 
Mice were assessed twice a week (e.g. bodyweight) or at the end of the study (e.g. 
anxiety tests). Our results showed significant differences in anxiety-related 
behavior between strains and housing systems. Mice in System Two, regardless 
of strain, defecated more in the Elevated plus Maze (EPM), spent less time in 
the open arms of the EPM, and less time in the central zone of the Open Field 
(OF). Strain differences in anxiety-like behavior were seen in the increased 
defecation by BALB/c mice in the OF and EPM and less time spent in the open 
arms of the EPM compared to C57BL/6J mice. These results suggest that 
different IVC housing systems can influence mouse behavior in different ways, 
with mice of both strains studied exhibiting more anxiety-related behavior when 
housed in System Two (air entry at the ‘animal’ level at 50 ACH), which could 
impact upon experimental data. 
 
Keywords: IVC systems, Rodent housing, Anxiety-related behavior 
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10.2 INTRODUCTION 
 
The housing environment of laboratory animals has been demonstrated to have 
a significant influence on the behavior, physiology, pathology and brain 
development of the animals housed within [1–5], thereby potentially impacting 
upon the comparability and reproducibility of the data generated [6,7].  
It is therefore important to identify what impact different aspects of the housing 
environment (e.g. stocking density, internal cage complexity) can have in order 
to be able to maximize both the welfare of the animals used in scientific studies 
(in accordance to European and International legislation) and ensure scientific 
rigor. Such an approach also allows modulating environmental factors, once 
identified, to be taken into consideration during experimental design and 
subsequent statistical analysis [8]. One important aspect of the housing 
environment is the design of the cage itself, and the manner in which it is 
managed. Traditionally, ‘open’ (conventional) cages have been used that are 
ventilated by the room ventilation system in which they are located. Open cages 
risk exposure of the animals to microorganisms present in the room and an 
increased exposure to potential allergens for human workers within the same 
environment. 
For this reason, and to maintain adequate ventilation, low relative humidity and 
reduced concentrations of ammonia and CO2 [9, 10] in the cages, Individually 
Ventilated Cage (IVC) systems have been developed that aim to ameliorate these 
problems. It has been suggested that providing a more stable and protected 
environment is beneficial to the animals and the personnel working in the animal 
rooms [11]. Consequently, the use of IVC systems has proliferated. However, 
the design of these systems – although sharing similar features – can vary 
markedly in a number of ways (e.g. ventilation rates, internal air pressure, and 
location of air delivery), and so it cannot be assumed that different IVC systems 
will influence laboratory animals in the same way.  
Yet, although there is so much variation between different IVC systems, little is 
known as to what impact these design differences can have on the animals and 
the data that is generated from them. 
Forced ventilation, noise and vibrations could potentially constitute chronic 
stressors for animals housed within IVC systems – and are often used to induce 
major changes in behavior and neurobiology [12–16] – and these are among the 
factors that typically vary between IVC systems. Previous studies have 
demonstrated that, when given the choice, mice avoided high ventilation rates 
and preferred air delivery in the cover of the cage rather than at the level of the 
animal [10], although see [17], indicating potential aversion for different factors 
within the IVC environment.  
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However, when assessing animal welfare –when the aim is to limit an animal's 
exposure to negative states such as anxiety – we need to consider not only the 
animal's choice and preference, but also its general behavioral and physiological 
response to the experience of a particular environment [18–20], what is known 
as an ‘indicator’ approach. 
This is because, whilst it is a valuable technique, preference/choice can be 
influenced by many factors, including: previous experience [21]; the balance 
between short and long-term preferences [22]; the influence of stress and 
affective state [23]; and animals making errors [24]. An indicator approach has 
previously been used to compare the impact of different IVC systems in 
comparison to conventional cages on anxiety-related behavior in mice [6,25], 
with the authors finding that mice housed in IVCs exhibited reduced activity and 
increased anxiety related behavior compared to those housed in conventional 
cages. However, Kallnik et al. [6] carried out their study on singly housed mice. 
Given that recommendations (e.g. Directive 2010/63/EU; Guide for the care 
and use of Laboratory Animals, U.S. National Research Council (Eighth 
Edition)) are for the group housing of laboratory mice, it is important to 
determine if a similar impact is found when mice are housed in groups — 
particularly given that there can be a degree of resilience against stress provided 
by the presence of conspecifics [26]. 
It is also important– given the great variation in design features between 
different IVC systems – to see whether an indicator approach can identify 
differences between types of IVC housing system, and few studies have 
investigated this issue. Champy et al. [27] studied the influence of three different 
IVC systems (M.I.C.E.® (Animal Care System), SealSafe® Plus (Tecniplast) and 
Innocage® (Innovive Inc.)) on mouse phenotypes, and found that there was 
little difference between these particular IVC systems on any of the parameters 
that they recorded, including anxiety-related behavior. An important 
consideration when investigating the impact of different IVC systems on 
laboratory rodent behavior is the potential influence of strain. Kallnik et al. [6] 
found that IVC housing (IVC Classic) influenced mouse behavior generally (i.e. 
having the same effect on more than one strain), reducing activity and enhancing 
anxiety related behavior, as well as acting in a strain-specific manner (i.e. having 
differential effects on strains), with increased acoustic startle response observed 
in C3HeB/FeJ, but not C57BL/6J, mice.  
In contrast, Mineur and Crusio [25] found only strain-specific effects. For this 
reason, we included two different mouse strains within our study in order to 
reveal, to at least some extent, any differential effect of housing conditions on 
the behavior of different strains of laboratory mouse.  
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We used C57BL/6J and BALB/c as strains that are typically used within 
laboratory settings [28] and show contrasting levels of anxiety related behavior 
[29]. 
The aim of this study was therefore to investigate the impact of two different 
IVC housing systems on the anxiety-related behavior and welfare of two strains 
of laboratory mouse using a variety of behavioral and physiological indicators as 
recommended when defining and implementing protocols for the welfare 
assessment of laboratory animals [30]. 
 
10.3 MATERIAL AND METHODS 
10.3.1 Subje c t s  and hous ing 
The subjects were 128 juveniles (6–7 weeks of age) female laboratory naïve mice 
of two commonly used, but behaviorally contrasting [31, 32], strains (C57BL/6J 
and BALB/c) obtained from a single external supplier (Charles River, Calco, 
Italy). Mice were individually identified (ear tags) as part of normal facility 
procedure, allowing us to record individual (e.g. injury/wounds) as well as group 
(e.g. position within the cage) measures. They were housed (random allocation) 
in groups of four individuals (same strain) in two types of IVC system. The IVCs 
differed in specific ways (see ‘Housing systems’), but were all provisioned with 
the same bedding material (hard wood shavings) and ad libitum food (Global 
Diet 2018S, Harlan Italy, S. Pietro al Natisone, Italy) and water. The mice were 
kept in the same room within a Specific Pathogen-Free animal facility with a 
regular 12:12 h light/dark cycle (lights on 07:00 a.m.), at a constant room 
temperature of 22 ± 2 °C, and relative humidity approximately 55 ± 10%.  
All cages were changed every 14 days after the first week, and inspected daily. At 
the end of the study all mice were euthanized by exposure to CO2 according to 
institutional protocol. 
Procedures involving animals and their care were conducted in conformity with 
the institutional guidelines at the Mario Negri Institute in compliance with 
national (Decreto Legge nr 116/92, Gazzetta Ufficiale, supplement 40, February 
18, 1992; Circolare nr 8, Gazzetta Ufficiale, July 14, 1994) and international laws 
and policies (EEC Council Directive86/609, OJL 358, 1, Dec. 12, 1987; Guide 
for the Care and Use of Laboratory Animals, U.S. National Research Council 
(Eighth Edition) 2011). 
 
10.3.2 Housing sys t ems 
In this design we compared two IVC systems (SealSafe® Plus (Techniplast) and 
Allentown) that differed in their air supply delivery systems: (System One) air 
delivery at the cage ‘cover’ level; (System Two) air delivery at the ‘animal’ level. 
The air supply ventilation rate also varied as both systems were operated 
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according to the manufacturer's specification, with 75 ACH for System One 
(cover level) and 50 ACH for System Two (animal-level).  
The two housing systems also differed slightly in size (System One: floor space 
501 cm2, height 17 cm, height without cover 13.5 cm, height of air delivery from 
the cage floor 16.5 cm; System Two: floor space 530 cm2, height 17.8 cm, height 
without cover 13.5 cm, height of air delivery from the cage floor 7.2 cm) and 
factors including the position of the food hopper, with the food hopper for 
System One at the back of the cage and the food hopper for System Two at the 
front. This degree of variation between systems meant that, although we could 
not identify which specific factor (i.e. air supply delivery or air supply rate or 
both) resulted in any observed differences in mouse anxiety-related behavior and 
welfare, this ‘systems approach’ would allow us to determine if there were any 
overall differences between the two housing systems, making the results directly 
transferable and highly relevant to researchers. 
If any system differences were identified, then these could be investigated in 
more detail in further studies. We observed eight cages (n = 8) for each of the 
housing systems (N = 16), but as two mouse strains were being studied this gave 
a total of 128 mice (N = 32 cages in total). 
 
10.3.3 Exper imenta l  pro toco l  
Cages from the two systems were balanced between racks (e.g. the same number 
from each system on each rack) and all cages were placed in the middle row of 
the racks in order to take into account any potential influence of rack location 
and position-within-rack on mouse behavior. Measurements were collected over 
a seven-week period, with the first week of the study allowing the mice to 
acclimatize prior to the start of the six-week experimental phase, although some 
measures were collected for all 7 weeks. The study was split across 2 weeks 
(balanced for strain/system), thus reducing the number of animals to be tested at 
the end of the study. 
Behavioral observations took place between 09.00 and 12.00 h. For those 
measures that were repeatable (e.g. bodyweight), data were collected twice a 
week, however, open field and elevated plus-maze tests only took place at the 
end of the study. This allowed us to identify both short and longer-term 
responses to the housing systems, and this was also reflected in the choice of 
behavior and anxiety-related indicators utilized. 
 
7.4 Measures  o f  g enera l  behavior  and anxie ty -re la ted behavior  
Whilst we selected measures that we believed would reveal underlying 
differences in behavior and anxiety (both short and longer-term), we particularly 
focused on those measures that could be simply, quickly and reliably recorded by 
staff (e.g. vets, technicians) to maximize the applicability of our results. 
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Our measures therefore focused either on indirect recording of behavior (e.g. 
injury scores as a reflection of aggression), ‘challenge’ tests that took place 
outside of the home cage (e.g. tests of anxiety-related behavior) or unambiguous 
behavioral observations (e.g. location of mice within the cage). 
 
 
10.4.1 Indire c t  behaviora l  and phys i ca l  measures  
These measures included: injury/wound scores [present/absent, in three zones: 
head zone; middle zone; and tail zone]; barbering (body hair removal) score 
[present/absent, in three zones: head zone; middle zone; and tail zone]; whisker-
trimming (whisker area only) score [present/absent]; bedding pushing (i.e. is the 
bedding covering the air delivery pipe in System Two or equivalent height in 
System One) score (score 0 (no bedding covering the air delivery pipe or 
equivalent eight); 1 (bedding partially covering air delivery pipe or equivalent 
height); 2 (bedding completely covering air delivery pipe or equivalent eight); 
bodyweight (g); water utilization (ml); food utilization (g). 
These observations were made twice a week (Monday and Friday) for every 
individual in each cage (e.g. injury/wound score) or each cage (e.g. water 
utilization). Bodyweight was also recorded at the end of the study prior to 
euthanasia. Observations were alternated between cages from the two different 
housing systems. 
 
10.4.2 Within-cage  behavior  
Twice a week (0900–1200), the number of mice in the front half of the cage was 
recorded for every cage in order to give a quick and unambiguous indication of 
animal location (i.e. possible values ranged from 0 to 4 animals), with a mouse 
judged as being in one half of the cage when the majority of the animal's body 
was in a particular half. In the unlikely event of an animal being 50% in each half 
of the cage, it was counted as being in whichever side its head was positioned. 
Observations were alternated between cages from the two different housing 
systems. 
 
10.4.3 Tes ts  o f  anxie ty-re la ted behavior  
Testing (Open Field (OF), Elevated Plus Maze (EPM)) took place at the same 
time (approx. 1000–1300) in two different rooms from where the animals were 
housed, under dim illumination provided by a 60 W lamp placed 1 m above the 
apparatus and pointed towards the ceiling.  
For both tests, mice were counted as being in a particular zone/location when all 
four of its legs were positioned within the zone [33], and the apparatus was 
wiped with 70% ethanol and dried prior to each test. The order in which animals 
were tested was alternated between cage systems.  
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Two mice from each cage were tested in the OF, and the other two tested in the 
EPM. An average from the pairs of mice was calculated to provide a cage 
average for both tests. The OF was a grey Perspex box (40 × 40 × 40 cm) with 
the floor divided into 25 (8 × 8 cm) squares. Mice were placed in the same 
corner as a ‘starting point’ and their behavior video-recorded for 5 min. The 
number of internal (the nine central squares) and external (the sixteen peripheral 
squares) squares crossed, the time spent in the central area of the open field (the 
nine central squares), the number of rears, duration of self-grooming, and the 
number of faecal boli were scored from video by experienced researchers ‘blind’ 
to the housing system as measures of general activity and anxiety-related 
behavior. 
The EPM was made of black Perspex with two open arms (30 × 5 cm) and two 
closed arms (30 × 5 cm) extending from a central platform (5 × 5 cm) raised 40 
cm above the floor. The closed arms had 25 cm walls and the open arms had 0.5 
cm raised lips along the edges. At the beginning of each test mice were placed on 
the central platform facing an open arm and their behavior video-recorded for 5 
min. The number of entries and the time spent in the open and closed arms, the 
number of rears, the duration of self-grooming, the number of faecal boli 
excreted were scored from video by experienced researchers ‘blind’ to the 
housing system as measures of anxiety-related behavior. 
 
10.4.4 Faeca l  cor t i cos t erone 
Faecal boli (ten per cage, to get at least the 0.05 g faecal matter required for 
assay) were collected immediately after the tests of anxiety related behavior (i.e. 
at the end of the study). The boli were stored (labelled Eppendorf, frozen -20 
°C) before subsequent analysis by enzyme immunoassay (EIA) to determine the 
levels of faecal corticosterone metabolites (EIA Kit: ADI-Nr 901-097 Enzo Life 
Sciences) in accordance with the manufacturer's instructions. 
 
10.5 Data analys i s  
This was a between-subjects design, such that mice were only exposed to one of 
the two treatment groups/housing systems. Because individual mice within a 
cage were non-independent, we used ‘cage’ as our experimental unit, with data 
collected for all four mice within each cage and their data combined to give a 
cage average.  
Consequently, our sample size was n = 8 cages per system/strain (N = 32 cages). 
Data conformed to parametric statistical requirements (e.g. normality of data). 
For those measures collected on more than one occasion, we used repeated 
measures General Linear Model (GLM) with Housing System (System One, 
System Two) and Strain (C57BL/6J and BALB/c) as between-subjects’ factors 
and Time as a within-subjects factor.  
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For those measures (e.g. tests of anxiety-related behavior) collected at only one-
time point, we used a two-way ANOVA (Housing System/Strain). The statistical 
package used was SPSS (version 19). Only statistically significant results are 
presented in full. If significant interactions were found, then related main factor 
results are not presented. 
 
10.6 RESULTS 
 
10.6.1 INDIRECT BEHAVIOR AND PHYSICAL MEASURES 
 
10.6.1.2 Bodyweight  
There was no significant difference between housing systems (F1, 28 = 0.411, P = 
0.527). There was a statistically significant Strain ∗ Time interaction (F14, 392 = 9.8, 
P <0.001) which revealed that for days 0, 4 and 7 the C57BL/6J mice were 
initially heavier than the BALB/c mice, but that this changed over time, with the 
BALB/c mice becoming heavier than the C57BL/6J mice for days 18, 21 and25 
during the mid-point of the study, but no difference between strains by the end 
of the study. The growth rate of both mouse strains was comparable to figures 
provided by the supplier (Charles River) (data not shown). 
 
10.6.1.3 Food ut i l izat ion 
It should be noted that ‘food utilization’ was calculated as change in total food 
weight (g) and therefore incorporates food removed/lost from the hopper but 
not necessarily ingested. There was a Time ∗ System interaction (F6, 168 = 4.7, P 
<0.001) showing that in week 1, mice, regardless of strain, utilized more food 
when housed in System Two compared to System One (see Fig. 1). There was 
also a significant Time ∗ Strain interaction (F6, 168 = 8.9, P <0.001) revealing that 
for weeks 1 and 3–7 C57BL/6J mice utilized more food than the BALB/c mice. 
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Figure 1. Food utilization (g) over time (weeks) for System One and System Two, for each mouse 
strain separately. Data are means ± standard error.  
 
10.6.1.4 Water  ut i l izat ion 
It should be noted that ‘water utilization’ was calculated as the change in total 
water volume (ml) and therefore incorporates water removed/lost (e.g. via 
evaporation) from the water bottle but not necessarily ingested.  
There was a System effect (F1, 28 = 10.9, P = 0.03), indicating that, regardless of 
strain and time, mice utilized more water in System Two compared to System 
One (see Fig. 2). There was also a Strain effect (F1, 28= 143.1, P <0.001), with 
C57BL/6J mice utilizing more water than the BALB/c mice.  
Finally, there was an effect of Time (F1, 28 = 36.7, P b 0.001), showing that the 
mice (regardless of strain and housing type) utilized water significantly more in 
week 1, then this dropped to a lower level before gradually increasing over time. 
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There were no significant interaction effects (System ∗ Strain: F1, 28= 0.03, P= 
0.865; System ∗ Time: F6, 168 = 0.753, P = 0.608; Strain ∗ Time: F6, 168 = 0.785, P= 
0.583; System ∗ Strain ∗ Time: F6, 168 = 1.49, P= 0.184). In order to identify any 
potential differences between housing systems in their background water 
evaporation rate (e.g. due to differences in ACH), we compared water loss in 
four cages of both housing systems over a period of 1 week in the absence of 
mice. We found no difference in water loss (F1, 6 = 0.844, P = 0.394) between 
the housing systems. 
 
Figure 2. Water utilization (ml) over time (weeks) for System One and System Two, for each mouse 
strain separately. Data are means ± standard error.  
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10.6.1.4 In jury/wound scores   
No injuries/wounds were recorded for any individual mouse of either 
strain/housing system.  
 
10.6.1.5 Bedding pushing s core   
There was a System effect (F1, 28 = 5.3, P = 0.029), with mice, regardless of strain 
or time, having higher bedding pushing scores when housed in System Two 
compared to System One. There was a Time effect (F13, 364 = 4.2, P <0.001), with 
a general increase in bedding pushing score over time. There was also a Strain 
effect (F1, 28 = 20.3, P b 0.001), with BALB/c mice having higher bedding 
pushing scores than C57BL/6J mice (see Fig. 3). There were no significant 
interactions (System ∗ Strain: F1, 28 = 0.012, P = 0.913; System ∗ Time: F13, 364 = 
1.298, P = 0.211; Strain ∗ Time: F13, 364 = 1.29, P = 0.216; System ∗ Strain ∗ 
Time: F6, 168 = 0.439, P = 0.955).  
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Figure 3. Bedding pushing scores over time (weeks) for System One and System Two, for each mouse 
strain separately. Data are means ± standard error. 
 
10.6.1.6 Barber ing  
Because barbering, once observed in an individual mouse, continued for the 
remainder of the study, data were only analyzed for the final week of the 
experiment. There was no System effect (F1, 28 = 1.201, P = 0.282). There was a 
Strain effect (F1, 28 = 4.8, P = 0.037), with C57BL/6J mice showing higher scores 
for barbering compared to BALB/c mice.  
 
10.6.1.7 Whisker  t r imming  
As for barbering, whisker trimming was only analyzed for the final week of the 
experiment. We found no statistically significant differences either between 
Systems (F1, 28 = 1.697, P = 0.203) or Strain (F1, 28 = 0.424, P = 0.52).  
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10.6.2 WITHIN-CAGE BEHAVIOR 
 
10.6.2.1 Pos i t ion o f  mice  in  the  cage 
There was a Strain ∗ System interaction (F1, 28 = 8.6, P = 0.007), with both 
BALB/c and C57BL/6J mice having greater numbers of individuals in the front 
half of the cage when housed in System Two compared to the System One. 
There was a Time ∗ System interaction (F13, 364 = 2.3, P= 0.006), with all days 
except days 39 and 42 showing significantly more individuals in the front half of 
the cage for those mice housed in System Two compared to System One. 
 
10.6.2.2 Open f i e ld  
There was a strain effect (F1, 28 = 60.2, P <0.001), with BALB/c mice producing 
more droppings than C57BL/6J mice. For ‘internal’ crossing frequency (INT to 
INT and EXT to INT) there was a Strain ∗ System effect (F1, 28 = 7.7, P = 0.01), 
with C57BL/6Jmice showing higher levels of internal crossing when housed in 
System One compared to System Two, and BALB/c mice showing no 
difference between housing systems.  
For ‘external’ crossing frequency (EXT to EXT and INT to EXT) there was a 
Strain effect (F1, 28 = 76, P <0.001), with C57BL/6J mice crossing more than 
BALB/c mice. Regardless of strain, mice housed in System One spent more 
time in the internal/central zone than those housed in System Two (F1, 28 = 6.2, 
P = 0.019). C57BL/6J mice also spent more time in the internal/central zone 
than BALB/c mice (F1, 28 = 4.9, P = 0.035) (see Fig. 4). C57BL/6Jmice were 
observed to rear more often than BALB/c mice (F1, 28 = 39.6,P <0.001) and for 
longer (F1, 28 = 12.4, P = 0.001). There was a System effect on grooming 
duration (F1, 28 = 8.2, P = 0.008) with mice housed in the System Two spending 
more time grooming than those housed in the System One. Although there were 
no strain differences in the frequency of grooming, C57BL/6J mice spent more 
time grooming than the BALB/c mice (F1, 28 = 10.3, P = 0.003). 
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Figure 4. Time spent (s) in the central/internal zone of the OF for System One and System Two, for 
each mouse strain separately. Data are means ± standard error. 
 
 
10.6.2.3 Elevated p lus  maze 
There was a System effect (F1, 28 = 12.2, P = 0.002), with mice housed in System 
Two producing more droppings in the EPM than those housed in System One. 
There was also a strain effect (F1, 28 = 19.6, P <0.001), with BALB/c mice 
producing more droppings that C57BL/6J mice. We found that mice housed in 
the System One spent more time in the open arm of the EPM than those housed 
in System Two (F1, 28 = 18.5, P <0.001) (see Fig. 5).  
There was also as strain effect, with C57BL/6J mice spending more time in the 
open (F1, 28 = 17.2, P <0.001) and closed arms (F1, 28 = 10.4, P = 0.003) than 
BALB/c mice, as well as moving more often into the open (F1, 28 = 44, P <0.001) 
and closed (F1, 28 = 29.4, P <0.001) arms. There was a Systems effect on time 
spent in the center of the EPM (F1, 28 = 13.6, P = 0.001), with mice housed in 
System Two spending more time in the center than those housed in System One. 
There was also a strain effect, with BALB/c mice spending more time in the 
center of the EPM compared to C57BL/6J mice (F1, 28 = 34, P <0.001). 
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Figure 5. Time spent (s) in the open arm of the EPM for System One and System Two, for each 
mouse strain separately. Data are means ± standard error. 
 
10.7 Faeca l  cor t i cos t erone 
We found no significant differences in the level of faecal corticosterone 
metabolites between the housing systems (F1, 43 = 0.034, P = 0.854), strains (F1, 43 
= 0.538, P = 0.467), or any interaction (F1, 43 = 0.009, P = 0.926) (see Fig. 6). 
 
 
Figure 6. Faecal corticosterone metabolite levels (pg/mg) for System One and System Two for each 
mouse strain separately. Data are means ± standard error. 
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10.8 DISCUSSION 
 
From the results it appeared that IVC housing System Two (with air delivery at 
the ‘animal’ level at 50 ACH) was more anxiety-inducing than IVC housing 
System One, with air delivery at the ‘cover’ level (and at 75 ACH), for mice of 
both strains (BALB/c, C57BL/6J). This was based upon observed differences in 
anxiety-related behavior shown by both strains of mouse housed in System Two 
compared to those housed in System One.  
In particular, the increase in defecation in the EPM, the decreased time spent in 
the open arm of the EPM, and the increased time spent in the starting position 
in the EPM for mice housed in System Two. Similar results were found in the 
OF test, with mice housed in System Two spending less time in the 
central/internal zone of the arena, suggesting reduced confidence compared to 
those mice housed in System One. These findings reflect those of Kallnik et al. 
[6] and Mineur and Crusio [25] who observed reduced activity and enhanced 
anxiety related behavior in mice housed in IVC systems compared to 
‘conventional’ housing, and extends this finding to group housed mice when 
housed in two different types of IVC housing system. Thus, not only does it 
appear that some IVC housing systems can increase anxiety, as determined by 
anxiety-related behavior, compared to conventional systems [6,25], but there also 
appear to be significant differences between IVC systems in their influence on 
mouse behavior and anxiety; including when group-housed.  
In contrast to our findings, however, Champy et al. [27] found little effect of the 
three different IVC systems that they compared on any of the parameters that 
they recorded — including anxiety-related behavior in the open field test. The 
three IVC systems that they compared were IVCM.I.C.E. ® (Animal Care 
System), IVC SealSafe® Plus (Tecniplast), and Innocage® (Innovive Inc.).  
These particular IVC systems differ in a great number of features, including 
shape of cage, and construction material, as well as aspects of ventilation (e.g. air 
flow rate and pressure). It is therefore perhaps surprising that they did not 
appear to observe any difference in anxiety-related behavior between the 
systems. However, one possibility is that because their mice were anxiety tested 
after 2 weeks of acclimatization, this may not have been sufficient time to induce 
differential levels of emotionality as compared to the 7 weeks prior to the testing 
of anxiety-related behavior in our study.  
Although changes to the housing environment can result in immediate 
behavioral changes, influences on affective state may take longer to establish. 
For example, changes in anxiety-like behavior in mice were observed after 6 
weeks of environmental enrichment [34]. 
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When assessing animal preference in IVC systems, Baumans et al. [10] found 
that mice avoided high ventilation rates and preferred air supply access in the 
cover of the cage rather than at the level of the animal, demonstrating that mice 
actively choose between IVC housing systems that vary in particular features. 
Our results indicate that IVC systems that vary in these same features also 
appear to influence anxiety-related behavior (in the absence of choice). Taken 
together, the findings from these two approaches suggest a reduction in welfare 
in mice housed in animal level ventilation systems.  
Interestingly, if, as determined by Baumans et al. [10], mice prefer air entry from 
the ‘cover’ level and low ventilation rates, then our data suggest that air entry 
level may be a significant feature in mouse choice, given that our mice exhibited 
least anxiety-related behavior when housed in cages with air entry at the cover 
level (preferred) despite also having higher ventilation rates (avoided).  
This appears to reflect the findings of Krohn and Hansen [17] who found that it 
was the presence of draughts that influenced mouse choice rather than the 
number of air changes per se. Clearly, further research is needed to disentangle 
these features. Grooming within the OF can be considered a sign of anxiety-
related behavior (e.g. as a displacement activity) and this was higher in the mice 
housed in System Two. However, although the strain effects observed in the OF 
typically followed the general pattern of Balb/c mice exhibiting more anxiety-
related behavior than C57BL/6jmice (see later), grooming behavior was an 
exception to this, with C57BL/6j mice grooming for longer than Balb/c mice. 
The interpretation of grooming behavior can vary, because it increases in the 
contrasting contexts of both stress and comfort, as well as between strains [35]. 
Consequently, data relating to position within the OF (and EPM) may be more 
reliable indicators of putative anxiety level. 
Strain differences mainly reflected the increased anxiety-like behavior of 
BALB/c compared to C57BL/6J mice, with BALB/c mice showing increased 
defecation in both OF and EPM, less time in the open arms of the EPM and less 
time in the internal/central zone of the OF. We also observed that BALB/c 
mice were reluctant to leave the starting point of the EPM. These results reflect 
the general finding in the research literature that BALB/c mice show more 
anxiety-like behavior thanC57BL/6J mice [29, 36].  
We did, however, observe higher levels of barbering in the C57BL/6J mice, 
which reflects epidemiological research revealing that C57BL/6J mice were likely 
to exhibit barbering behavior [37] — suggesting a potential dissociation between 
barbering behavior and putative anxiety level. 
The confirmation in our own study of the predicted differences in strain-related 
emotionality thus strengthens our results concerning the observed anxiety-
related differences between the housing systems.  
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Although the majority of results followed a pattern of independent effects of 
both strain and housing system, we did also observe some interactions between 
these factors (e.g. internal crossing in the OF. Thus, along with Kallnik et al. [6], 
but in contrast to Mineur and Crusio [25], we found both general and strain-
specific effects of IVC housing system on mouse anxiety-like behavior. In 
addition, it is perhaps worth emphasizing the importance of selecting the 
appropriate strain when investigating the impact of the housing environment.  
In order to show a behavioral change in response to a particular housing 
environment, animals need to be at a level that allows for potential change. For 
example, BALB/c mice may not have shown the same reduction in frequency of 
‘internal crossing’ in the OF as C57BL/6J mice when housed in System Two, 
because they were already at a low level of activity and could therefore not go 
any lower. Mouse position within a cage can be influenced by a variety of factors 
Including activity levels, food hopper position, and the level of light/disturbance 
and/or refuge location [38].  
Behavior within the cages appeared to back up the findings from the tests of 
anxiety-related behavior, that System Two resulted in increased anxiety-like 
behavior, because mice housed in System Two were more frequently found in 
The front half of the cage — away from the position of air entry. This could 
suggest that the mice in System Two were avoiding the area of the cage where air 
entered – despite this resulting in them having to spend more time in the front 
of the cage – an observation that would reflect mouse avoidance of aversive 
stimuli/environments [39]. However, position in the cage could also have been 
influenced by differences in cage design between the two housing systems (e.g. 
location of food hopper) and so has to be interpreted with caution.  
In System One the food hopper was located at the back of the cage, whilst for 
System Two the food hopper was at the front of the cage — the opposite end to 
the air delivery. This could explain the observed increase in time spent at the 
front of the cage in System Two — although our observations were in the light 
period when mice would typically be inactive rather than feeding. Mice were also 
found to have higher ‘bedding pushing’ scores in System Two, a finding that 
may have reflected attempts to cover the point of air entry — a potential 
response to what may be considered an aversive stimulus as seen in the 
‘defensive burying’ paradigm [40]. 
Mice in IVC systems have previously been observed to build higher walled nests 
that may act to protect them against draughts [10]. Evidence that this behavior 
might be related to an anxiety-like state is suggested by the fact that we also 
observed a strain effect on ‘bedding pushing’, with BALB/c mice doing more 
bedding pushing than C57BL/6J mice in both IVC systems, potentially reflecting 
commonly found differences in anxiety-like behavior between these two strains 
[29]. 
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There was also a potentially interesting result in that mice housed in System Two 
utilized more water (as measured by water loss) than those housed in System 
One. This result could be explained by differences in ventilation rate between 
the two housing systems (System One: 75ACH; System Two: 50 ACH).  
However, as we found no differences in evaporation rate between the two 
Systems when they did not contain mice, this result suggests that the difference 
in water loss was due to the activity of the mice — although consumption may 
not be the only factor involved. Other authors have interpreted similar increases 
in apparent drinking behavior as indicating prolonged stress, i.e. polydipsia [41, 
42], which would reflect the higher levels of anxiety-related behavior that we 
observed for mice housed in System Two. We observed an unexpected 
difference between housing systems in food utilization in the first week of the 
study. The overall high level of food utilization during the first week (compared 
to week 2) after arrivals typical for the period of initial acclimatization to the 
laboratory environment following the stress of transport [43].  
However, it is not immediately clear why there might have been a difference 
during this period between the two systems — one possibility being that the 
previously discussed differences in food hopper location/food acquisition may 
have required more familiarization due to initial novelty for those animals in 
System One (that fed less). 
Perhaps surprisingly, we did not observe a difference in the level of faecal 
corticosterone metabolites for those mice housed in System Two compared to 
System One. Other studies have demonstrated significant changes in faecal 
corticosterone metabolite levels as a consequence of changes to the housing 
environment (e.g. from14 to 70 days after environmental enrichment: [44]; 
following removal of individuals: [18]; following single housing: [45]). However, 
Gurfein et al. [44] also assessed the impact of environmental enrichment on 
anxiety behavior in the EPM, but found no significant effects — thereby 
demonstrating that expected correlations between different measures of stress 
and welfare may not always be revealed [46]. 
In conclusion, it appears that for the two strains of laboratory mice observed in 
this study, being housed in System Two (air entry at the ‘animal’ level at 50 
ACH) resulted in more behavioral indicators of anxiety than being housed in 
System One (air entry at the ‘cover ‘level at 75 ACH). This provides further 
evidence that changes in the housing environment – even between two different 
types of IVC housing system– have the potential to impact upon anxiety-like 
behavior in mice and, as a consequence, the robustness and comparability of 
experimental data. This reflects the importance of taking such potential 
influences into consideration during experimental design and when interpreting 
and comparing results.  
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Specifically, it demonstrates that the term ‘IVC’ cannot be generalized across 
different IVC systems, but that variation between these systems may well have 
differential influences upon mouse behavior and research data. 
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